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Abstract
Papillomaviruses are small DNA viruses, which cause benign and malignant lesions in 
the  differentiated  epithelium  of  mammals  and  birds.  A  small  subset  of  human 
papillomaviruses  (HPV’s),  have  been  identified  as  the  etiological  agent  of cervical 
cancer, with HPV 16 being found in over half of all cases. The HPV 16 E1A E4 protein 
is expressed late in the virus lifecycle. The protein can induce cell cycle arrest through 
an  interaction  with  CyclinB/Cdk,  and  this  is  thought  to  facilitate  viral  genome 
amplification.  E1A E4  can  also  associate  with  the  cytokeratin  network  leading  to  its 
collapse, although this function is poorly understood.
The  work  described  in  this  thesis  shows  that  ElA E4s  ability  to  bind  to  keratins  is 
conserved  amongst  different  members  of the  a  HPV  group,  and  to  a  lesser  extent 
amongst  members  of the  more  distantly  related  y-group.  When  expressed  in  SiHa 
cervical  epithelial  cells,  16  E1A E4  induced  the  collapse  of  affected  keratin  8/18 
network, and lead to the formation of Mallory body-like structures.  Western blotting 
and immuno-precipitation revealed that the ElA E4/keratin association results in keratin 
phosphorylation  and  ubiquitination.  16  E1A E4  increases  in  abundance  towards  the 
epithelial  surface,  and coincides with keratin disruption in the upper epithelial  layers. 
Immuno-fluorescence and biochemical  analysis of HPV  2 and  16 lesions  support the 
idea that keratin phosphorylation and ubiquitination may also occur in vivo. An effect of 
16  E1A E4  on  keratin  dynamics  was  apparent  when  YFP-16E1A E4  was  followed  in 
monolayer  cells  by  time-lapse  microscopy.  Although  filament  polymerisation  and 
migration  are  not necessarily  disrupted by  16  E1A E4,  it  appears that the progressive 
accumulation  of E1A E4  can  lead  to  filament  stabilization,  and  eventually  to  keratin 
network disruption.
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NIMR National Institute for Medical Research
NLS Nuclear localisation sequence
NZW New Zealand white
ORC Origin recognition complex
ori Origin of replication
PBS Phosphate buffered saline
PCNA Proliferating cell nuclear antigen
PCR Polymerase chain reaction
PEN Penicillin
PDGF Platelet-derived growth factor
PKA Protein kinase A
PML Promyelocytic leukaemia protein
PV Papillomavirus
QLM Quantitative laser module
RNA Ribonucleic acid
rAd Recombinant adenovirus
r.t. Room temperature
s e e Squamous cell carcinoma
SDS Sodium dodecyl sulphate
STREP Streptomycin
TAD Transactivation domain
TEMED N,N,N,N,-Tetramethylethylenediamine
TRAIL Tumour necrosis factor-related apoptosis-inducing ligand
TRIS Tris hydroxymethylaminomethane
URR Upstream regulatory region
UV Ultraviolet
VLP Virus-like particle
YFP Yellow fluorescent protein
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1  Introduction 
1.1  Viruses
1.1.1  Virus discovery
Viruses have been responsible for countless disease outbreaks thoughout human history. 
Epidemics  of smallpox  have  killed  countless  millions;  an  outbreak  of flu  ini918  is 
estimated to have killed 40 million people worldwide. The concept of a pathogen was 
first thought up back in 1880 when Robert Koch and Louis Pasteur published their now 
famous germ theory.  It wasn’t until  1892 that Pasteur identified the agent responsible 
for rabies which he referred to as a virus (Latin for poison) (reviewed in (Mendelsohn, 
2002).  A  few  years  later  in  1892,  Dmitri  Iwanowski  was  able  to  demonstrate  that 
extracts of diseased tobacco plants which passed through ceramic filterers smaller than 
any  known  bacteria,  were  able  to  transmit  disease.  The  magnitude  of Iwanowski’s 
discovery was not made clear until 1898 when Martinus Beijerinick referred to tobacco 
mosaic virus as contanium vivum fluidium (soluble living germs), so identifying viruses 
as a distinct new form of pathogen (Fields, 2001).
1.1.2  What is a virus?
Viruses  are  obligate  intracellular  parasites  and  lack  the  ability  to  replicate 
independently,  hence  are  not  considered  to  be  living  organisms.  A  virus  is  a 
microscopic particle that contains nucleic acid wrapped in a protein coat.  The nucleic 
acid can be single or double stranded RNA or DNA depending on the virus type. The 
protein  coat  is  typically  made  from  repeating  units  of proteins  which  assemble  into 
capsids. Viruses infect host cells where they unpackage their genetic material and hijack 
the cells transcriptional and translational machinery  in order to replicate and package 
more viral genomes which are released as new virions.
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1.1.3  Papillomaviruses
In 1907 it was discovered that common warts could be transmitted by cell free filtrates 
thus identifying the infectious agent as a virus (Ciuffo, 1907). Since then much has been 
learnt  about  papillomaviruses.  Papillomaviruses  consist  of  a  large  family  of  non­
enveloped double stranded DNA viruses, with genomes of approximately 8 kb in size. 
Papillomavirus  infections  have  been  found  in  a  wide  variety  of higher  vertebrates, 
causing benign and malignant lesions of the  epithelium (reviewed in (Doorbar, 2006; 
Laimins,  1996; Zur Hausen,  1996). Despite many variations, papillomaviruses all share 
a  few  key  similarities.  Papillomaviruses  are  highly  tissue  and  host  specific,  virus 
lifecycle completion requires differentiating epithelium,  viruses also  share a common 
genome organisation and protein expression sequence.
The  first  papillomavirus  to  be  identified  in  animals  was  the  cotton  tail  rabbit 
papillomavirus (CRPV) identified in  1933 (Shope,  1933).  Since then papillomaviruses 
have  been  identified  in  a  wide  variety  of animals  including  ungulates(Koller  et  a l, 
1971; Koller et al, 1972), cats, dogs (Chambers et a l, 1959) and cetaceans (Lambertsen 
et a l,  1987; Van  Bressem  et al,  1999a;  Van Bressem  et al,  1999b).  More  recently 
papilloma viruses have been identified in a few species of birds (O'Banion et al,  1992; 
Tachezy  et al,  2002).  To  date  over  100  human papillomaviruses  (HPVs)  have  been 
identified (reviewed in (de Villiers et al, 2004). Although papillomaviruses have been 
identified in a wide variety of animal PVs show a high degree of species specificity and 
lack  the  ability  to  complete  a  productive  life  cycle  when  cross  species  infections 
occasionally occur (Howley, 1996).
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1.1.4  Classification of papillomaviruses
Papillomaviruses were first classified according to the location and the pathology of the 
lesions  they  induced.  As  more  research  was  done  and  new  viruses  discovered, 
classification switched  to techniques based on the nucleotide sequence homology of the 
highly conserved genes El, E6 and LI  (Chan et al.,  1992; Chan et al.,  1995b).  Since 
then there have been several reworkings of the classification system (Villiers de, 2001). 
The  currents  classification  system  recognised  by  the  international  committee  on  the 
taxonomy of viruses states, that for papillomaviruses to be described as from the same 
genera they must share >60% identity in their LI  ORF. Isolates that are to be described 
as from the same species must share between 60-70 % LI  sequence homology. Isolates 
described  as  PV  types,  must  have  71-89  %  conservation  within  the  LI  sequence. 
Viruses with 2-10 % sequence variation can be called subtypes whereas isolates with LI 
sequence variations of less that 2 % can be defined as variants (de Villiers et al., 2004). 
For the current papillomaviridae phylogenetic tree see (Fig 1.1)
Phylogenetically  grouped  viruses  tend  to  share  evolutionary  related  hosts  (a 
papillomaviruses  infect  primates,  6  papillomaviruses  infect  ungulates).  The  current 
papilloma  taxonomy  does  however  have  its  limitations.  Phylogenetically  grouped 
viruses  can  have  very  divergent  characteristics  and  do  not  necessarily  share  tissue 
tropism, lesion morphology or risk of neoplastic progression.
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Figurel.lThe papillomavirus phylogenetic tree
Figure shows the current papillomaviridae phylogenetic tree and contains sequences of 
118 papillomavirus types.  LI  ORF sequences were analyzed and used to construct the 
tree.  The numbers at the ends of each branch identify an HPV type. C-numbers refer to 
candidate HPV types.  All other abbreviations refer to animal papillomavirus types.  The 
outer most semicircular symbols identify papillomavirus genera e.g  the genus alpha- 
papillomaviruses.  The numbers in the inner circles refer to papillomavirus species. 
Image taken from (de Villiers et al., 2004).
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1.1.5  Papillomavirus transmission
Productive  papillomavirus  lesions  shed  newly  formed  virions  into  the  environment. 
Unlike  blood  bom  viruses  such  as  HIV  which  degrade  within  minutes  in  hostile 
environments,  PV  virions  are  stable  for  prolonged  periods,  and  appear  resistant  to 
desiccation allowing them to remain infectious in hostile environments for substantial 
periods of time (Roden et al,  1997). Cutaneous lesions typically produce more virions 
than  mucosal  types.  HPV2  infection  which  causes  verrucas,  are  thought  to  be 
transmitted by contact with contaminated surfaces such as changing room floors.
In  contrast  to  cutaneous  subtypes,  some  mucosal  tropic  viruses  appear  to  produce 
smaller lesions with virions being shed into the mucosal secretions and spread by direct 
contact.  Epidemiological  studies  show  that  many  mucosal  viruses  are  passed  on  by 
sexual transmission (Sargent,  1992; Schiffman et al.,  1993). A number of studies have 
been  able  to  find  a  direct  correlation  between  the  prevalence  of infection  and  the 
number  of sexual  partners  (Frega  et  a l,  2003).  Some  genital  HPV  types  are  rarely 
detected  in  people  before  they  become  sexually  active  (a  fact  which  may  cause 
controversy when targeting a future HPV vaccine).
Genital contact can lead to infection of oral mucosa by anogenital tropic HPV’s (Panici 
et  a l,  1992).  Recent  studies  have  revealed  an  increase  in  the  prevalence  of  HPV- 
induced oral carcinomas that may be linked to changing sexual behaviour (Kreimer et 
a l, 2004).  In addition to this,  genital  infections can be passed from mother to child 
during  labour  causing  laryngeal  infections.  The  appearance  of genital  lesions  in non 
sexually active individuals suggests non-sexual transmission is also possible (Dunne et 
a l, 2005; Frega et a l, 2003; Handley et a l, 1993).Chapter 1 Introduction
Some  viruses  cause  large  lesions  which produce  a large  number  of virions,  and  can 
regress in a matter of months, which suggests a burst-like strategy of transmission. In 
contrast  many  sexually  transmitted  mucosal  viruses  cause  inapparent  infections  that 
persist for years.
1.1.6  Papillomavirus infection
Papillomaviruses are thought to infect mitotically active cells in the basal compartment 
of the epithelium with viruses gaining access to these cells through micro-wounds in the 
skin.  The  a6  integrin  receptor  has  been  proposed  as  a  candidate  for  virion  cell 
recognition  (Evander  et  a l,  1997).  Subsequent  studies  have  revealed  that  neither 
HPV11  nor BPV viruses like particles (VLPs) require a6 integrin to bind cells (Joyce et 
al.,  1999;  Sibbet et a l,  2000).  More recent work has suggested that heparin sulphate 
proteoglycans (HSPGs) are required for PV infection (Bousarghin et al, 2005; Giroglou 
et al, 2001a).
HSPGs  are  found  on the  surface  of most cells  as well  as  in the  extracellular  matrix 
(Oksala  et  al,  1995).  The  HSPG,  syndecan-1,  has  been  identified  as  a  candidate 
receptor for HPV infections in vivo (Shafti-Keramat et al, 2003). Furthermore, studies 
have  shown  that  lactoferrin  is  able  to  inhibit  HPV 16  VLPs  from  entering  cells. 
Lactoferrin is found in many bodily secretions and is known to inhibit herpesvirus and 
poliovirus  from  infecting  cells  by  blocking  heparin  sulphate  (Drobni  et  al,  2004). 
Conflicting studies have confirmed that heparin sulphate is required for the infection of 
many  cell  lines,  but  are  not  required  for  the  infection  of  natural  host  cells 
(keratinocytes) (Patterson et al, 2005). A new as yet unidentified receptor component 
uniquely  secreted  into  the  basal  extracellular  matrix  by  keratinocytes  which  can 
facilitate  infections  that  cannot  be  inhibited  by  heparin  has  recently  been  identified
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(Culp et a l, 2006). The study also suggested that heparins sulphate binding may attach 
virions into wounds and that virus then use this second receptor to identify target cells.
After binding to  cells  it is thought that the papillomavirus  can  be  endocytosed by  a 
clathrin dependent pathway (Day et a l, 2003). This work was further supported by the 
finding that chlorpromazine,  an  inhibitor  of the clathrin pathway  was  able to  inhibit 
internalisation of both BPV and HPV 16 VLPs. Interestingly the half-life of adsorption 
was found to be 4  h,  verses  5-15  min for a typical  ligand (Day  et al.9   2003).  These 
finding  were  confirmed  in  a  second  study  which  suggested  that  papillomaviruses 
infection  is  a  slow  process  and  remains  susceptible  to  neutralisation  hours  after 
adsorption (Culp et al, 2004). Mechanisms down stream of virus endocytosis may also 
be  involved  in tissue tropism.  The  virions  lacking  the  L2  protein  are  100 times  less 
infectious (Holmgren et al, 2005). L2 is required for egress of papillomavirus genomes 
from  endosomes  (Kamper  et  al,  2006)  and  transport  of the  viral  genome  into  the 
nucleus  (Yang  et  al,  2003b).  These  findings  suggest  that  papillomavirus  tissue 
specificity  may  be  regulated  at  multiple  levels  including  binding,  entering  and 
intracellular transport.
1.2  Site of infection
All papillomaviruses cause infections of mucosal and/or cutaneous epithelium. The skin 
is composed of three separate layers: the hypodermis, the dermis and the epidermis. The 
hypodermis is the lowest layer made of adipose and connective tissue and also contains 
the skins vascular infrastructure. The dermis is the principal mechanical barrier of the 
skin and contains smooth muscle, neurons and a network of elastic fibres that give the 
skin its elasticity.  The epidermis (a type of epithelium)  is the outer most layer of the 
skin and is composed of keratinised, stratified squamous epithelium. Skin epithelia can
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be divided into two types, cutaneous and mucosal. Cutaneous epithelium covers most of 
the  human  body  and  forms  a  tough  barrier  against  external  insult  and  desiccation. 
Mucosal  epithelium  covers  oral,  anal  and  genital  sites;  and  is  moist  with  less 
mechanical strength (Alberts, 2002).
1.2.1  The epithelium
The  epithelium  is  composed  of  several  cell  types,  the  principal  of  these  being 
keratinocytes.  In addition to these, dendritic cells are also present and are responsible 
for  immuno-surveillance  of the  skin.  Cutaneous  epidermis  also  contains melanocytes 
which are involved in pigment production. The epidermis forms a protective barrier that 
is continually replacing itself as dead cells slough off from the surface. As cells move 
through  the  epithelium  they  undergo  a  process  of  differentiation,  changing  in 
morphology, protein expression and function (Fig 1.2). The basal layer is one cell thick 
and  contains  mitotically  active  cells  continually  producing  daughter  cells  to  replace 
those shed from the surface (Walker et a l, 2003). Basal cells are anchored to the basal 
lamina by  hemi-desmosomal  connections.  Keratinocytes  in  the  basal  layer  express  a 
simple keratin 5 and 14 network (see Chapter 4 for further information).
The  parabasal  layer,  also  referred to  in  cutaneous  epithelium  as the  spinous  layer  is 
defined  as the  first cell  layer  above the  basal  layer.  Parabasal  cells  contain  a mixed 
population of cells some maintaining expression of basal keratin with others expressing 
differentiation-specific keratins  1/10 (cutaneous)  and 4/13  (mucosal) networks.  Cells 
also begin to adhere to each other more tightly by up-regulating cadherins and integrins 
responsible for cell-cell adhesion junctions (Garrod, 2004; Nakano et a l, 2005). Cells in 
cutaneous  epithelium  undergo  terminal  differentiation  to  form  the  granular  layer  so 
called because of the presence of keratohyalin granules (Swanbeck et al., 1965).
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Figure 1.2 The organisation of squamous epithelial tissue
Two distinct types of epithelial tissue exist referred to mucosal and cutaneous 
epithelium  The basal layer of epithelium consists of largely undifferentiated mitotically 
active cells  In cutaneous epithelium (A) cells of the spinous layer become progressively 
less mitotically active and increasingly robust as they up-regulate desmosomal 
connections and keratin expression  The granular layer is only a few cells thick and 
acquired its name due to the presence of keratohyalin granules which contain loricrin 
and profilaggrin (the filaggrin precursor). The upper cornified layers are composed of 
dead cells surrounded by a cornified envelope and have lost intracellular organelles.  In 
mucosal tissue (B) the layers are referred to as the parabasal, intermediate and 
superficial layers. Mucosal tissue organisation is similar but lacks granular cells, a 
cornified layer is generally much thinner  Mucosal epithelium is moist and is not 
required to protect the underlying tissue from desiccation
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Keratohyalin granules contain  filaggrin precursors  and  loricrin.  Filaggrin  is a keratin 
associated protein that cross-links keratin filaments to form thick fibres increasing their 
resistance to mechanical stress (Lynley et al., 1983).
Cornified  cells  are  only  found  in  cutaneous  epithelium,  and  consist  of  flattened 
metabolically  inactive  cells  lacking  organelles.  Cells  in  the  cornified  layer  are 
surrounded by a shell  of protein laid down under the cell membrane,  and commonly 
referred to as the cornified cell envelope (CCE). The CCE is composed of a network of 
highly cross-linked proteins, the main component of which is loricrin. The proteins in 
the  CCE  are  linked  by  intermolecular  isopeptide  bonds  formed  by  the  enzyme 
transglutaminase.  As cells reach the  surface of the skin,  desmosomal  connections  are 
lost and dead cells slough off into the environment (Fuche et al., 1994).
1.3  Papillomavirus related pathologies
Papillomaviruses are known to cause a wide variety of epithelial lesions in humans and 
animals.  The lesions vary in severity from inapparent flat warts to the large horn like 
structures  caused  by  cotton  tail  rabbit  papillomavirus  (CRPV).  Papilloma  related 
pathologies  are  further  complicated  by  the  ability  of some  PV  infections  to  induce 
malignancies (Fig 1.3).
1.3.1  Animal papillomas
A recent attempt to find more by a group in Sweden involved a trip to the local zoo. 
Armed  with  skin  swabs,  the  group  managed  to  identify  53  new  putative  animal 
papillomaviruses  in  healthy  animals  (Antonsson  et  al,  2002).  It  has  recently  been 
suggested that most mammals may harbour papillomaviruses although not all infections 
result in visible lesions (de Villiers et al, 2004). These sections will discuss
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Figure 1.3 The papillomavirus causes a variety of lesions with varying pathologies 
in many different vertebrates
Image A shows HPV 2 induced flat wart of the hand, (B) shows an HPV  1   induced 
lesions of the foot (B  )  (C) HPV  16 causes an inapparent flat wart of the cervix, such 
lesion can spontaneously regress but can also progress into cervical cancers (D) (images 
taken from (Gross and Barrasso,  1997). Papillomaviruses can infect a variety of 
different animal, some of which cause debilitating lesions such as cottontail rabbit 
papillomavirus (CRPV) (E)(image taken from
(www.lafayette.edu/~hollidac/jacksforreal.html). (F) Bovine papillomaviruses (BPV’s) 
can cause a variety of lesions in cattle (BPV2 pictured) some of which can result in 
epithelial  malignancies (image taken from www.duke usask.ca/- 
misra/virolgy/stud/2002/wart/spesies html)
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some  of  the  more  commonly  encountered  animal  papillomaviruses  which  are 
commonly used as laboratory models.
1.3.2  Rabbit models
Rabbit models have been invaluable tools in the study of papillomaviruses. Rabbits are 
small,  easy  to  breed  animals  that  (as  no  papillomavirus  have  yet  been  identified  in 
laboratory rat or mouse strains) offer the most convenient research tool.  CRPV causes 
large  horn-like  structures  in  its  natural  host,  which  can  regress,  persist  or  induce 
malignancies (see Fig  1.3).  CRPV is unable to complete its lifecycle in New Zealand 
white  (NZW)  rabbits  and  often  causes  carcinomas  representing  a  valuable  model  of 
carcinogenesis  (Christensen  et al,  2000).  The  link between papilloma infections  and 
malignancies  was  made  in  CRPV  long  before  the  association  was  made  in  humans 
(reviewed in (Campo, 2002).  CRPV has also been used to  investigate the role of the 
immune  system  in  clearing  infections  (Hopfl  et a l,  1995).  The  first  papillomavirus 
vaccine trials were also conducted on rabbits and demonstrated that both prophylactic 
and therapeutic vaccines may be viable (Breitburd et a l,  1995; Leachman et al., 2000; 
Xiao et a l, 1996).
1.3.3  Bovine models
To date several BP  Vs have been identified belonging to two distinct branches of the 
papillomavirus phylogenetic  tree.  BPV  1   and  2  cause  cutaneous  and  penile  warts  in 
cattle that can become  so  severe that  infected animals have to  be  destroyed  {see  Fig
1.3). Interestingly BPV1  & 2 can cause abortive infections in horses, deer, mules and 
hamsters which can result in sarcoid carcinomas (Koller et a l,  1972; Lancaster et al, 
1977). The BPV-1  model has been used to identify some of the functions of papilloma 
virus proteins and their interactions with the host cell (Band et a l,  1993; Campo, 2002; 
Day et al., 2003; Ham et al, 1991; Ustav et al, 1991).
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BPV4 causes lesions of the oral mucosa with the potential to induce malignancies.  A 
high incidence of cancer in cattle grazing on bracken ferns was first noticed in the late 
1970’s  (Jarrett,  1980).  It  has  since  been  demonstrated  that  brackens  contain 
immunosuppressant  and  carcinogenic  compounds  which  can  cause  malignancies  in 
BPV 4 infected cattle (Campo et a l 1992). The same phenomenon has been observed 
in humans, with mucosal HPV infection developing into carcinomas of the oesophagus 
after consuming bracken (Nagao et al, 1989). BPV 4 were used extensively in the early 
development of papillomavirus vaccines (Campo et al, 1993; Campo et al, 1994)
1.4  Pathologies  associated  with  human  papillomavirus 
infections
1.4.1  Cutaneous pathologies in humans
To date over  100 complete HP  Vs genomes have been sequenced and several hundred 
more putative sequences identified (de Villiers et al, 2004). The majority of papilloma 
infections are asymptomatic with dozens of papilloma DNA sequences showing up in 
the  skin  of healthy  individuals  (Antonsson  et  al.,  2000).  This  finding  suggests  that 
papillomaviruses  are  a  part  of the  natural  floral  and  fauna  of  human  skin.  Some 
papillomaviruses  are  known to  be  responsible  for  a number  of clinically  significant 
conditions. HPV 1  are frequently associated with common warts of cutaneous epithelium 
found on the hands (Fig  1.3).  HPV6  and  11  are the causative  agent  of genital  warts 
(Walboomers et al,  1999). HPV 2 cause deep plantar warts (verrucas) of the foot (Fig
1.3). Most HPV infections will spontaneously regress after a few months although HPV 
DNA can commonly be detected long after the lesion has disappeared (Hsu et al, 2003; 
Sarian et al, 2005; Schiffman et al, 2002).
1.4.2  Epidermodysplasia verruciformis
Despite  the  connection between  animal  papilloma  infections  and  cancer having  been
known about for several years it wasn’t until the late  1970s that the link between HPV
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and  human  cancers  was  discovered  (Jablonska  et  al.,  1978;  Orth  et al,  1977).  The 
discovery  was  made  in  patients  with  the  rare  genetic  condition  epidermodysplasia 
verruciformis (EV) (Jablonska et al.,  1978; Lutzner et al,  1980). EV patients have an 
increased  susceptibility  to  papilloma  infections  and  suffer  from  flat  scaly  warts  and 
pigmented  macula  like  lesions  caused  by  HPV  5  and  8.  Sun  exposed  EV  lesions 
undergo neoplastic progression to non-melanoma skin cancer in approximately 50% of 
EV patients (Jablonska et al.,  1994). EV type HPV DNA has also been found in non­
myeloma skin cancers of non EV patients, although the role of HPV infections in these 
cancers  is  currently  uncertain.  There  is  some  limited  evidence  linking  HPV  5  and  8 
infections  with  psoriasis,  although  the  role  of  the  virus  in  this  inflammatory  skin 
condition is at present unclear (Favre et al., 1998; Wolf et al., 2004).
1.4.3  Mucosal Cancers
Cervical  cancer  is  the  second  most  prevalent  cancer  in  women  globally  and  is 
responsible for -275,000 deaths annually (Ferlay et al.,  2001; Parkin et al.,  2005).  A 
sub-set of papilloma viruses which infect mucosal epithelium and cause inapparent flat 
warts (Fig  1.3), and which are commonly referred to as the high risk papillomaviruses 
are the  etiological  agent  of cervical  cancer  (Munoz  et al.,  1994;  Walboomers  et al., 
1999). The most common is HPV 16, which is detected in over 50% of cases (Munoz et 
al.,  2003).  Other  high  risk  papillomaviruses  commonly  found  in  mucosal  cancers 
(including oral and anal sites) include HPV  18, 31, 33, 35 and 42. As well as causing 
cervical  cancers,  high-risk papillomavirus DNA has been found  in  cancer of the  oral 
mucosa (Kreimer et al., 2004; Kundu et al., 1995)
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1.5  Papillomavirus models
The papillomaviruses require  differentiated epithelium for productive  infections.  This 
makes the virus challenging to  study in the laboratory.  Over the years many different 
systems have been used to study various aspects of the virus lifecycle.
1.5.1  Monolayer cell culture
Unlike  human  immunodeficiency  virus  (HIV)  and  influenza,  to  date  papillomavirus 
have  not  been  made  to  replicate  successfully  inside  monolayer  cell  culture  systems. 
Despite this,  such systems are an invaluable tool and are commonly used to  study the 
function  of  individual  viral  proteins.  The  effect  of  viral  proteins  on  host  cell 
mechanisms  such  as the  cell  cycle  has  revealed  a huge  amount  in  recent  years  and 
allowed the identification of possible therapeutic targets for future drugs. Draw-backs of 
such experiments are that proteins expressed in such systems are not under endogenous 
promoter control and are commonly over-expressed, which may result in the reporting 
of interactions which do not occur in vivo.
1.5.2  Epithelial raft cultures
Epithelial raft cultures can be produced by seeding HPV-infected keratinocytes onto a 
fibroblast containing medium such as a collagen gel. The keratinocytes are grown at a 
liquid air interface where they undergo differentiation.  Such systems require medium 
containing  specific growth factors,  serum and high calcium.  The medium is absorbed 
though  the  tissue  via  capillary  action  producing  a  gradient  which  causes  the 
keratinocytes to differentiate, (Chow et al,  1997; Flores et al,  1999). Raft cultures are 
technically demanding and hard to establish, but are currently the method of choice for 
the study of HPV lifecycle. It is possible to produce fully differentiated tissue, complete 
with comified layer, in the laboratory. Such systems will support productive papilloma 
infections  including  virion  production  and  release  (Flores  et  al,  1999).  A  major
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advantage of such systems is the ability to study human rather than animal viruses. Cells 
containing mutant genomes  can also be cultured  in this  system,  allowing the  role of 
individual or mutant proteins to be assessed with regards to the virus lifecycle (Dollard 
et al., 1992; Steenbergen et al., 1998; Wilson et al., 2005). The major draw back of raft 
cultures is that the tissues lack an immune system so cannot be used in studies interested 
in the resolution of infection.
1.5.3  Xenographs
The  species  specificity  of papilloma  virus  infections  means  that  viruses  will  only 
produce productive infections in the correct tissue of their natural hosts. This fact makes 
the  study  of HPV  infections  very  challenging  as  deliberately  infecting  humans  with 
pathogens  is  ethically  unacceptable.  The  discovery  of  two  strains  of  immuno­
compromised mice  incapable  of rejecting xenotransplants,  provided a new model  for 
use  in  papillomavirus  research.  Experiments  in  athymic  (nude)  mice  showed  that 
HPV 11  infected human foreskin and cervical tissue grafted under the kidney capsule, 
were capable of supporting productive viral  infections (Bryan et al., 2001;  Kreider et 
al., 1986; Stoler et al., 1990). Experiments that involved challenging skin from different 
areas of the human body to determine the tissue tropism of HPV  11, were conducted 
using the kidney capsule model (Kreider et al.,  1987), which was later used with foetal 
skin  to  study  HPV  1   infections  (Kreider  et  al.,  1990).  Severe  combined 
immunodeficiency mice  SCID (Bosma et al.,  1983) suffer from a  defective adaptive 
immune system,  and are also  capable  of supporting human tissue grafts (Renz et al., 
1996).  These provide another valuable model  for the study  of HPV  infections.  SCID 
mice have been shown to be capable of supporting productive high risk HPV infections 
such  as  with  HPV 16  that  has  been  introduced  into  the  animal  by  grafting  infected 
foreskin  keratinocytes  onto  the  backs  of  the  mice.  Infections  in  SCID  mice  are
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morphologically  comparable  to  naturally  occurring  infections  and  produce  correctly 
packaged infectious virions (Bonnez et al., 1993; Brandsma et al, 1995).
1.5.4  Clinical samples
Clinical samples are ultimately the most important source of data on HPV infections, as 
they are caused by the viruses of interest in their natural hosts (Humans).  Despite this 
due to ethical and legal barriers, researchers in the United Kingdom struggle to gather 
samples of interest, and usually can only access material collected from patients having 
problematic  lesions  surgically  removed.  Many  lesions  are  left to regress  naturally  or 
treated with topical agents such as salicylic acid or imiquimod (Micali et a l, 2004). As 
such  most  of what  is  known  about high risk viruses  like  HPV  16,  comes  from  CIN 
lesions where the virus life cycle has already begun to fail (Middleton et al, 2003). It 
may well be that these viruses favour foreskin over cervical sites but as such lesions are 
not of medical significance and are difficult to obtain for study.  Another limitation is 
that human infections cannot be artificially manipulated by researchers,  so  cannot be 
used in knock out or mutant studies.
1.5.5  Animal models
Animal  models  offer  another  source  of valuable  information  as they  can  be  used  to 
study  papilloma infections  in their  natural hosts.  Animal  models  have  been  used  to 
study latency and regression of papilloma lesions as well as the role played by the host 
immune  system  in  resolving  infections.  None  of the  other  laboratory  systems  offers 
these possibilities, and as a result of this animal models have played an invaluable role 
in the development of papillomavirus vaccines (Campo, 2002).
1.6  Overview of Papillomavirus lifecycle
The papillomavirus replication depends  on  finding  the  correct type  of differentiating 
epithelium tissue  in a permissible host for completion of its productive  lifecycle.  An
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infection begins when a virus particle gains access to mitotically active cells in the basal 
layer of the epithelium (Egawa, 2003).  Once inside a suitable host cell the genome is 
uncoated and the virus genome appears to undergo an initial round of replication in the 
nucleus with  infected  cells  containing  between  10-200  copies  of the  viral  DNA  (De 
Geest et al.,  1993). It is presumed that the expression of the early proteins El & E2 are 
required for this to occur although expression levels are such that no viral protein can be 
detected in basal cells (Ozbun et al.,  1998b; Wilson et al., 2002). Expression of the E6 
and E7  proteins then cause infected cells to undergo  several  rounds of replication to 
produce  a  pool  of infected  cells  capable  of viral  production  (reviewed  in(Doorbar, 
2006).  The  E6  &  E7  proteins  override  barriers  to,  and  apoptosis  associated  with 
unsanctioned cell cycle entry, by interacting with cellular checkpoint proteins including 
RB and p53 (Dyson et al., 1989; Scheffner et al., 1990; Wemess et al., 1990). The viral 
genome then undergoes a second round of replications to produce multiple copies of the 
viral genome for packaging. All the early proteins including E1A E4 and E5 are believed 
to be required for genome amplification (Fehrmann et al., 2003; Peh et al., 2004).  LI 
and L2 capsid proteins are expressed after genome amplification allowing assembly of 
virions (Ozbun et al.,  1998a). Newly formed virus particles then shed from the surface 
of the epithelium as terminally differentiated cells slough off (Fig 1.4).
1.6.1  Papillomavirus virions
Papillomavirus virions are non enveloped  structures approximately  55nm  in diameter 
(Kimbauer et al.,  1992).  The virion contains a single circular double stranded histone 
bound DNA molecule. The viral genome is contained within a protein capsid composed 
of the viral proteins LI and L2 with a stoichiometry of 1:5 
(Belnap et al., 1996). The proteins associate into 72 rosette-like capsomeres, which
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Figure  1.4 The papillomavirus lifecycle
The papillomavirus lifecycle begins when viruses infect cells of the basal layer, which 
they are though to do through a micro wound in the skin. The virus begins to express El 
and E2 which are involved in an initial burst of viral genome amplification.  Expression 
of the E6 and E7 proteins induce proliferation of infected cells and increase the number 
of cell that can be used to produce progeny virions.  Higher in the epithelium El, E2 
and E1AE4 levels increase allowing viral genome amplification to occur.  The viral 
capsid proteins LI  and L2 are expressed towards the surface of the epithelium after 
genome amplification, allowing packaging of genomes. Newly formed infectious 
virions are though to be shed from the surface of the epithelium as terminally 
differentiated cells slough off into the environment.
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self-assemble  into  an  icosahedral  shaped  protein  coat  (Howley  et  al.,  2001;  Zur 
Hausen, 1996)
1.6.2  Viral genome organisation
All  papillomaviruses  share  a  highly  conserved  genomic  organisation.  Genomes  are 
made of double stranded circular DNA approximately 8 kb in size (see Fig 1.5). RNA is 
transcribed  from  a  single  strand  of  the  DNA  in  polycistronic  transcripts.  RNA 
transcription  and  splicing  varies  depending  on  the  position  of  the  cell  within  the 
differentiated epithelium. The viral genome is divided into two regions referred to as the 
early (E) and Late (L) genes  (Howley et al., 2001). Early genes are transcribed in the 
low and mid regions of the  epithelium and are involved in genome maintenance  and 
amplification,  regulation  of  viral  transcription,  immune-evasion,  and  preventing 
apoptosis  of  infected  cells.  The  late  genes  are  transcribed  in  upper  terminally 
differentiated layers of the epithelium and encode the viral capsid proteins (reviewed in 
(Doorbar,  2005;  O'Brien et al,  2002).  The  viral  genome  also  contains  a non-coding 
region sandwiched between the LI and E6 ORF’s, referred to as the long control region 
(LCR), or the upstream regulatory region (URR). The LCR contains sequences involved 
in transcriptional regulation including binding sites of viral transcription factors such as 
the viral protein E2 (Dong et al., 1999; Spalholz et al., 1985; Spalholz et al., 1988). The 
LCR also contains the viral origin of replication (OR!) and has binding sites for the viral 
replication initiator El as well as several cellular proteins (Frattini et al., 1994; Waldeck 
et al.,  1984). Viral LCR’s vary in length and may play a role in the tissue selectivity of 
some  papillomaviruses  (Sailaja  et  al.,  1999).  Experiments  have  also  been  able  to 
demonstrate the transcriptional activity of transcription factors present in keratinocytes 
but  not  fibroblasts,  supporting  the  hypothesis  that  events  down  stream  of  viral 
adsorption are responsible for tissue selectivity (Offord et al., 1990).Chapter 1 Introduction
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Figure 1.5 The HPV 16 Genome
The HPV  16 genome consists of a molecule of double stranded DNA approximately 
8kb in size. Eight genes are encoded and are located on the same strand, in some cases, 
open reading frames partially overlap. The genome contains two main promoters the 
early promoter P97, and the late promoter P 670. The LCR is a non coding region and 
contains sequences involved in the regulation of viral gene transcription.
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1.6.3  Control of viral genome transcription
Control  of viral protein expression is regulated by  several  mechanisms these  include 
differential transcription and splicing of polycistronic mRNAs, varying proteins, protein 
levels  and  protein  isoforms  encoded.  Transcription  from  the  viral  genome  can  be 
divided  into  two  main  stages,  events  under  control  of the  early  promoter  and  those 
controlled by the differentiation dependent promoter. The changeover results in a major 
shift in RNA transcripts (Ozbun et a l, 1997; Ozbun et a l, 1999; Wettstein et a l, 1987). 
The P97 promoter located in the LCR is thought to be the first active viral promoter and 
is regulated by both viral and cellular factors specific to epithelial cells (Taniguchi et 
a l,  1993).  Both E2  and E6 have been shown to  act as transcriptional  activators  and 
repressors regulating one another’s expression (Cripe et a l,  1987; Sanders et a l,  1994; 
Stubenrauch  et a l,  1998).  Early  viral  mRNA transcripts  encode  El,  E2,  E6  and  E7 
(Higgins et a l,  1992;  Sherman et a l,  1992b).  The  late promoter activity  is under the 
control of differentiation-dependent transcription factors (Geisen et a l,  1996; Spink et 
al, 2005). Late viral  mRNAs encode the E1A E4, E5, LI  and L2 proteins, expression of 
which  is  heavily  influenced  by  differential  splicing  of transcripts  (Barksdale  et  al, 
1995; Danos et al,  1985; Doorbar et al,  1990a; Hummel et al,  1995; Sherman et al, 
1992a).
1.7  Papillomavirus proteins
Papillomaviruses express relatively few proteins (usually 8 although isoforms increase
this),  with expression profiles following a differentiation-dependent sequence.  Recent
research suggests that LI, L2, El  and E2 are the core ancestral proteins with the other
viral proteins being acquired at different stages from different sources through history
(Garcia-Vailve et al, 2005). As well as controlling protein expression, protein functions
is  also  believed  to  be  modulated  in  a  differentiation-dependent  manner  by
multimerisation, phosphorylation, proteolyitic cleavage, altered cellular localisation and
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the  expression  of  splice  variants  (Grand  et  a l,  1989;  Knight  et  al.,  2004; 
Vaeteewoottacham  et  al.,  2005).  This  modulation  allows  single  proteins  to  perform 
multiple  functions  at  varying  stages  throughout  the  virus  life  cycle.  The  current 
understanding of papillomavirus proteins suggest that they are multifunctional, existing 
in a complex dynamic state of equilibrium with one another.
1.7.1  Early gene expression
The  early  genes  are  expressed  in  the  basal,  parabasal  and  mid  layers  of  infected 
epithelium. Expression of these genes results in the forced proliferation of infected cells 
and the blocking of apoptotic pathways triggered by host cell responses.  Early  genes 
also regulate the transcription of viral and cellular genes, as well as the maintenance and 
replication of the viral genome (reviewed in (Doorbar, 2005). In addition to this early 
genes have been shown to play a role in immune evasion by down regulation and miss- 
localising cellular systems involved in immune surveillance (reviewed in (O'Brien et a l, 
2002; Zhang et al., 2003).
1.7.2  The Role of the E7 in the papillomavirus lifecycle
Papillomavirus genomes do not encode any polymerase enzymes and so viruses need to
hijack  the  host  cells  replication  machinery  for  viral  genome  replication  to  occur 
(Melendy et a l,  1995). The primary role of the E7 protein is to force quiescent cells 
back into cell cycle which increases the multiplicity of infected cells and allows viral 
genome amplification to occur at the required region of infected epithelium.
1.7.3  E7 overrides tumour suppressor pathways
Early work using the animal model system CRPV showed that the E7 gene is required 
for  papilloma  formation  resulting  from  hyperproliferative  growth  of  epithelium 
(Brandsma et a l,  1991). Expression of HPV 18 E7 has been shown to be necessary and 
sufficient to  induce quiescent differentiated keratinocytes to re-enter the  cell  cycle in
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raft  culture,  demonstrating  the  importance  of E7  in  perturbing  differentiation  of the 
inducible  infected  epithelium  (Cheng  et  al.,  1995).  Latter  studies  conducted  in  raft 
systems  using  HPV  16  E7  knockout  genomes  showed  that  E7  is  required  for  virus 
genome  amplification  and  late  gene  expression  (Flores  et  al.,  2000).  E7  mRNA 
transcripts and protein have been found in HPV 16 and 18 transformed cell lines and are 
believed to be required for the maintenance of the malignant phenotype (Smotkin et a l, 
1986). E7 has since been shown to induce cell proliferation via an association with the 
tumour suppressor retinoblastoma protein (pRB) and in the case of E7s from high risk 
viruses this  results in its degradation (Boyer et al.,  1996; Dyson et al.,  1989). A similar 
mechanism has also been reported to occur with the El A SV40 protein (Chellappan et 
al., 1992)
1.7.4  E7 and the retinoblastoma protein
E7 has been shown to associate with pRB causing the release of the transcription factor 
E2F resulting in initiation of S-Phase. Under normal circumstances pRB binds E2F but 
stimulation  of mitogen  activated  pathways  results  in  the  phosphorylation  of pRb  by 
cyclin dependant kinases (CDK’s) CDK4 and 6 leading to the release/activation of E2F 
(reviewed  in  (Dyson,  1998).  Upon  release  E2F  activates  the  transcription  of genes 
required  for  S  phase  entry,  including  DNA  polymerase  a,  thymidine  kinase, 
minchromosome  maintenance  proteins  (MCMs)  and  cyclins  A  and  E  (reviewed  in 
(Herwig et a l, 1997). Antibodies against these proteins can be used as surrogate makers 
of E7 expression.  E7 proteins from  low risk viruses typically have a reduced in their 
affinity for pRb and a reduced ability to transform cells in vivo (Gage et al, 1990; Heck 
et al, 1992).
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1.7.4.1  pRB independent effects of the E7 Protein
E7  has  been  demonstrated  to  override  other  pRB  independent  cell  cycle  inhibitor
pathways by interacting with members of the pocket family of proteins pi07 and pi 30. 
E7 associates with and  induces transactivation of the API transcription factors Fos and 
Jun  (Antinore et al.,  1996). E7 proteins have also been shown to have the capacity to 
stimulate  cell  proliferation  independently  of pocket proteins  by  interacting  with  and 
deactivating  the  inhibitors  of cyclins  A,  and  E  p21  and  p27,  which  are  capable  of 
blocking PCNA mediated DNA replication (Funk et al.,  1997; Jones et al,  1997). The 
ability of E7 to stimulate proliferation is supported by the finding that E2 can suppress 
HeLa  cell  growth  by  repressing  the  transcription  of the  constitutively  active  E6/E7 
promoter (Nishimura et al., 2000)
1.7.5  The role of the E6 protein
The  main  objective  of the  E6  protein  appears  to  be  to  block  apoptotic  pathways 
activated in cell undergoing unsanctioned entrance into the cell cycle as result of the 
expression of E7, in order to allow viral genome replication to occur.
1.7.6  The E6 protein
The E6 protein is found in most PVs (with the exception of some ungulate  and bird 
viruses). It is one of the two major transforming proteins and expression is maintained 
during  neoplastic  progression,  E6  is  expressed  at  low  levels  in  during  productive 
infections. Four different splice variants of the E6 protein are thought to exist (reviewed 
in  (Myers,  1995)  and  are  believed to  play  a role  in modulating  E6  function  and  E7 
levels (Pirn et al., 1999; Smotkin et al., 1989; Stacey et al., 1995).
1.7.7  E6  prevents  apoptosis  by  interacting  with  the  tumour 
suppressor protein p53
All E6 proteins are believed to associate with and modulate the function of members of
the p53  tumour suppressor protein family.  p53  is a major cellular tumour suppressor
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commonly  referred to  as  the  guardian  of the  genome,  and  triggers  cell  cycle  arrest 
followed  by  apoptosis  upon  detection  of defective  or  unsanctioned  DNA  replication 
(Lane,  1992). p53 acts as an upstream sensor protein and functions by  modulating the 
transcription of other genes  involved in tumour  suppressor pathways  (Hofseth et a l, 
2004).  E6  is  able to  modulate  p53  activity  by  direct association  and  by  inducing  its 
degradation. Only E6 proteins from high risk viruses cause 26S -proteasome mediated 
degradation of p53 (Crook et al, 1991; Li et al, 1996; Pirn et al, 1994; Scheffner et al, 
1994).
1.7.8  E6 and the ubiquitin system
E6 has been shown to mediate p53 degradation via the E6 associated protein (E6-AP). 
E6-AP was found to be a member of the E3 ubiquitin ligase protein family, a domain in 
the  C-terminus  of the  protein  was  later  used to  identify  E3  activity  in  a  number  of 
seemingly  unrelated  proteins,  now  termed  homologous  E6AP  C-  terminus  proteins 
(HECT’s)  (Huibregtse  et  al,  1995).  Ubiquitination  is  an  essential  cellular  process 
affected  by  a  multi-enzyme  cascade  involving  classes  of  enzymes  known  as  Els 
(ubiquitin-activating enzymes),  E2s  (ubiquitin-conjugating enzymes / Ubcs),  and  E3s 
(ubiquitin-protein  ligases)  (Scheffner  et  al,  1995).  E6  acts  as  a  bridging  adaptor 
redirecting E6 AP to a substrate (p53) which under normal circumstances would have 
no affinity for it. This same adaptor mechanism of redirecting E3  ubiquitin ligases to 
target cellular proteins for degradation has since been identified in a number of other 
viruses including HIV and adenovirus (Margottin et al, 1998; Querido et al, 2001).
1.7.9  E6 can inhibit multiple apoptotic pathways
Alpha group HPV E6 proteins also have the ability to inhibit differentiation-dependent 
apoptosis induced by the Bcl-2 pro-death domain protein family (Magal et al, 2005). 
As with p53, E6 has been shown to bind directly to the Bcl-2 member, Bak, resulting in
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its degradation.  This observation suggests that E6 proteins are able to inhibit multiple 
apoptotic pathways. Bak expression is abundant in normal differentiated epithelium but 
significantly reduced in HPV induced carcinomas. As with p53, E6 proteins from high 
risk viruses have  an  increased  ability to  promote  ubiquitination  and  26S  proteasome 
mediated Bak degradation (Thomas et al.,  1999). Both p53 and Bak-induced apoptotic 
pathways  would  be  activated  in  response  to  E7-induced  cell  proliferation;  by 
deactivating these pathways the virus gains total control of the infected cell (Butz et al., 
2003; Horner et al, 2004; lives et a l 2003). Finding a novel way of knocking-out E6 
activity  allowing  reactivation of p53  would be a very  efficient way  of treating  HPV 
induced carcinomas (Cho et a l, 2002).  This approach is currently under investigation 
using siRNA, peptides and  intra body technology to target E6, and has been shown to 
induce apoptosis in the HPV transformed cell  line (Griffin et al.,  2006;  Putral  et a l, 
2005; Sterlinko Grm et a l, 2004).
1.7.10  The role of E6 in immune evasion
E6 has been shown to play a role in immune evasion through an ability to down regulate 
proteins  involved  in  cell-cell  adherens  junctions.  E-cadherin  mediates  calcium 
dependent  cell-cell  focal  adhesions  between  keratinocytes  and  Langerhan  cells 
(epithelial  antigen  presenting  cells)  (Tang  et  al,  1993).  Expression  of E6  has  been 
demonstrated to down regulate surface expression of E-cadherin.  Loss of E-cadherin  in 
turn results  in decease in the number of Langerhan cells  in  lesions  (Matthews  et a l, 
2003). Some evidence also suggests that loss of E-cadherin renders cell less susceptible 
to  apoptosis (Ferreira et al,  2005).  The  loss of E-cadherin also  increases the  risk of 
tumours invading the underlying tissue and has been observed in a number of cancers 
(Hirohashi, 1998; Oka et al, 1992).
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1.7.11  E6 proteins interact with and degrade PDZ domain proteins
Expression  of  E6  has  been  show  to  cause  mislocalisation  and  induce  proteasome
mediated degradation of certain PDZ domain proteins (Kiyono et al,  1997; Lee et al., 
2000).  PDZ  domains  are  involved  in  protein-protein  interactions  and  are  commonly 
found in trans-membrane receptors. PDZ proteins known to be affected by E6 include 
Dig, MAGI 1-3 and MUPP1, which are believed to be involved in the regulation of cell 
growth and polarity (Gardiol et al.,  1999; Lee et al., 2000; Thomas et al., 2001). HPV 
genomes propagated in raft culture  systems expressing mutant E6s unable to  interact 
with PDZs show a reduction in viral genome copy number and in the growth of cells. 
Interestingly no change was detected in the expression level of PDZ domain proteins 
(Lee et al., 2004).
1.7.12  The HPVE5 protein
E5  is  a  hydrophobic,  membrane-bound  protein,  with  weak  transforming  properties 
(DiMaio et al., 2001; Horwitz et al., 1988). E5 is primarily localised to the endoplasmic 
reticulum  (ER)  but  can  also  be  found  in the  Golgi  apparatus  and plasma membrane 
(Conrad et al,  1993; Disbrow et al, 2005). Despite sharing the same name and general 
hydrophobicity,  E5  gene  products  vary  greatly  between  different  papillomaviruses 
groups (Garcia-Vallve et al, 2005). Interestingly 4 different isoforms of E5 exist in A 
group viruses,  with the a-isoform being found in all viruses associated with cervical 
cancer (Bravo et al, 2004).  The position of the E5 ORF within the genome also varies 
between viruses, suggesting that the virus may have acquired “E5” genes from different 
sources at different times throughout history (Garcia-Vallve et al, 2005).
1.7.13  The functions of the E5 protein
The transforming properties of the E5 protein vary dramatically between viruses; the E5 
protein of BPV1  is a true oncogene and serves as the major viral transforming protein
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(DiMaio  et al,  1986).  In contrast transformation of cells by  HPV 16  E5  requires the 
presence of E7 and expression of E5 is not maintained in HPV  16 transformed cancers. 
E5  is encoded in all polycistronic viral mRNA transcripts except those encoding the 
capsid proteins,  suggesting  it is required throughout the virus  lifecycle  (Baker et al., 
1996; Fehrmann et al, 2003).
1.7.14  The role of E5 in immune evasion
Low  levels  of E5  expressed  in the  basal  layer  of infected  epithelium  are  thought to 
enable the virus to shield infected cells from the immune-system.  Immune evasion is 
thought  to  be  achieved  by  reducing  detection  of  infected  cells  from  cytotoxic  T 
lymphocyte  (CTL)-mediated  clearance  by  reducing  surface  expression  of  major 
histocompatibility class I complexes, HLA-A and HLA-B (Ashrafi et al, 2002; Ashrafi 
et al, 2005; Marchetti et al, 2002; Zhang et al, 2003).  MHC proteins cycle to and 
from the cell surface allowing them to pick up/bind foreign (viral) antigens which can 
then be presented to the immune system. Infected cells displaying viral antigens on their 
surface alert the  immune system to the presence of a pathogen  and  are stimulated to 
induce apoptosis by T-cells, thus preventing the  spread of the  infection.  Viruses that 
establish  long-term  infections  in  their  hosts  have  evolved  a  number  of methods  to 
interfere with MHC activities (Lilley et al, 2005). The E5 protein has been shown to 
affect the maturation process of MHC proteins which are retained in the Golgi apparatus 
(Ashrafi et al, 2005; Marchetti et al, 2002).
1.7.15  The E5 protein plays a role in preventing apoptosis
The expression of the viral proteins E2  and E7 can promote apoptosis preventing the
virus  from  completing  its  lifecycle.  To  combat this,  the  virus  uses  both  E5  and  E6 
proteins.  Upon discovery by the immune  system,  CTLs would force  infected  cells to 
undergo  FAS  and  TRAIL  (tumour  necrosis  related-factor  apoptosis-inducing  ligand)
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mediated  apoptosis.  Studies  have  shown  that  expression  of HPV  16  E5  desensitizes 
cells  to  these  apoptotic  pathways  (Kabsch  et  al.,  2002b;  Kabsch  et  al.,  2004). 
Interestingly  HPV 16  E5  was  shown  to  sensitize  cells  to  osmotic  stress-induced 
apoptosis (Kabsch et al., 2002a) which may aid virion release in mucosal infections.
1.7.16  E5 induces cell cycle modification
E5  is also thought to play a role  in the  genome amplification phase  of the virus  life 
cycle.  Studies  conducted  on  E5  knockout  HPV  35  genomes  in  an  organotypic  raft 
culture  system  showed  that  loss  of  E5  resulted  in  a  reduction  of  late  viral  gene 
expression, suggesting that E5 may play a role in stimulating late life cycle events.  A 
reduction in the levels of the cell cycle regulators cyclin A and B was also  observed 
indicating that E5 may also affect the cell cycle (Fehrmann et al., 2003). HPV 16 E5 has 
also  been  shown  to  cooperate  with  E7  to  stimulate  cell  proliferation  and  late  gene 
expression (Bouvard et al.,  1994). A third study suggested that the HPV  16 E5 protein 
plays a quantitative role in the virus lifecycle with E5 knockout raft cultures having a 2 
fold decrease in the number of suprabasal cells undergoing DNA synthesis (Genther et 
al., 2003). E5 is believed to promote cell cycle progression through interactions with the 
epidermal growth factor (EGF) and platelet derived growth factor (PDGF) receptors. E5 
has been shown to cause a 2-5 fold increase in EGF receptor density and enhance signal 
transduction, rendering cells hypersensitive to ligand stimulation (Straight et al.,  1993). 
Contradicting studies have suggested that receptor density is not affected and that cell 
proliferation is stimulated by an amplified signal cascade (Gu et al., 1995; Leechanachai 
et al.,  1992; Ziegert et al., 2003).  Several studies have also shown that the E5 gene is 
dispensable and that normal productive infection can occur in its absence (Brandsma et 
al., 1992; Genther et al., 2003).
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1.7.17  The E1  protein
The El  gene sequence is highly conserved throughout papillomaviruses suggesting that 
its  function  is  vital  to  the  virus.  The  El  protein  consists  of two  globular  domains 
separated by a linker region (Enemark et al, 2000). All El  proteins contain a nuclear 
localisation signal, a DNA binding domain in the N-terminus, and ATP-dependent DNA 
helicase activity in the C-terminus. El  is believed to be expressed in the lower and mid 
levels of the epithelium at very low levels as it cannot be detected in tissue (Ozbun et 
al,  1998b).  Experiment  have  shown  El  to  be  essential  for  maintenance  and 
amplification of viral genomes (reviewed in (Wilson et al, 2002).
1.7.18  The role of E1  in viral genome replication
In  vitro  experiments have  shown that El  at high  levels is  capable of binding  to  and
initiating replication of DNA (Kuo et al,  1994; Santucci et al,  1995; Seo et al,  1993a;
Seo et al,  1993b).  El  binds DNA forming multiple hexameric complexes with ATP-
dependant helicase activity (Yang et al,  1993). In vivo the protein is expressed at such
low levels that this is thought unlikely to occur unaided. Experiments have been able to
demonstrate  that  in  the  absence  of the  E2  protein,  El  associates  non-specifically  to
DNA (Sanders et al, 2000).  Co-expressing El  and E2 results in the recruitment of El
to the viral origin of replication (ORI) where it assembles into hexamers. El  is thought
to bind cooperatively with E2 to the El binding site, located adjacent to the E2 binding
site (Mohr et al,  1990). It is believed that the binding of El  and E2 to the ORI causes
the DNA to wrap which in turn allows the recruitment of a further two El  molecules.
E2 is then displaced from the complex by the competitive binding of ATP to the El  C-
terminus (Sanders et al,  1998).  El  has been shown to form bi-hexameric complexes
known  to  be  required  for  the  bidirectional  DNA  synthesis  observed  in  HPV  DNA
replication.  Interestingly  El  shares  considerable  homology  with  the  SV40  large  T
antigen which has similar properties (Melendy et al,  1995).  Interestingly  it has been
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suggested that SV40 small T antigen may be a functional homolog of the cellular MCM 
proteins  which  form  the  hexameric  helicase  complexes  required  for  cellular  DNA 
replication, these finding may  shed light on El  function (Chong et a l, 2000; Gomez- 
Lorenzo et al., 2003; Patel et al, 2000).
1.7.19  The role of E1 in viral genome transcription
El  has been  shown to modulate the  binding of the viral transcription factor E2  in a
concentration dependent manner. The El  protein of BPV has been shown to represses 
E2-mediated transactivation from the early promotor p89 (Ferran et al, 1998; Sandler et 
al,  1993).  The  equilibrium  between  occupancy  of the  El  and  E2  binding  sites  may 
switch the viral genome from a transcriptionally active state to a replicative state.
1.7.20  The E2 protein
The  E2  protein  is  highly  conserved  throughout papillomaviruses  and  is  involved  in 
replication, genome maintenance, and in the control of viral transcription. The protein is 
comprised  of two  globular  domains  connected  by  a  linker  region.  The  N-terminus 
contains  a  trans-activating  domain  and  the  C-terminus  is  a  DNA-binding  and 
dimerisation  domain  (Giri  et  al,  1988;  McBride  et  al,  1988).  As  with  other 
papillomavirus proteins E2 protein function appears to be modulated by both proteolytic 
cleavage and phosphorylation (Hubbert et al, 1988; McBride et al, 1989).
1.7.20.1  Vegetative viral genome replication and maintenance
The E2 protein has been demonstrated to play a role in viral genome replication through
an interaction with the El protein. Two E2 binding sites are located adjacent to the viral 
ORI  (Sverdrup  et al,  1995).  The  loading  of E2  onto  these  sites  allows  the  specific 
recruitment  of the  viral  helicase  El  to  the  viral  ORI,  which  in  turn  allows  genome 
amplification to occur (Sverdrup et al,  1994; Sverdrup et al,  1995). Another function
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of E2  is  to  ensure  even  distribution  of viral  genomes  into  daughter  cells,  which  is 
mediated by E2s ability to bind viral genomes onto the mitotic spindles (Bastien et a l, 
2000; lives et al, 1999).
1.7.20.2  E2 and transcription regulation
Initial  transcription  of the  viral  genes  is  controlled  by  cellular  transcription  factors
binding the LCR,  this is then modulated by E2  in a concentration-dependent manner 
(Sanders et al., 1994; Stubenrauch et al.,  1994). Occupancy of the four E2 binding sites 
in  the  LCR  is  the  principal  mode  of  transcription  modulation,  although  a  direct 
interaction with other cellular protein also occurs (Li et al.,  1991). The significance of 
E2’s role in transcriptional regulation is still unclear with some studies suggesting that 
the protein’s role in transcription  is only secondary to its role in genome maintenance 
(Bechtold et al., 2003; Stubenrauch et al.,  1998). Truncated and modified forms of E2 
have been identified in several HP  Vs and are believed to dimerise to full-length E2, but 
due to their lack of a trans-activating domain are thought to act as a repressor (Doorbar 
et al., 1990b; Lambert et al, 1987; Stubenrauch et al., 2000).
1.8  Late gene expression
Late genes are involved in viral genome packaging and possibly virion release. E1A E4 
is believed to play a role throughout the virus lifecycle but is only expressed at high 
levels at late time points. As the work in this thesis is primarily interested in these later 
roles of E1A E4, the description of the protein has been included in this section.
1.8.1  Papillomavirus capsid proteins
The papillomavirus expresses two capsid proteins LI  and L2. LI  and L2 expression is 
controlled by the late differentiation-dependent promoter. Both proteins are expressed in 
the upper layers of infected epithelium after viral  genome amplification has occurred 
(Ozbun et al.,  1998a).  LI  is the major and L2 the minor capsid protein. They combine
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with a stoichiometry of 5/1  to from rosette structures, with 72 rosettes making up the 
viral capsid (Baker et al.,  1991). Both proteins have an NLS motif located in the C -  
terminus comprising  of a cluster of basic amino acids (Zhou et al., 1991a). It is thought 
that the NLS allows the proteins to enter the nucleus via interactions with members of 
the karyopherin receptor family (Fay et al., 2004; Merle et al., 1999).
1.8.2  Functions  of  the  L1  and  L2  proteins  during  early  lifecycle 
events
Ll  has been shown to associate with heparin sulphate and is involved in initial virus 
entry into uninfected cells (Joyce et al., 1999). Once the virus has gained access to cells, 
L2 has been shown to facilitate transport of viral DNA to the nucleus via interaction 
with  P-actin.  Deletion  of the actin binding  domain  (amino  acids 25-45)  significantly 
reduces the infectivity of HPV 16 pseudo virions (Yang et al., 2003a).
1.8.3  Functions  of  the  L1  and  L2  proteins  during  late  lifecycle 
events
L2 is synthesised prior to Ll, and is transported into the nucleus where it accumulates in 
Promyelocytic  leukaemia  (PML)  bodies,  in  which  it  is  believed  that  viral  genome 
amplification and packaging  occurs (Florin et al., 2002;  Swindle et al.,  1999).  L2  is 
known to be responsible  for the recruitment of Ll  and E2  to the  PMLs  (Day  et al., 
1998; Florin et al., 2002). It has been postulated that the recruitment of E2-bound DNA 
may facilitate selective packaging of the viral genome.  The Ll  protein associates into 
pentamers  in  the  cytoplasm  of infected  cells,  and  these  are  recruited  to  the  NDlOs 
following the L2 induced release of SP100 (Florin et al., 2002; Okun et al., 2001). Both 
the N and C terminus domains of L2 interact with Ll  pentamers, and are required for 
virus encapsulation (Okun et al., 2001).
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1.9  Papillomavirus E1AE4 proteins
The E1A E4 proteins are encoded by a spliced mRNA comprising the first few amino 
acids of the El  ORF (5 in the case of HPV 16 E1A E4) spliced onto the gene product of 
the E4  ORF  (Doorbar et al.,  1987;  Doorbar et al.,  1988a; Nasseri  et al.,  1987).  The 
E1A E4 ORF lies within a region of the E2 ORF that codes for the linker domain (see Fig 
5.5).  Analysis  of  viral  mRNA  transcripts  suggests  that  the  protein  is  expressed 
throughout  the  virus  lifecycle,  although the  E1A E4  protein  can  only  be  detected  by 
indirect immuno-fluorescence in upper layers of the epithelium (Doorbar et al,  1992; 
Peh et al., 2002). It has been suggested that build up of E1A E4 is caused by an increase 
in  transcription  from  the  differentiation-dependent  promoter  (Hummel  et  al.,  1992), 
although  it is  conceivable that protein  stabilisation  or reduced turnover may  also  be 
involved.
1.9.1  Characteristics of E1AE4 proteins
E1A E4 proteins are typically small proteins varying in size from 88 to  134 amino acids 
for  HPV 18  and  ROPV  respectively.  There  is  very  little  sequence  homology  shared 
between  E1A E4  proteins  from  different  genera,  suggesting that  they  have  undergone 
significant  evolution/mutation  when  compared  to  other  papillomavirus  proteins 
(Narechania et al.,  2005)  (see  Chapter 3).  Despite this,  some  features are  commonly 
observed.  Most E1A E4 proteins contain a proline rich region and a region of charged 
residues  and  many,  (specifically  a-group  ElA E4s)  also  contain  a  leucine  cluster 
(reviewed in (Doorbar,  1996). Another commonly observed feature is a well conserved 
C-terminal  region  believed to  be  involved  in  self association  (Ashmole  et al.,  1998; 
Bryan et al., 1998).
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1.9.2  Multimerisation of E1AE4 proteins
HPVl E1A E4 has been shown to from stable trimers or tetramers (Doorbar et al., 1996) 
and  the capacity of HPV 16 E1A E4  to from dimers and hexamers has also been reported 
(Roberts  et al.,  1997;  Wang  et al.,  2004).  Mutation  of a cysteine  in  HPV 16  E1A E4 
(conserved  in A9  E1A  E4s)  destabilised  multimers,  leading  to  dissociation following 
SDS  gel  electrophoresis.  The  cysteine  mutation  did  not  prevent  self  association 
suggesting that disulphide bond formation alone is not responsible for multimerisation 
(Ashmole  et al.,  1998;  Roberts  et al.,  1997).  The  lack  of cysteine  residues  in  some 
E1A E4 proteins, as well as the ability of some multimers to survive treatments in strong 
reducing  environments  suggests  that  disulphide  bonds  are  not  essential  for 
multimerisation.
1.9.3  Proteolytic cleavage of E1AE4
Proteolytic cleavage of E1A E4 has previously been observed resulting in an increase in 
truncated protein isoforms towards the surface of the epithelium (Breitburd et al., 1987). 
The exact reason for truncation is not properly understood although to date it has been 
observed in HPV  1   and 16 E1A E4 proteins (Doorbar et al.,  1997; Rogel-Gaillard et al., 
1992a).  The  distribution  of  truncated  ElA E4s  suggests  processing  may  be 
differentiation-dependent.  This  may  provide  the  virus  with  an  additional  way  to 
modulate protein function by modifying the phenotype of the  infected cell  to  favour 
virus synthesis or virus release throughout the virus lifecycle.
An N-terminally truncated form of HPV 16 E1A E4 has previously been suggested from
immunofluorescence  studies  although  its precise  role  is  still  unclear  (Doorbar  et al.,
1997).  A  truncation  of HPV  1   E1A E4  has  also  been  reported  in  vitro  and  in  vivo.
Truncated isoforms of the protein also  appear to  be more  abundant at the  surface of
lesions.  Truncation of the protein was  shown to remove the  ability to  associate with
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cytokeratins and displays an altered cellular distribution (Doorbar et al., 1988b; Roberts 
et al, 2003; Rogel-Gaillard et al, 1992b).
1.9.4  Phosphorylation of E1AE4 proteins
Phosphorylated forms of E1A E4 have been detected in HPV  1,11  and 16 (Bryan et al, 
2000b; Das, 2005; Grand et al,  1989; Wang et al, 2004). HPV  1   E1A E4 was noted to 
become  phosphorylated  by  protein  kinase  A  (PKA)  in  vivo.  In  addition  to  this  the 
phosphorylation state of the protein was shown to increase towards the surface of the 
lesion (Breitburd et al., 1987). It was also reported that a second unidentified kinase was 
likely  to  be  involved  in the  phosphorylation.  HPV  11  E1A E4  has  been  shown  to  be 
phosphorylated  in  vitro  by  PKA  and  mitogen  activated  protein  kinase  (MAPK)  at 
consensus  kinase  motifs  in  the  central  region  of the  protein.  There  is  also  strong 
evidence of phosphorylation of HPV11  occurring  in vivo.  Sequence analysis has also 
identified  putative  phosphorylation  sites  in  other  E1A E4  proteins  (Peh,  2002). 
Computational  analysis  of HPV  16  E1A E4  has  identified putative  MAPK,  CDK  and 
PKA  phosphorylation  motifs  and  recent  work  has  shown  these  sites  to  be 
phosphorylated in vitro as predicted (Das, 2005). As yet little is known about the role 
phosphorylation  plays  in  modulating  a-group  E1A E4  function,  although  it  has  been 
suggested that it may function as a differentiation-dependent protein switch between a 
role in genome amplification and a role to one of viral egress (Bryan et al, 2000b).
1.9.5  E1AE4 Functions
1.9.6  Genome amplification/replication
The role that E1A E4 plays in viral genome amplification was first identified in HPV1 
lesions where  it was noticed that high  levels  of E1A E4  coincided with viral  genome 
amplification (Breitburd et al,  1987).  Since then studies on E1A E4 knock-out CRPV 
lesions have shown E1A E4 to be essential for viral genome amplification and  late gene
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expression  (Peh  et  al.,  2004).  The  role  of  HPV  16  and  31  E1A E4  in  genome 
amplification have also been demonstrated in organotypic raft cultures suggesting this 
function is conserved to varying degrees in E1A E4 proteins from unrelated HPV types 
(Nakahara et a l, 2005; Wilson et al., 2005). Interestingly, the study investigating HPV 
16 E1A E4  suggested that it was also required for genome maintenance in addition to 
amplification, suggesting that the protein may play a role in early life cycle events. HPV 
1,  16 and  18 E1A E4 proteins have been shown to cause G2/M cell  cycle arrest when 
expressed at high levels in epithelial cells (Davy et a l, 2002; Nakahara et a l,  2002). 
The  purpose  of  ElA E4-induced  cell  cycle  arrest  is  believed  to  be  to  produce  a 
favourable environment for virus genome amplification in which the virus hijacks active 
cellular replication machinery. The presence of the viral proteins El  and E2, probably 
allows the virus to circumvent the cellular DNA replication licensing system (Madine et 
al.y  1995) allowing multiple rounds of viral genome replication to occur in the absence 
of cellular DNA replication. Two threonine residues located in the proline rich domain 
of HPV 16 E1A E4 have been shown to be essential for mediating cell cycle arrest (Davy 
et a l, 2002). E1A E4 was shown to associate with, and cause the retention of, the active 
cyclin B1/CDK1  complex in the cytoplasm (Davy et a l, 2005).  Interestingly mutation 
of a single threonine in a similar region of HPV1  E1A E4 also prevents cell cycle arrest 
from occurring.  Cyclin B1  was not observed  in HPV1  E1A E4  expressing-cells  and  it 
was suggested that the protein induce G2/S phase arrest by preventing the accumulation 
of the  complex  (Knight  et  al.,  2004).  Interestingly  Cyclin  B  is  abundant  in  E1A E4 
expressing cells in vivo (Davy et al., 2005).
1.9.7  HPV 16 E1AE4 interacts with a putative RNA helicase
E1A E4 may also have a putative role in the regulation of gene expression,  as a yeast
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novel DEAD box protein,  E4-DEAD box binding protein,  (E4-DBP)  (Doorbar et a l, 
2000). E4-DBP is predominantly located in the nucleus but has also been demonstrated 
to shuttle between the nucleus and cytoplasm. Although no role has been attributed to 
E4-DBP, DEAD box proteins are known to be involved in the processing, stability and 
transport  of  RNA  molecules  (Tanner  et  a l,  2001).  Papillomaviruses  are  heavily 
dependent on RNA processing for regulation of gene expression and the virus is also 
believed to be able to alter host cell transcription (Baker et a l,  1996; Lehr et a l, 2002). 
It has been  speculated that E1A E4  interactions with E4-DBP  may  allow the  virus to 
control both processes (Doorbar et a l, 2000).
1.9.8  E1AE4’s role in virion release
The exact role E1A E4 plays in virion release is unclear. The expression time frame and 
location of abundant E1A E4 strongly suggests that it may be involved in virion release. 
This hypothesis is  supported by  a number of studies  into the  function of the  protein 
which have shown that the ability of HPV  1,  11,  16 and 31  ElA E4’s to associate with 
and in some cases disrupt components of the cell cytoskeleton and CCE that form the 
mechanical barrier of the skin (Brown et al, 2000; Doorbar,  1991; Pray et a l,  1995a; 
Roberts et a l, 1993; Wang et a l, 2004)
1.9.9  E1AE4 interacts with the cytokeratin network
The  cytokeratins  found  in  differentiated  keratinocytes  in  the  upper  layers  of  the
epithelium provide a tough mechanical barrier which protects the underlying tissue from 
desiccation and external insult. As well as providing a protective barrier for host tissue 
they  also present the virus with an obstacle through which newly  made virions  must 
pass if they are to infect new hosts. Keratin filaments are composed of type  1   (acidic ) 
and type 2 (basic) keratins that polymerise with specific partners at a stochometry of 1/1 
(discussed in more depth in Chapter 4) (reviewed in (Coulombe et a l, 2002). HPV 1, 2
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and  16  E1A E4  proteins  have  been  shown to  associate  with  keratins,  HPV  2  and  16 
ElA E4’s  association  causes  keratin  filament  network  to  collapse.  HPV  16  E1A E4 
contains an N-terminal leucine cluster (YPLLXLL) that is highly conserved through a- 
group E1A E4 proteins and is known to be involved in keratin association (Roberts et al, 
1994; Roberts et al, 1997). Experiments have demonstrated that  a heavily truncated N- 
terminal 16 E1A E4 peptide containing the leucine cluster is sufficient to localise GFP to 
keratin filaments (Wang et al, 2004). Later experiments showed that HPV  16 E1A E4 
was able to bind directly to keratin 18 (a type 1  keratin) but not its type 2 partner keratin 
8 (Wang et a l, 2004). The ability of HPV  16 to cause cytokeratin network collapse is 
also  affected  by  the  E1A E4  C-terminus,  which  is  involved  in multimerisation.  It  has 
been  suggested  that  multimerisation  of E1A E4  may  cause  filament  collapse  through 
cross linking, although this model  is brought into question when it is considered that 
monovalent Fab antibody  fragments are also  able to  induce  similar network collapse 
(Waseem et a l, 2004).
1.9.10  E1AE4 disrupts the cornified cell envelope
As  well  as  associating  to  keratins  HPV  11  and  59  E4  have  been  demonstrated  to
associate with and disrupt the cornified cell envelope (CCE) (Brown et al, 2004; Bryan 
et al, 2000a). The CCE forms a robust shell of proteins around cells in the upper layers 
of cornified epithelium providing mechanical strength and resistance to desiccation. The 
CCE is composed of proteins such as loricrin ,  involucrin,  keratins and small proline 
rich  proteins,  cross-linked  by  N-(y  glutamyl)  lysine  isopeptide  bonds,  created  by 
transglutaminase  (Kalinin  et  al,  2001).  Transglutaminase  is  activated  by  the  high 
calcium  environments  encountered  towards  the  surface  of differentiated  epithelium 
(Agardh et al, 2005). Interestingly activation of calcium-dependent PKC is required for 
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the CCE and E1A E4 expression are dependent on the same differentiation signal (Pray et 
al., 1995a). Immuno-fluorescence analysis showed cells expressing HPV 11 E1A E4 lack 
detectable  loricrin and keratin  10.  EM data also  demonstrated that CCEs  were up to 
65% thinner and displayed morphological aberrations in the presence of HPVI1  E1A E4. 
HPV  11  infected,  E1A E4  positive  cells  were  also  shown to  be  more  fragile.  HPV 11 
E1A E4 could be co-purified with the CCE. Experiments showed E1A E4 to be disulphide 
bonded to components of the CCE (Brown et al, 2000; Bryan et al., 2000a; Bryan et 
al., 2001).  Further experiments demonstrated that levels of loricrin mRNA transcripts 
were reduced suggesting that cell reinforcement systems may be  affected by  protein- 
protein interactions and at a transcriptional level (Lehr et al., 2002). In natural HPV  1  
lesions,  cells  expressing  E1A E4  also  showed  lower  levels  of loricrin  and  filaggrin, 
indicating that the CCE may be targeted by diverse papillomaviruses (Doorbar et al., 
1996).
1.9.11  HPV  16  E1AE4  interacts  with  mitochondria  inducing 
apoptosis
HPV  16 E1A E4 has been shown to associate with mitochondria when expressed at high 
levels in vitro. Mitochondrial association was seen to occur after association with, and 
collapse of the cytokeratin network.  Association of ElA E4-with mitochondria resulted 
in the formation of perinuclear aggregates, loss of membrane potential and apoptosis. It 
was suggested that ElA E4-induced apoptosis in the terminally differentiated layers of 
the epithelium may facilitate virion release (Raj et al., 2004).
1.10Papillomaviruses and cancer
The link between cervical cancer and papillomavirus infections was first made  in the
early 80’s(Reid et al., 1982). Why only a few papillomaviruses have the ability to cause
malignancies  is  still  not understood clearly.  Cervical neoplasias  are  graded using the
cervical intraepithelial neoplasia (CIN) scale ranging from CIN I to CIN III. As tissue
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progresses to CIN I a slight thickening of the mitotically active compartment occurs and 
by  CIN  III,  differentiation  in  the  tissue  is  lost  and  the  entire  epithelium  can  be 
mitotically active. Invasive cancer begins when transformed cells breakthrough into the 
dermis  and  invade  the  underlying  tissue.  Typically  only  10%  of CIN  I  lesions  will 
progress to CIN II with the rest spontaneously regressing. A significant percentage of 
CIN  III  lesions  may  progress  to  invasive  cancers.  Lesions  typically  take  years  to 
progress from CIN I through to invasive cancers, suggesting there are a series of stages 
that cells go through before cancers develop (Arends et al., 1998; Murthy et al., 2000).
1.10.1  HPV genome integration
One factor found to significantly increase the chances of neoplastic progression is viral 
genome integration into the host cell DNA (Vernon et al.,  1997).  In productive viral 
infections,  the  viral  genome  is  maintained  as  an  episome.  Although  integration  can 
occur at various sites in the host cells DNA,  the integration site  in the viral  genome 
remains relatively well conserved and results in the disruption of the of E1A E4 and E2 
ORF. While integrating viral DNA stands a chance of disrupting cellular oncogene and 
does  sometimes  occur,  the  effect  of  restructuring  viral  DNA  is  well  understood. 
Disrupting E1A E4 expression may prevent cyclin B1  mediated arrest from occurring. 
Loss of E2 expression results in the up-regulation of the HPV early promoter resulting 
in higher expression of the viral oncogenes E6 and E7 (Jeon et al.,  1995a; Jeon et al., 
1995b).  Integration  events  appear  to  occur  more  frequently,  with  high  risk  viruses 
suggesting that  certain DNA  sequences may be  partly responsible  for their high risk 
status  (Kessis  et  a l,  1996).  The  discovery  of  invasive  cancers  with  exclusively 
episomal  viral  DNA  shows  that  although  integration  plays  a  role  in  neoplastic 
progression it is not a prerequisite (Matsukura et a l,  1989). The finding of integrated
55Chapter 1 ______________________________________________________ Introduction
genomes  in  low  grade  lesions  also  suggests  that  secondary  factors  are  important  in 
malignant progression.
1.10.1.1  The role of HPV proteins in neoplastic progression
The HPV E6 protein is expressed in all cervical carcinomas and HPV transformed cell
lines.  Loss  of E6  expression  is  sufficient  to  reactivate  dormant  tumour  suppressor 
pathways inducing apoptosis in HeLa cells (Goodwin et a l, 2000). E6 proteins disrupt 
p53 function that normally guards cells against acquiring genetic mutations by arresting 
mitotic  cells  and/or  activating  apoptotic  pathways  following  the  detection  of DNA 
damage.  Prolonged  expression  of E6  can  allow  cells to  accumulate  genetic  damage, 
which  would  not  otherwise  be  permitted.  Cells  expressing  E6  have  been  shown  to 
withstand irradiation without undergoing cell  cycle  arrest or apoptosis  (Kessis et al., 
1993;  Storey,  2002).  Resistance  to  apoptotic  stimulation  also  makes  cells  more 
susceptible  to  genetic  damage  induced  by  exposure  to  environmental  carcinogens 
(Kjellberg et al, 2000).
A further function seemingly unique to high risk viruses is their ability to target cellular 
proteins for degradation.  Interactions between high risk E6  and E7s with their target 
proteins result in the degradation of RB  and p53.  This process is tightly regulated in 
normal viral  infections,  and the upregulation of these proteins  as a result of genome 
integration accentuates this affect resulting in a higher risk of cancer (Sherman et al, 
1996).
As with E6 and E7, the HPV E5 protein has transforming properties and is commonly 
referred  to  as  an  oncogene  (DiMaio  et  al,  2001),  although  the  exact  extent  of its 
involvement  in  neoplastic  progression  is  unclear.  E5  is  known  to  have  oncogenic
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properties such as the ability to stimulate anchorage independent growth of cells in vitro 
via its interaction with growth receptors (Leechanachai et al., 1992). Unlike E6 and E7, 
E5  is rarely  detected  in  invasive  cancers  and this  gene  is  commonly  lost during the 
integration process (Stoler et al, 1992).
1.10.2  Other risk factors linked to cervical cancer
Although  the  presence  of  high  risk  viral  DNA  is  though  to  be  essential  for  the 
development of squamous  cell  carcinoma (SCC),  it  is  clear that  other  factors play  a 
significant  role.  Additional  risk  factors  include  duration  between  puberty  and 
menopause (oestrogen exposure), use of the contraceptive pill,  genetic predisposition, 
immuno-suppression (especially after organ transplants), smoking, obesity, exposure to 
environmental  carcinogens  and  secondary  infection  such  as  HIV  and  chlamydia 
(Brisson et al.,  1994;  Daling et al.,  1992;  Kjellberg et al.,  2000;  Lacey  et al.,  2003; 
Luesley et al., 1994; Moreno et al., 2002; Munoz et al., 1997; Peng et al, 1991).
1.11  HPV management
1.11.1  Cervical screening
Cervical  cancer  is  the  second  most  prominent  female  cancer  (after  breast  cancer) 
globally responsible for >250,000 deaths annually (Parkin et al, 2005). In some western 
nations it has dropped to one of the most common female cancers due to the success of 
screening programs (Boyle et al., 2005). The relatively long period between hyperplasia 
and  invasive  cancer  (~4  years)  means  that  potentially  problematic  lesions  can  be 
detected and destroyed before they progress. The current cervical screening program is 
based on the Papanicolaou staining technique and involves the detection of abnormal 
cells based on their morphology alone (Warner et al.,  1989). The introduction of cell 
proliferations  markers  such  as  PCNA,  Ki67,  MCM,  and  pi6  may  revolutionise
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screening in the next couple of years (Doorbar et al., 2005; Dray et al., 2005; Freeman 
et al, 1999; Keating et al, 2001; Nieh et al., 2005; Williams et al, 1998).
1.12Papillomavirus vaccines
There are currently two different lines of vaccine research; these can be described as 
prophylactic and therapeutic. Prophylactic vaccines generate neutralising antibodies to 
virus capsid proteins preventing infections from occurring, whereas therapeutic vaccines 
work by stimulating the adaptive immune system in order to clear existing infections.
Recent research has demonstrated that papilloma vaccines are highly  subtype  specific 
and  provide  little  if  any  protection  against  closely  related  viruses  making  a 
comprehensive  cervical  cancer  vaccine  unlikely  in  the  near  future  (Giroglou  et  al, 
2001b).  The most promising line of research into a prophylactic vaccine using VLP’s 
consisting of LI  and L2 from both HPV 6,  11,  16 andl8 (Stanley, 2005;  Yang et al, 
2005; Zhou et al,  1991b).  A recent breakthrough was made when large scale clinical 
trials  results  showed  it to  provide  100%  protection  against  acquiring  new  infections 
(Harper et al, 2006; Koutsky et al, 2002; Mao et al, 2006; Villa et al, 2005) and the 
vaccine  is  now  considered  ready  for  FDA  approval.  Although  the  target  groups  is 
currently undecided, it has been suggested that the vaccine should be targeted at young 
girls between the ages of 11-13 before they become sexually active, as will provide less 
protection  to  those  already  infected  with  high  risk  viruses  (Short  et  al,  2006; 
Soubeyrand et al., 2005). Despite this success, many questions are left unanswered. The 
vaccine  is  still  relatively  expensive  to  manufacture  and  it  is  not  known  how  long 
protection  lasts  so  its  economic  viability  remains  to  be  seen  (Garnett  et  al,  2000). 
Another unknown factor is whether infections by  other high risk viruses will become
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more prevalent if HPV  16 and  18 infections are eradicated. The ability of the virus to 
evolve when placed under selective pressure also remains to be seen.
Work on therapeutic vaccines has looked at the early virus proteins El, E2, E5, E6 & 
E7.  E6  and E7  based  vaccines  have  been  shown to  provide  some  protection against 
subcutaneously  seeded  tumour  cells  (Meneguzzi  et  al.,  1991).  The  holy  grail  of 
research, a vaccine that could not only prevent infection but also treat lesions as well as 
associated tumours is still some way off.
1.12.1  Papillomavirus therapies
Despite the recent success of the new vaccine much remains to  be done to find new 
therapies  to  treat  pre-existing  papilloma  infections.  At  present  there  are  very  few 
therapeutic  options  available  for  the  treatment  of  lesions  and  these  are  relatively 
primitive.  The  most  commonly  used  treatment  involves  removal  or  destruction  of 
infected tissue.  Salicylic acid is currently used to bum away HPV 2 infected tissue in 
verrucas.  Persistent  cervical  lesions  can  be  ablated  using  cryotherapy,  loop 
electrosurgical  excision  procedure  or  surgical  excision.  More  recently  some  new 
products  such  as  imiquimod  cream  have  come  onto  the  market.  Imiquimod  is  a 
immunomodulatory  cream that  induces the  production  of cytokines  increasing  lesion 
clearance times (Beutner et a l,  1998). Although primarily intended for use on genital 
warts,  Imiquimod  has  recently  been  trialled  against  other  cutaneous  papilloma 
infections with some success (Harwood et al., 2005).
1.13  Virus release mechanisms
Viruses have evolved many mechanisms to identify, access and replicate inside specific 
host cells and numerous mechanisms have also developed to allow progeny virions to 
escape infected cells. The mechanism by which viruses exit their host cells depends on
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the final configuration of the mature virion, intended route of viral transmission and the 
intended duration of virus infection.  Enveloped viruses must pass through a host cell 
membrane  to  acquire  their  lipid  coats,  whereas  non-enveloped  viruses  have  evolved 
different  exit  strategies.  Virus  release  mechanisms  can  be  divided  into  three  main 
categories; budding, exit via secretory pathways, and cell lysis. Cell lysis should not be 
confused with cytopathic effect (CPE), which is commonly observed during viral egress 
from infected cells and is induced by a build up of toxic viral proteins and disruption of 
normal cell function.
1.13.1  Lytic exit strategies
The T4 bacteria phage has a simple exit strategy using the viral enzyme  lysozyme to 
cleave  open  cell  walls  and membranes  of infected  cells,  allowing  new  virions to  be 
released  into  the  environment  (Fischetti,  2005).  Viruses  of eukaryotic  hosts  have  to 
control  virion  release  more  carefully,  depending  on  whether  chronic  or  transient 
infections are to be established. Viruses intent on establishing chronic infections control 
virion  release  and  CPE-induced  cell  lyses  so  as  minimise  detection  by  the  immune 
system and excessive damage to host tissue. Transient infections such as with influenza 
tend to use more explosive infection strategies resulting in significant CPE and tissue 
damage. The high rate of virion release enables such viruses to out pace host immune 
responses (Smith et al., 2002).
1.13.2  Exit through secretary pathways
Simian virus 40 (SV40) belongs to the Polyomaviridae family of non enveloped viruses 
which  escape  from  cells  without  inducing  cell  lysis.  Newly  made  virions  are 
concentrated in intracellular vesicles, from where they are transported to the cell surface 
and released by membrane fusion event.  Release of SV40 can be blocked by treating 
cells  with  the  inhibitor  of intracellular  vesicular transport  monensin  (Clayson  et al,
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1989).  Vaccinia virions  are  shed  by  endocytosis  and  CPE  induced  lysis,  and  virions 
shed  by  different  methods  are  distinct  with  the  exocytosis-released  virions  being 
membrane bound and more infectious.
1.13.3  Lytic viral egress
Adenovirus is also a non-enveloped virus whose release is generally believed to require 
host cell lysis (Zhang et a l,  1994). Infection results in disruption of vimentin prior to 
viral  gene  expression  by  rapid  reaction  to  viral  adsorption  (Belin  et  a l 1987).  The 
adenovirus  E1B  protein  also  disrupts  the  vimentin  filament  network.  Collapse  of 
vimentin filaments results in the formation of perinuclear bundles (Janoff et a l,  1991). 
The  adenovirus  also  has the  ability to  disrupt keratin  filaments  using  the  adenovirus 
protease  (AVP).  Unlike  the  papillomavirus  this  is  caused  by  enzymatic  cleavage  of 
keratin 18 at amino acid 74 resulting in headless keratin molecules unable to polymerise 
(Chen et a l, 1993) AVP requires actin as a co factor for proteolytic cleavage of keratins 
(Brown  et  al,  2002).  In  addition  to  disrupting  the  cell  cytoskeleton,  adenovirus 
structural  proteins  are  also  toxic  to  cells  enhancing  CPE  and  possibly  aiding  virion 
release (Pettersson et a l,  1969). Adenoviruses appear to use CPE as a mechanism of 
virion release although  CPE  is aided by  specific proteins which  purposefully  disrupt 
host cell systems that may interfere with virion release.
1.13.4  Papillomavirus virion release ??
To  date very  little  is known about the papillomavirus release  mechanisms.  Egress  of 
mature  papillomavirus  virions  occurs  at  the  surface  off  terminally  differentiated 
epithelium and  so  is not directly  linked to viral  pathology.  It has been assumed that 
virions  are  released  into  the  environment  as terminally  differentiated  cell  slough  off 
from the  surface.  This  model  may  be true  to  a certain  extent  but  it  is probable  that 
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distribution and would more likely function to encapsulate virions (Luby-Phelps,  1994; 
Seksek et al,  1997).  It has previously been shown that the  E1A E4 protein associates 
with and disrupts keratin filaments in vitro and in vivo (Doorbar et al,  1991; Roberts et 
al,  1994;  Sterling  et al,  1993a;  Wang  et al,  2004).  HPV  11  E1A E4  has  also  been 
shown to disrupt and weaken cornified cell envelopes (Brown et al, 2004; Bryan et al, 
2000a;  Bryan  et  al,  2000b).  The  dramatic  upregulation  of E1A E4  towards  the  cell 
surface also points to it playing a role in virus egress. By disrupting and degrading the 
cytokeratin network the virus is likely to increase cell fragility, allowing fragmentation 
of terminally differentiated keratinocytes and the release of virus particles.  This effect 
would likely be enhanced by direct physical contact.
1.14Aims
The aims of this thesis are threefold.
1. To examine the mechanism by which HPV 16 E1A E4 induces keratin filament 
collapse in undifferentiated cells grown in monolayer culture {in vitro), and to 
determine the fate of affected keratins.
2. To relate these findings to the events which follow E1A E4 binding to keratins in vivo 
during natural infections in differentiated epithelium.
3. To establish the extent to which ElA E4-keratin interactions persist amongst HPV’s of 
distinct evolutionary origin, in an attempt to provide an insight into the role of the 
E1A E4 proteins during productive HPV infections.
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2  Materials and Methods
2.1  Materials
2.1.1  Suppliers of reagents
Except where specified, or in the exceptions given below, reagents were obtained from 
Sigma-Aldrich  Company  Ltd.  (Poole,  UK)  or  VWR  International  Ltd.  (Lutterworth, 
UK).
Agarose,  ammonium  persulfate  (APS),  ethidium  bromide  (EtBr),  sodium  dodecyl 
sulfate  (SDS) and N, N, N \ N’-tetramethylethylenediamine  (TEMED)  were  obtained 
from Bio-Rad Laboratories Ltd. (Hemel Hempstead, UK). Foetal calf serum (FCS) was 
obtained  from  Perbio  Science  UK  Ltd.  (Cramlington,  UK).  EMPIGEN  BB  ™  was 
obtained from Calbiochem, VWR International Ltd. ECL reagents, rainbow molecular 
weight markers, glutathione sepharose 4B and protein G sepharose beads were obtained 
from  Amersham  Pharmacia  Biotech  UK  Ltd.  (Little  Chalfont,  UK).  Ultra  Pure 
ProtoGel®  acrylamide  was  obtained  from  National  Diagnostics  Ltd.  (Hull,  UK). 
Restriction  endonucleases  and  Complete  Protease  Inhibitor  Cocktail  Tablets  were 
obtained  from  Roche  Diagnostics  Ltd.  (Lewes,  UK).  Phospho-specific  keratin 
antibodies (8250, 3055, LJ4 and 2D6) were kindly provided by Bishr Omary.
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2.1.2  Media and buffers
Name Components
1   x  Phosphate  buffered 
saline (PBS)
1   %  (w/v)  NaCl,  0.025  %  (w/v)  KC1,  0.14  %  (w/v) 
Na2HP04,  0.025  %  (w/v)  KH2  P04.  The  pH  was 
adjusted to 7.4 with concentrated HC1.
1   x  Tris-borate-EDTA 
(TBE)
1.21  % (w/v) Tris base, 0.62 % (w/v) boric acid, 0.19 
% (w/v) EDTA. pH 8.0.
2 x Laemmli buffer 4%  (w/v) SDS, 20 % (v/v) glycerol, 0.12M Tris, ImM 
DTT PH 8, containing a trace of bromophenol blue
Table 2.1 General buffers
Name Components
Luria-Bertani  (LB) 
medium
1   %  (w/v)  Tryptone,  0.5  %  (w/v)  yeast  extract,  1% 
(w/v)  NaCl.  The  pH  was  adjusted  to  7.0  with  5  N 
NaOH.
LB agar LB  medium  containing  2%  Bacto  agar  (Difco 
Laboratories Ltd., Detroit, USA).
Selective LB media LB medium or LB agar containing antibiotics [50 mg/1 
ampicillin (Amp) or kanamycin (Kan)l.
2 x TY medium 1.6 % (w/v) Tryptone,  1   % (w/v) yeast extract, 0.5  % 
(w/v)  NaCl.  The  pH  was  adjusted  to  7.0  with  5  N 
NaOH.
Table 2.2 E. coli growth media
Name Components
Trypsin-Versene 0.8  %  (w/v) NaCl,  0.02  %  (w/v)  KC1,  0.12  %  (w/v) 
NA2HP04,  0.02  %  (w/v)  KH2P04,  0.01  %  (w/v) 
EDTA,  0.01  %  (w/v)  trypsin,  0.001  %  (w/v)  phenol 
red.
Medium A DMEM  (Sigma)  containing  10  %  (v/v)  FCS  (unless 
otherwise  indicated),  0.01 % (w/v)  streptomycin  and 
0.006 % (w/v) penicillin.
Time-lapse medium C02  Independent  Medium  (Gibco)  containing  10  % 
(v/v)  FCS,  0.01 % (w/v)  streptomycin,  0.006  % (w/v) 
penicillin and 10 mM ascorbic acid.
Cell freezing solution FCS  containing  10%  (v/v)  dimethyl  sulfoxide 
(DMSO).
Table 2.3 Cell culture media and reagents
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2.2  Molecular biology techniques
2.2.1  DNA constructs used
In  cell  culture  wild  type  HPV  16E1A E4  was  expressed  by  transfection  of  the 
pMV11.16ElA E4  construct  (Davy  et  al,  2002)  and  by  infection  with  recombinant 
adenovirus  containing the rAD16ElA E4  construct  (Doorbar  et al.,  2000).  M2  E1A E4 
was expressed by infection with recombinant adenovirus containing the e M2 rAdM2 
construct (Wang  et al,  2004).  The T22A,  T23A mutant of E1A E4  was  expressed by 
transfection of the pMVll  E1A E4 T22A, T23A expression vector (Davy et al, 2002). 
|3gal was expressed by infection of recombinant adenovirus containing the rAD p— gal 
construct  (foumierl999).  HPV  2,  4,  18  31,  35,  45  and  65  E1A E4  proteins  were 
expressed by the transfection of the pcDNA 3 expression vectors kindly provided by Dr 
Heather  Griffin,  National  institute  for  medical  research,  London.  pYFP-ElA E4  was 
produced by cloning wild type E1A E4 into the pEYFP-Cl (Clonetech).
2.2.2  Details of the E. coli strain used
Strain Genotype Supplier
DH5a deoR  end  Al,  gyrA96,  hsdR17(rk-  mk+), 
recAl,  relAl,  supE44,  thi-1,  A(lacZYA- 
argFV169) <j>806tacZAM15, F-, X-
Clontech
(Basingstoke, UK)
2.2.3  Culture of E. coli
Cells were grown in LB medium containing suitable selective antibiotics to prevent loss 
of plasmids. Cultures were incubated at 37 °C either on agar plates or in liquid medium 
with 200 rpm shaking.
2.2.4  Long term storage of E. coli cultures
E.coli cultures were  stored for prolonged periods as  glycerol  stocks.  Glycerol  stocks 
were prepared by  mixing  equal  volumes  of mid-log  cultures  with  50  %  (v/v)  sterile 
glycerol. Solutions were mixed by inversion and stored at -70 °C.
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2.2.5  Preparation of electrocompetent E. coli
E.  coli cells (DH5a) were grown in LB medium at 37 °C with vigorous shaking to an 
A6oo value of 0.5. All subsequent steps were carried out at 4 °C.  Cells from 200 ml of 
culture were harvested by centrifugation at 4000g for 10 min in 250 ml centrifuge tubes 
(Coming,  UK)  using  a  J6  centrifuge  (Beckman  Coulter  UK  Ltd.).  Cells  were 
resuspended in 200 ml ice-cold ddtLO.  Cells were then centrifuged and resuspended 
three more times as above, but resuspension was performed sequentially in ddLLO (100 
ml),  then  10  %  glycerol  (4  ml)  and  then  10  %  glycerol  (200  pi).  The  final  cell 
suspension was stored in aliquots at -70 °C.
2.2.6  Transformation of E. coli by plasmid DNA
Approximately 100 ng of DNA was used to transform 40 pi of electrocompetent E.  coli 
cells  in  a  0.2  cm  cuvette  using  a  Gene  Pulser  (Bio-Rad  Laboratories  Ltd.,  Hemel 
Hempstead,  UK)  with  the  following  settings:  1.5  kV,  25 pF,  200 Q.  Cells  were 
recovered by suspension in 1   ml of S.O.C. medium (Invitrogen Ltd., Paisley, UK) and 
incubation  at  rt.  in the  absence  of an  antibiotic.  Cell  suspension  (100  pi)  was  then 
spread onto an LB  agar plate containing a suitable  selective  antibiotic  and incubated 
overnight at 37 °C.
2.2.7  Purification of plasmid DNA using commercially available kits
Plasmid  DNA  was  purified  from  E,  coli  using  the  Wizard®  Plus  Miniprep  DNA
Purification System (Promega UK Ltd., Southampton) or a Plasmid Maxi Kit (QIAGEN 
Ltd., Crawley, UK), in accordance with the manufacturer’s instructions.
2.2.8  Purification of DNA on a CsCI gradient
Plasmid  DNA  that  was  prepared  as  described  above  and  which  gave  poor  results 
following transfection was purified on a CsCI gradient as follows.  Bacteria containing 
plasmid DNA were  streaked onto a suitable selective LB agar plate.  A single colony
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was transferred into 5 ml of selective LB medium and incubated overnight at 37 °C with 
shaking.  A  1:1000  dilution  of this  was  used  to  inoculate  400  ml  of  selective  LB 
medium.  Following  incubation  as  above,  cells  were  harvested  by  centrifugation  as 
described in Section  1.2.4. The cell pellet was suspended in 4 ml of Buffer  1   (50 mM 
glucose, 25 mM Tris base,  10 mM EDTA, pH 8). Lysozyme solution (1  ml) was added 
to a final concentration of 5 mg/ml and the suspension was incubated for 5 min at r.t. 
Buffer 2 (0.2 M NaOH, 1  % SDS; 10 ml) was added and the lysate was incubated for 5 
min on ice.  Buffer 3  (3  M potassium  acetate,  11.5  %  (v/v)  acetic  acid;  7.5  ml)  was 
added and the solution mixed immediately and incubated for 5 min on ice. The solution 
was cleared by centrifugation at lOOOOg for 15 min at 4 °C in a JA20 rotor using a J25 
centrifuge (Beckman Coulter UK Ltd.). Propan-2-ol (13.5 ml) was added to the cleared 
supernatant, which was incubated for 5 min at r.t and centrifuged again as before. The 
nucleic acid pellet was washed with 70 % ethanol, air dried, resuspended in 4.95 ml of 
TE  buffer  (10  mM  Tris,  1   mM EDTA,  pH  8.0)  and  incubated  at  60  °C  until  pellet 
dissolved. This DNA solution was added to a tube containing 5.25 g of CsCI and 50 [i\ 
of 10 mg/ml EtBr. The solution was added to a 5.1 cm Quick-SeaKD ultracentrifuge tube 
(Beckman Coulter UK Ltd.) and centrifuged in a VTi 65.2 rotor using a Beckman L- 
90K  ultracentrifuge  at  200,000  g  overnight  at  20  °C.  The  DNA  band  was  collected 
using  a  syringe  and  needle.  EtBr  was  removed  by  washing  repeatedly  with  CsCI 
saturated  propan-2-ol.  Absolute  ethanol  was  added to  a final  concentration  of 75  % 
(v/v) and the DNA was precipitated by centrifugation  lOOOOg for  15 min at 4 °C in a 
JA20 rotor using a J25  centrifuge.  The pellet was washed in 70 %  (v/v) ethanol,  air- 
dried and resuspended in 0.5  ml TE  buffer.  An equal  volume  of equilibrated phenol 
chloroform was added, to obtain an aqueous phase the samples were vortexed for  10 s 
and centrifuged (10000 g, 2 min). The upper layer was removed into an equal volume ofChapter 2 Materials and Methods
phenol:chloroform:isoamylalcohol (24:24:1) and an aqueous phase obtained as before. 
To remove traces of phenol a final extraction was performed with an equal volume of 
chloroform.  The aqueous phase was collected and ethanol precipitated and the DNA 
pellet dissolved in 500 pi endonuclease-free water.
2.2.9  Quantification of DNA
DNA  concentrations  were  assayed  using  an  Ultrospec™  3300  pro  UV/Visible 
Spectrophotometer  (GE  Healthcare  UK Ltd.,  Chalfont  St.Giles,  UK).  DNA  solutions 
were diluted  1:500 and their A260 value measured.  It was assumed that an A260 of 1.0 
was equal to a DNA concentration of 50 pg/ml.
2.2.10  Agarose gel electrophoresis
PCR products and plasmids were separated on 1.5 % or 1  % agarose gels, respectively. 
Gels were buffered with  1   x TAE and contained  1   mg/ml EtBr.  Samples were mixed 
with  1/10  volume  their  volume  of  10  x  loading  buffer  (50  %  glycerol,  0.5  % 
bromophenol blue and 0.4 % (w/v) xylene cyanol). Electrophoresis was carried out at a 
constant  voltage  of  80  V,  limiting  to  200  mA.  DNA  bands  were  visualised  using 
transmitted  UV  illumination  and  compared to  DNA  markers  (New  England  Biolabs 
Ltd.,  Hitchin,  UK)  of known  molecular mass.  Images  were  captured  using  a  Kodak 
Image station 440 and digital science software ID software (Perkin Elmer Life sciences, 
Ltd., Cambridge)
2.2.11  Digestion of DNA with restriction endonucleases
DNA was digested with the appropriate restriction endonuclease in  1   x reaction buffer
(according  to  the  manufacturer’s  recommendation);  BSA  was  added  when  required. 
DNA (0.05-5 pg) was digested with 5 U of enzyme in a total volume of 40 pi for 1  h at 
37 °C. Enzyme was heat inactivated at 60 °C for 5 min.
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2.2.12  Treatment of plasmid DNA with alkaline phosphatase
To prevent self-ligation of endonuclease-digested plasmid DNA, the linearized vectors
were dephosphorylated at their 5’  ends.  Approximately  5  pg of vector was incubated 
with 5 U of calf intestinal alkaline phosphatase (Roche Diagnostics Ltd., Lewes, UK) in 
a total volume of 80 pi buffer for 1  h at 37 °C.
2.2.13  Polymerase chain reaction (PCR)
2.2.13.1  Primer design
A set of forward and reverse primers was designed to be complementary to the E1A E4
target gene sequence. Additional nucleotide sequences were added in order to encode a
Kozak  start  site  (Alberts,  2002)  (forward primer  only)  and to  incorporate  restriction
sites (Hind III, BamH I).  PrimerSelect software (DNASTAR Inc., Madison, USA) was
used to predict and minimize the formation of primer dimers and hairpin loops.  Primers
were obtained from Oswel Research Products Ltd. (Romsey, UK).
AAG AAG G /AA GCT T /AC CAT GGC TGA TCC TGC AGC -forward 
Hind III  E4
ATC ATT GTG ATG TGG GTA TC /CCTAGG/ TGG TGG  -reverse 
E4  BamH I
2.2.13.2 PCR reaction mix
Reagents used per 25 pi reaction:
Template DNA 100 ng
Deoxyribonucleotides (dNTPs) 2.5 mM each
10 x PCR buffer (ABgene) 2.5 pi
MgCl2  (ABgene) 2.5 mM
Forward primer 10 pmol
Reverse primer 10 pmol
Taq Gold polymerase (ABgene) lpl
The total volume was made up with ddH20.
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2.2.13.3 PCR conditions
PCR was performed on a PTC-200 DNA Engine Thermal Cycler (MJ Research, GRI,
Braintree,  UK)  using  the  following  program:  1   min  at  94  °C  (DNA  denaturation) 
followed  by  1   min  at  54 °C  (primer  annealing)  followed  by  1   min  at  72  °C  (DNA 
elongation). This cycle was repeated 30 times and followed by a final DNA elongation 
step of 10 min at 72 oC. A heated lid was used throughout.
2.2.13.4 Purification of PCR product
Following  separation on a  1%  agarose  gel,  the  PCR reaction products  were  purified
using the  QIAquick Gel  Extraction Kit (QIAGEN Ltd.,  Crawley,  UK)  in accordance 
with the manufacturer’s instructions.
2.2.14  Ligation of insert into vector
Following  restriction  endonuclease  digestion,  the  concentrations  of  the  insert  and 
vector were determined by gel quantification on a  1   % agarose gel using a low DNA 
mass ladder (Invitrogen Ltd., Paisley, UK). The insert was ligated with 0.5 pg of vector 
at a 6:1 molar ratio, using 40 U of T4 DNA ligase (New England Biolabs Ltd., Hitchin, 
UK)  in a total volume of 20 pi, and by incubation at 4 °C for  16 h,  according to the 
manufacturer’s instructions
2.2.15  Colony selection following ligation
Ligation reactions were used to transform E.coli as described in Section 2.2.6. To select 
colonies containing  a correctly  orientated insert,  individual  colonies were picked and 
used to  inoculate  2.5  ml  of LB,  containing  a  suitable  selective  antibiotic.  Overnight 
cultures were subsequently  screened by  PCR and restriction digest to  assays.  A PCR 
reaction was then  carried  out to  determine the presence  of an  insert;  reactions  were 
carried out as described in Section 2.2.12. Reaction products were run on a 1% agarose 
gel. Reactions resulting in a 300 bp band in the gel indicated the presence of insert in
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the  culture.  The  plasmid  was  prepared  by  miniprep  as  described  in  Section  2.2.7. 
Plasmid was  digested  as  described  in  Section 2.2.11  and the  reactions  run  on  a  1% 
agarose gel to check for the presence of insert.  Colonies with a positive result in both 
these  assays  were  selected.  DNA  was  prepared  from  these  colonies  as  described  in 
Section 2.2.7.
2.3  Cell culture techniques
2.3.1  Cell lines
2.3.1.1  SiHa cells
SiHa cells  (Friedl  et al.,  1970) are a transformed cervical  epithelial  cell  line derived 
from a tumour containing integrated HPV 16 genomes. SiHa cells constitutively express 
E6/E7 but lack E1A E4 expression due to loss of the E1A E4 ORF caused by integration 
of the viral genome.  This cell type gives high efficiency infection with recombinant 
adenoviruses (rAd).
2.3.1.2  AK8 & AK13 cells
Both cell lines were derived from a vulva carcinoma cell line and were kindly provided
by Rudolph Leube (Windoffer et al., 1999); (Stmad et al., 2001). AK8 cells were stably 
transfected  with  ECFP-human  keratin  8  plasmid  and  express  a  ECFP-tagged  8/18 
keratin network.  AK13  cells were stably transfected with an EGFP-human keratin  13 
plasmid. Both cell lines are grown in 1   pg/ml geneticin every fourth passage to maintain 
expression levels.
2.3.1.3  HaCaT cells
HaCaT  cells  are  a  human  keratinocyte  cell  line  which  was  obtained  following  the
transformation of normal skin cells by culturing in calcium-rich medium (Boukamp et
71Chapter 2 Materials and Methods
al, 1988). HaCaT cells express numerous keratin subtypes, including K8/18 and K5/14, 
and also Kl/10 and K5/13, which are differentiation-dependent.
2.3.1.4  SW13 C2 and T7K cells
The  SW13  C2  cell  line  was  derived  from  a human  adrenal  tumour  (Hedberg  et al.,
1986).  This  cell  line  lacks  expression  of  any  intermediate  filament  networks  but 
contains intact microtubule and actin cytoskeleton networks. The  SW13 T7K cell line 
also expresses a functional keratin 8/18 network.  These cell lines could be transfected 
and rAd infected.
2.3.2  Routine cell culture
Unless otherwise stated, cells were grown in medium A in flasks of surface area 75 cm2 
at  37  °C  and  5  %  (v/v)  CO2.  Cells  were  grown  to  80  %  confluence  before  being 
subcultured.  To  do  this,  cells  were  washed  in  2  ml  trypsin/versene  then  2  ml  fresh 
trypsin/versene  was  applied  to  the  cells  for  approximately  5  min  at  37°C  until  they 
became  detached  from  the  flask.  Trypsin was  quenched  by  the  addition  of 5  ml  of 
medium. Cells were routinely split 1/20 into a new flask containing 10 ml of medium.
2.3.3  Long term storage of cells
Cells were detached from the flask as described above and harvested by centrifugation 
at 2500 g for 5  min at r.t.  Cells were suspended in 5  ml  cell  freezing  solution (FCS 
containing 10 % DMSO) and divided into 1  ml aliquots which were then wrapped in 5 
layers of paper tissue.  Tubes were then transferred to a -70 °C freezer for  16 -  24 h. 
After freezing, cells were transferred to liquid nitrogen for long term storage.
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2.4  Cell transfection and infection techniques
2.4.1  DNA transfection
Cells were seeded onto glass cover slips in the wells of a 24 well plate at a density of 
3x104 cells in 0.5 ml medium per well and grown for 24 h as described in Section 2.3.2. 
Cells  were  then  transfected  using  GeneJuice®  transfection  reagent  (Novagen, 
Nottingham,  UK)  in  accordance  with  the  manufacturer’s  instructions  using  vectors 
prepared as described in section 2.2.1.
2.4.2  Infection of cells with adenovirus
2.4.2.1  G1/S phase synchronization of SiHa cells
To arrest SiHa cells at the Gl/S phase boundary prior to rAd infection, 70% confluent
flasks  of SiHa cells  were  grown  in  low-serum medium  (medium  A  containing  0.5% 
(v/v) FCS) for 48 h. Cells were then treated with trypsin (Section 2.3.2) and grown in 90 
mm dishes at a density of 5x105 cells per dish in 5 ml medium A containing 2 p,g/ml 
aphidicolin.  Cells were released from this block after 24 h by washing 3 x in 5 ml of 
sterile PBS and incubation in medium A.
2.4.2.2  Adenovirus infection of SiHa cells
Adenovirus  was  applied  to  SiHa  cells  at  a  multiplicity  of  infection  of  100  virus
particles per cell in 5 ml of medium A for 24 h medium was then removed and the cells 
were washed twice with 5 ml PBS and incubated in fresh medium A. Time points were 
measured from the point of rAd addition to cells.
2.5  Biochemical and cell biology techniques
2.5.1  Antibody techniques
2.5.1.1  Preparation of phage antibody
The B11  Fab antibody was purified from the periplasmic space of E. coli as follows. An
overnight culture of E.  coli, transformed with pUC119His.6myc containing an HPV  16
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immunoglobulin  gene  (Doorbar  et al,  1997),  was  set  up  in  10  ml  2  x  TY  medium 
containing 1  % glucose. This was used to inoculate two flasks each containing 1.5 1  TY 
medium and 0.1 % glucose. Cells were grown at 37 °C to an A6oo value of 0.8, induced 
with 1  mM IPTG and grown for 3 h at 30 °C. Cells were harvested by centrifugation in 
a Beckman J6 centrifuge at 2000 g for 15 min at 4 °C. They were gently suspended in 
ice-cold resuspension buffer (0.6 M sucrose, 1  mM EDTA, 30 mM Tris, pH7.9) and left 
for 20 min on ice. Cells were then centrifuged in a Beckman JA20 rotor at 5000 x  g for 
10 min at 4 °C and the supernatant was reserved on ice. The pellet was resuspended in 
ice-cold 5 mM MgSC> 4 and incubated for 20 min on ice.  Cells were centrifuged once 
more  as  before,  the  supernatant  was  combined  with  the  previous  one  and  this 
preparation (termed the “periplasmic prep”) was stored at -20 °C. If either supernatant 
was cloudy then it was centrifuged at 5000 g as above until all particulate material had 
been removed. Ni-NTA Agarose resin (QIAGEN) was centrifuged at 200 g for 5 min at 
4 °C in a bench top centrifuge. The ethanol was removed and discarded and the beads 
were washed in  10 ml of binding buffer (0.5 M NaCl,  5 mM imidazole, 20 mM Tris, 
pH7.9) by centrifugation as before. Washed beads were added to the periplasmic prep 
and  put  on  an  end  over  end  rotator  at  4  °C  for  1   h  to  allow  binding.  Beads  were 
centrifuged as before and the supernatant discarded. The beads were resuspended in 80 
ml of binding buffer and placed on the end over end rotor for a further 10 min followed 
by centrifugation as before.  The resin was then washed twice more in 30 ml binding 
buffer by resuspension and centrifugation as before. Beads were resuspended in 30 ml 
of binding  buffer  and then transferred to  a Poly-Prep  column  (Bio-Rad  Laboratories 
Ltd.). The excess buffer was allowed to run through and the column was washed with a 
further 5 ml buffer. The antibody was eluted with 6 ml of elution buffer (0.5 M NaCl,  1  
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(Pierce SnakeSkin™, 7000Da cut-off, Perbio Science UK Ltd.) and dialysed overnight 
against 3  1  of PBS  at 4 °C.  The PBS was changed for another 3  1  and dialyzed for a 
further 3 h. The final solution was snap frozen and stored at -20 °C.
2.5.1.2  Conjugation of phage antibody to Alexa Fluor® 488
The  protein concentration in the  antibody preparation was  determined  by taking  the
A280  value  as  described  in  Section  2.2.9.  The  solution  was  then  concentrated  in  an 
Amicon®  Ultra-15  Centrifugal  Filter  Device  (Millipore  Ltd.,  Watford,  UK;  MWCO 
10000)  to  a  concentration  of  2  mg/ml.  The  protein  was  then  labelled  using  the 
Molecular Probes™ Alexa Fluor® 488  Labelling Kit (Invitrogen Ltd.)  in accordance 
with the manufacturer’s instructions.
2.5.2  Sample  preparation  from  cells  prior  to  immunoprecipitation 
and/or gel electrophoresis
2.5.2.1  Treatment of cells with proteasome inhibitors
Cells were infected with 16E4 or p-gal rAd as described in Section 2.4.2.2. Cells were
treated with either  10  pM ALLN  (Calbiochem,  VWR International  Ltd.),  10  pM  of 
MG132  (Sigma-Aldrich  Company  Ltd.)  or  5  pi  of vehicle  (DMSO)  18  h  prior  to 
harvesting.
2.5.2.2  Harvesting cells treated with proteasome inhibitors
Cells were washed twice in PBS and the plates were inverted and blotted dry on clean
tissue.  Lysis buffer  (1  %  (w/v)  SDS/PBS  150  pi  per plate)  was  added  and the  cells 
scraped off with a cell scraper. Genomic DNA was digested from lysate by the addition 
of Benzonase (125 U/Plate) Novagen, Merck Biosciences Ltd., Nottingham, UK).
2.5.2.3  Treatment of cell lysate with isopeptidase
SiHa cells were seeded in a 90 mm dish at a density of 5 x  105  cells/dish.  Cells were
infected  with  rAd  as  described  in  Section  2.4.2.2  24  h  after  seeding.  Cells  were
75Chapter 2_____________________________________________ Materials and Methods
harvested 48 h post infection by incubation in  1   mM EDTA in PBS followed by cell 
scraping and centrifugation at 2500 g for 5 min at r.t. The pellet was suspended in 400 
pi of reaction buffer (25 mM HEPES pH 7.5, 10 mM DTT, 0.5 % NP40 (v/v)) and the 
resulting cell lysate was treated with 0.5 pi Benzonase (125U) and placed on ice for 30 
min, mixing every  10 min during the incubation. Isopeptidase (4 U, Calbiochem) was 
added to 5 pi of reaction buffer and incubated at r.t. for 15 min. Cell lysate (2 pi) was 
added and the mixture incubated at r.t. for 20 min. The mixture was boiled for 5 min in 
Laemmli  buffer  and  the  proteins  were  separated  on  a  12  %  SDS-PAGE  gel  and 
visualized  by  western  blot  (Section  2.5.5).  To  determine  the  extent  of the  reaction 
treated and untreated control samples were probed with a ubiquitin antibody. Successful 
reactions were determined by significant redistribution of ubiquitin bands.
2.5.2A  Cell fractionation
SiHa cells were fractionated according to solubility in different detergents.  Following
rAd infection and harvesting (see Section 2.5.2.2 ) the cell pellet was suspended in 200 
pi  of lysis buffer (1  % (v/v) NP40,  0.5  pi  Benzonase  (125U)  and  25  mM  Complete 
Protease Inhibitor Cocktail in PBS). The cell lysate was incubated with rotation for 1   h 
at 4 °C and then centrifuged at 10000 g for 10 min at 4 °C. The supernatant (the “NP-40 
fraction”)  was  reserved.  The  pellet  was  suspended  in  200  pi  PBS  containing  1% 
EMPIGEN BB™ (v/v) and 25 mM Complete Protease Inhibitor Cocktail by vigorous 
pipetting, and incubated with rotation as before. The extract was centrifuged as before 
and the supernatant (the “Empigen fraction”) was reserved. The remaining protein pellet 
was suspended in 200 pi of 9 M urea (the “urea fraction”). All fractions were stored at -  
20 °C.
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2.5.3  Sample  preparation  from  tissue  sections  prior  to 
immunoprecipitation and/or gel electrophoresis
2.5.3.1  Sectioning lesions using a cryostat
HPV lesions stored under liquid nitrogen were defrosted and fixed in acetone for 3 min
at -20 °C. Following 5 min rehydration in 20 ml distilled water they were placed in a 
plastic  mould  and  covered  in  OCT  compound  (VWR  International  Ltd.).  OCT 
compound was solidified by dipping the mould into absolute ethanol cooled to -78 °C 
with  solid  CO2.  The block was then  crudely trimmed  using  a razor blade  and  left a 
further 10 min in the cryostat (Leica JUNG CM3000). A piece of moistened filter paper 
was attached to a cryostat chuck by immersion in chilled ethanol, OCT compound was 
applied  to  this  and the  lesion  attached  by  solidifying  the  OCT  compound  in  chilled 
ethanol.  The  chuck  was  mounted  into  the  cryostat  and  excess  OCT  compound  was 
removed with a razor blade. Slices (20 pm) were taken through each lesion from top to 
bottom.  Sections were collected in pairs using forceps pre-cooled on dry ice; each pair 
was stored at -80 °C in a 1.5 ml microcentrifuge tube.
2.5.3.2  Protein extraction from lesions
Sectioned lesions were defrosted and 40 pi of protein extraction buffer (1 mM DTT, 10
%  (w/v)  SDS  in  PBS)  added to  each tube.  Following  2  min  incubation  with  0.5  pi 
Benzonase  (125U)  at  4  °C,  the  protein  was  solubilized  vigorously  using  a  pipette. 
Samples were boiled for 20 min before SDS-PAGE (Section 2.5.5).
2.5.4  Immunoprecipitation techniques
2.5.4.1  Covalent coupling of antibody to protein G sepharose beads
Protein G sepharose beads (50 pi) were equilibrated by washing in binding buffer (1 %
NP-40 / PBS) and centrifuged 3000 g for 5min to remove ethanol  (two washes were
performed).  For  antibody  coupling,  equilibrated  beads  were  suspended  in  1   ml  of
binding buffer and antibody was added. The mixture was rotated for 1  h at 4 °C to allow
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antibodies to bind. Beads were washed twice in 1   ml 0.2 M sodium borate (pH 9.0) by 
centrifugation as before.  Beads were suspended in  1   ml of this buffer and 20 pi were 
taken for analysis. Solid dimethyl pimelimidate (DMP) was added to a concentration to 
20 mM. The mixture was rotated for 30 min at r.t. and 20 pi were taken for analysis. 
The reaction was stopped by washing the beads once in 1  ml of 0.2 M ethanolamine (pH 
8.0)  by  centrifugation as before  followed  by  suspension  in  1  ml  fresh  ethanolamine 
buffer and rotation for 2  h at 4  °C.  Beads  were  then washed twice  in  1   ml  PBS  by 
centrifugation as before,  suspended in  1   ml  of PBS  containing  0.01  % (w/v)  sodium 
azide and stored at 4 °C.
2.5.4.2  Analysis of antibody coupling efficiency
Beads were removed prior to and after the addition of the covalent cross linking agent
DMP, as described above. They were boiled for 5 min in 2 volumes of Laemmli buffer, 
and  separated  by  SDS-PAGE  and  stained  with  Coomassie  Brilliant  Blue  R-250  as 
described in Section 2.5.5.  Coupling was deemed successful if antibody heavy chains 
could not be detected after the addition of DMP.
2.5.4.3  Immunoprecipitation
SiHa cells were grown in 90 mm dishes and infected with rAd as described in Section
2.4.3. They were harvested 24 h post infection in 200 pi of lysis buffer (1 % (w/v) SDS 
in PBS), treated with 0.5 pi Benzonase (125 U) and centrifuged at 13000 g for 10 min. 
Supernatant (50 pi) was mixed with 950 pi binding buffer (1  % (v/v) NP-40 in PBS), 
incubated at 4 °C on an end over end rotator for 1   h and centrifuged at  13000 g for 10 
min at 4 °C to remove any precipitated protein.  The  supernatant (950 pi) was mixed 
with  5 pg  antibody  and  allowed  to  bind  on  an  end  over  end  rotator  as  before. 
Equilibrated  protein  G  sepharose  beads  (Section  2.5.4.1;  50  pi)  were  added  to  the 
mixture, which was rotated for 1  h at 4 °C. Following centrifugation at 1000 g for 2 min
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at r.t. beads were suspended in 1   ml of binding buffer, this wash was repeated 4 times. 
The proteins were eluted by boiling in 20 pi Laemmli buffer (-DTT) for 5 min at 95 °C 
and visualised by SDS-PAGE and western blot (Section 2.5.5).
2.5.4.4  Immunoprecipitation  using  antibodies  coupled  to  protein  G 
sepharose beads
Beads that had been coupled to antibodies were washed 3 times in binding buffer and 
suspended in  1   ml of binding buffer as described in  Section 2.5.4.1.  Cell  lysates and 
beads were incubated with rotation for 3 h at 4°C. Beads were then washed and treated 
as described in the previous section.
2.5.5  Gel electrophoresis and protein analysis
2.5.5.1  SDS polyacrylamide gel electrophoresis (SDS-PAGE)
Gels  were  cast  in  Mini-PROTEAN®  II  gel  apparatus  (Bio-Rad  Laboratories  Ltd.)
according  to  the  table  below.  Samples  were  loaded  onto  gels  and  separated  by 
electrophoresis in gel running buffer (25 mM Tris pH 8.3, 200 mM glycine, 0.1 % SDS) 
at  150  V  and  200  mA  until  the  dye  front  reached  the  end  of the  gel.  Rainbow™ 
Molecular  Weight  Markers  (Amersham  Pharmacia  Biotech  UK  Ltd.)  were  used  to
determine the mass of separated proteins.
12 % 15% Stacking gel
Water 3.3 ml 2.3 ml 6.8 ml
ProtoGel®  (30  %  acrylamide,  0.8  %  bis- 
acrylamide)
4.0 ml 5.0 ml 1.7 ml
1.5 M Tris (pH 8.8) 2.5 ml 2.5 ml -
1.0 M Tris (pH 6.8) - - 1.25 ml
10% SDS 0.1 ml 0.1 ml 0.1 ml
10% APS 0.1 ml 0.1 ml 0.1 ml
TEMED 4 pi 4 pi 10 pi
Table 2.4 Polyacrylamide gel recipes
2.5.5.2  Silver staining of SDS-PAGE gels
Gels were fixed in 50 % (v/v) methanol for 30 min, incubated in 0.019 % (w/v) sodium
thiosulfate solution for 1   min and briefly washed three times in ddH20. Gels were then
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incubated  with  staining  solution  (0.37  %  (w/v)  formaldehyde,  0.26  %  (w/v)  silver 
nitrate) for 8 min and briefly washed three times with ddlHhO.  Bands were visualized 
using developing solution (2 % (w/v) sodium carbonate, 0.016 % (w/v) formaldehyde, 
0.004 % (w/v) sodium thiosulfate).  The staining reaction was stopped with  1   % (v/v) 
acetic acid.
2.5.5.3  Coomassie blue staining of SDS-PAGE gels
SDS-PAGE  gels  were  incubated  in  Coomassie  blue  stain  (0.25  %  (w/v)  Coomassie
Brilliant  Blue  R-250,  50%  (v/v)  methanol,  10  %  (v/v)  acetic  acid)  for  30 min  with 
shaking. Gels were rinsed three times in ddH20 and incubated in destain solution (50 % 
(v/v) methanol,  10 % (v/v) acetic acid) overnight with shaking, a tissue being placed in 
the container to soak up excess dye.
2.5.5.4  Transfer of proteins to membranes (western blotting)
Protein from gels was transferred to Immobilon-P membrane (Millipore Ltd.) using a
Mini Trans-Blot® (Bio-Rad Laboratories Ltd.)  at  150 V,  200 mA for 2  h in transfer 
buffer (25 mM Tris-HCl pH 8.3, 200 mM glycine, 20 % (v/v) methanol). Membranes 
were  blocked  by  incubation  with  Marvel  solution  (5  %  (w/v)  Marvel  (Premier 
International Foods Ltd., Spalding, UK) in PBS) overnight at 4 °C.
2.5.5.5  Detection of protein on membranes
Primary  and  secondary  antibodies  were  diluted  in  Marvel  solution  before  use  (see
antibody table “Table- 2.5”). Membranes were incubated in primary antibody for 1   h at 
r.t., rinsed in PBS and washed three times in PBS containing 0.1  % (v/v) TWEEN® 20 
(Sigma-Aldrich Company Ltd.)  for  5  min at r.t. This process was repeated using the 
appropriate  secondary  antibody.  Binding  of the  secondary  antibody  was  visualized 
using the ECL ™ Western blotting analysis system (Amersham Biosciences Ltd., Little
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Chalfont,  UK)  followed  by  exposure  to  Kodak  MXB  X-ray  film  (Xograph  Imaging 
Systems Ltd., Tetbury, UK).
2.6  Staining and imaging techniques
2.6.1.1  Antibody staining of cells grown on cover slips
Cells that  had  been  grown  on  and  either  transfected  or  infected  on  cover  slips  (see
Section 2.4) were washed twice in PBS, fixed in  100 % methanol for 2 min at -20 °C 
and washed twice in PBS. They were then blocked in 300 pi of blocking solution (2 % 
(w/v)  BSA  in  PBS)  for  1   h.  Antibodies  were  diluted  (see  “Table2  5.”)  in  staining 
solution (1 % (v/v) FCS in PBS). Cover slips were inverted and each was placed on a 50 
pi  drop  of primary  antibody  on a sheet of sealing  film  and  incubated  in  a darkened 
humidified chamber for 1  h at r.t. They were then washed once in PBS containing 0.1 % 
(v/v) TWEEN® 20 and three times in PBS. If required, cover slips were incubated in a 
second primary  antibody  and then washed  as before.  They  were  then  incubated  in  a 
solution of secondary antibody(s) containing 1  pg/ml DAPI as above. They were washed 
as  before,  rinsed  in  distilled  water,  blotted  dry  and  mounted  on  a  5  pi  drop  of 
Citifluor™ (Agar Scientific Ltd., Stansted, UK) on a microscope slide.
2.6.1.2  MitoTracker staining of cells grown on cover slips
Cells  were  transfected  on  cover  slips  as  described  in  Section  2.4.1.  Medium  was
removed  30  min  prior  to  fixation  and  replaced  with  500  pi  medium  containing 
MitoTracker  Red  (Molecular  Probes™,  Invitrogen  Ltd.)  diluted  1/4000  from  stock 
(1 pM in DMSO stored -20 °C). Cells were incubated in 5 % CO2 for 30 min at 37 °C 
before being fixed with methanol and stained as above.
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2.6.1.3  Antibody  staining  of  formalin  fixed  paraffin  embedded  tissue 
sections
Formalin  fixed  paraffin  embedded tissue  sections were  given three  5  min washes  in 
xylene,  rehydrated  in  graded  ethanol  (100  %,  80  %,  50  %  and  then  30  %  (v/v), 
sequentially; 5 min in each) and washed in PBS. They were then heated in a microwave 
on high power for 18 min in phosphate citrate buffer (0.05 M sodium phosphate, 0.025 
M citric acid, pH 6.0). The sections were allowed to cool on the bench for 5 min before 
two 5 min washes in PBS. The sections were then blocked for 2 h in 10 % (v/v) normal 
goat  serum  (Dako  Ltd.,  Ely,  UK)  in  PBS.  Antibody  solutions  were  prepared  as  in 
Section 2.6.1.1. Sections were wiped to remove excess blocking solution, 50-200 pi of 
primary antibody was applied to the tissues, and the slides were placed in a darkened 
humidified chamber overnight at 4 °C. They were then washed three times for 5 min in 
PBS containing 0.1  % (v/v) TWEEN® 20. The incubation was repeated with a second 
compatible  (i.e.  rabbit  and  mouse)  primary  antibody  solution;  sections  were  washed 
again  and  subsequently  incubated,  with  Alexa  488  and  594  conjugated  secondary 
antibodies  containing  1   pg/ml  DAPI,  washing  after  each  incubation  as  before.  The 
slides  were  then  rinsed  in  distilled  water  and  mounted  in  Citifluor  using  an 
appropriately sized cover slip.
2.6.2  imaging techniques
2.6.2.1  Low power microscopy
Low power images of tissue  sections were  acquired using  a Labophot II  microscope
(Nikon  Ltd.,  Kingston-upon-Thames,  UK).  Images  were  acquired  using  a  SenSys 
monochrome camera using IPLab imaging  software  (Roper  Scientific,  Marlow,  UK). 
Three colour images were produced using the software to overlay separate channels.
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2.6.2.2  Confocal microscopy
Cells  images  were  acquired  using  a  Leica  DMRXE  upright  microscope  (Leica
Microsystems Ltd., Milton Keynes, UK) and a  100 x objective lens, unless otherwise 
stated.  Specimens were scanned using the following excitation (ex) and emission (em) 
wavelengths: DAPI, ex 359 nm, em 395-520 nm; Alexa-488, ex 488 nm, em 505-685 
nm;  Alexa-594,  ex  568  nm,  em  595-710  nm;  Cy5,  ex  647  nm,  em  655-725  nm. 
Fluorophores were  excited  sequentially to reduce cross channel  bleed through and to 
allow  maximum  emission  detection.  Specimens  were  scanned  with  0.5  pm  intervals 
between Z sections with 4 accumulations per frame. Images are presented as an overlay 
projection  of all  frames,  resulting  in a composite  image,  or  as  an  individual  optical 
section when examining fine structures.
2.6.2.3  Quantitative confocal microscopy
To quantify protein expression levels (using fluorescence), samples were stained using
identical  concentrations of both primary and  secondary  antibodies.  Image  colour was 
adjusted using  the  overglow-underglow function;  where  possible,  gain  and  overglow 
were adjusted to remove all off scale pixels (green pixels have grey  scale values <0, 
blue pixels have grey scale values >255. When this was not possible, settings were set 
to  give  the  lowest  fluorescence  at  which  an  image  could  be  obtained.  Fluorescence 
intensities were analysed using built-in software (Leica. Microsystems Ltd.).
2.6.2.4  Time-lapse microscopy
Cells  were  seeded  at  3x105  cells  per  dish  in  60  mm  glass  bottom  dishes  (MatTek
Corporation,  Ashland,  USA).  Cells  were  grown  for  24  h  (medium  A)  before  being 
transfected with EYFP16E4 using Genejuice (Section 2.4.1). Medium was replaced 12- 
24  h  after  transfection  with  2  ml  of warmed  time-lapse  medium.  The  cells  were 
transferred to the chamber of a DeltaVision microscope (Olympus Ltd., London, UK)
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that had been preheated to 37 °C. The cells were left to equilibrate for at least 1  h then 
imaged using a 100 x lens at Bin 1.
2.6.2.5  Fluorescence recovery after photobleaching (FRAP)
FRAP experiments were performed on living cells plated as described previously using
a  DeltaVision  microscope  equipped  which  a  488  nM  Quantifiable  Laser  Module 
(QLM).  The beam expander was set to position  1   and the Laser spot centred using a 
target cell. During centring, the laser intensity was set to  12 % for the minimum spot 
size.  Targets  were  then  aligned  using  the  pre-adjusted  cross  hairs.  Targets  were 
bleached by a 0.05 s pulse with the laser set at 25  % power.  Subsequent images were 
captured  using  softWoRx®  QLM  software  (Applied  Precision®,  LLC,  Marlborough, 
UK). Bleached targets were then tracked using a custom built patch (provided by Dan 
Zue  NIMR)  in  ImageJ  and  then  exported  to  and  analyzed  using  Microsoft®  Office 
Excel software.
84Antigen Antibody Raised in Supplier Western
Blot
Immunohistochemitry/
Immunocytochemitry
HPV 16E4 TVG402 Mouse In House 1/20 1/10
High  risk  HPV 
ElA E4’s
TGV405 Phage In House - 1/100
Pan Keratin 
Ab cocktail (C2562)
(C2562)  C-ll,  PCK-26, 
K.S-90,  K.S-1A3,  M20, 
A53-B/A2
Mouse Sigma 1/1000 1/200
Pan Keratin Ab8797 Rabbit abeam - 1/1
Keratin 5 & 8 Cam5.2 Mouse MRC 1/100 1/10
Keratin 18 Cy-90 Mouse Sigma 1/1000 1/200
Keratin 1 LH1 Mouse ICRF 1/10
Keratin 1 NCL-CK1 Mouse Novacastra - 1/100
Keratin 4 NCL-CK4 Mouse Novacastra - 1/100
Keratin 5 LH8 Mouse ICRF - 1/10
Keratin 5 NCL-CK5 Mouse Novacastra - 1/100
Keratin 16 LL025 Mouse ICRF - 1/10
Keratin 10 NCL-CK10 Mouse Novacastra - 1/100
Keratin 10 K0199-12 Mouse US Biological 1/100 -
Keratin 13 NCL-CK13 Mouse Novacastra - 1/100
Keratin 14 LL001 Mouse ICRF - 1/10
Keratin 14 NCL-11002 Mouse Novacastra - 1/100
Keratin 14 C9097-14B Mouse US Biological. 1/200 -
LJ4 LJ4 Mouse Omary MB. 1/1000 1/100
3055 3055 Rabbit Omary MB. 1/2000 1/1000
2D5 2D6 Mouse Omary MB. 1/1000 1/100
8250 8250 Rabbit Omary MB. 1/2000 1/1000
IB4 IB4 Mouse Omary MB 1/1000 1/100
a Tubulin B512 Mouse Sigma - 1/250
85a Mouse A488 A-11029 Goat Molecular Probes - 1/200
a Rabbit A488 A-11034 Goat Molecular Probes - 1/200
a Mouse A594 A-11032 Goat Molecular Probes - 1/200
a  Rabbit A594 A-11037 Goat Molecular Probes - 1/200
a  Goat A594 A-11058 Donkey Molecular Probes - 1/200
a Mouse HRP NA931 Goat Amersham 1/2000 -
a  Rabbit HRP NA934 Donkey Amersham 1/2000 -
a  Rat A594 A-21211 Rabbit Molecular Probes 1-200
HPV2 E4 - Rabbit In House - 1/750
HPV 11 E4 - Rabbit In House - 1/100
HPV1 E4 - Rat In House - 1/500
HPV1 E4 - Rabbit In House - 1/?
HPV 18 E4 - Rabbit In House - 1/500
HPV 4 E4 - Rabbit In House 1/750
HPV65 E4 - Rabbit In House 1/750
Mitochondria Mtco2 Mouse RDI - 1/100
Cyclin B GNS11 Mouse Neomarkers - 1/200
MCM7 47DC141 Mouse Neomarkers - 1/150
GAPDH MAB374 Mouse Chemicon 1/2000 -
Ubiquitin Sc-8017 Mouse Santa cruze 1/200 1/100
Ubiquitin Z0458 Rabbit DAKO 1/2000 1/500
Table 2.5 Antibodies
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3  Conservation of function between E1AE4 proteins
3.1  Aims
The  E1A E4  protein  is  a  complex  protein  with  multiple  and  varying  functions,  the 
purposes  of which  are  not  yet  fully  understood.  The  aim  of this  study  was  to  use 
immunofluorescent staining to determine whether the known functions of the HPV  16 
E1A E4 protein (mitochondrial, keratin and cyclin B binding) are conserved in other high 
risk a-group E1A E4 proteins. The properties of HPV 2 E1A E4, and a-group virus that 
causes benign cutaneous infections, was also investigated to determine if viruses with 
mucosal and cutaneous tropism from the same genera behave in the  same fashion.  In 
addition to these viruses, it was decided to investigate whether the E1A E4 proteins from 
an evolutionary  distant branch of the phylogenetic tree  share functions with a-group 
E1A E4 proteins. The closely related HPV types 4 and 65 y-group viruses, which cause 
benign cutaneous infections, were included in the study in order to determine whether 
they shared any functions with each other, the cutaneous HPV2 E1A E4 protein or other 
a-group E1A E4 proteins.  It is hoped that the finding of this study will help to better 
understand the role of the E1A E4 protein in the virus lifecycle.
3.2  Introduction
3.2.1  Methods used to classify papillomaviruses
Initial  attempts  to  classify  papillomaviruses  have  investigated  tissue  tropism, 
hybridisation and restriction enzyme mapping in order to characterise different isolates 
(O'Banion  et  al,  1987).  More  accurate  classifications  were  achieved  using  DNA 
sequence data (Cole et a l, 1987). The first comprehensive papillomavirus classification 
was  achieved  by  amplifying  a  fragment  of the  LI  open  reading  frame  of different 
papillomaviruses  and  comparing  the  DNA  sequences  (Chan  et  a l,  1995b).  Several 
classifications  have  since  followed,  resulting  in  papillomaviridae  phylogenetic  trees
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with  similar  topologies.  The  currently  recognised  classification  system  includes  118 
papillomavirus types which have been classed into genera (de Villiers et a l, 2004)  (see 
Fig  1.1).  In  addition  to  this,  resent  classification  strategies  have  investigated  whole 
genome  alignments,  which  have  suggested  that  genomes  may  have  evolved  in  a 
modular fashion and that the high risk papillomaviruses may be more closely related 
than previously thought (Garcia-Vallve et a l, 2005).
3.2.2  Virus evolution
Papillomaviruses have been detected in both mammals and birds, (Chan et a l,  1992; de 
Villiers  et  a l,  2004)  and  appear  extremely  species  specific.  This  suggests  that 
papillomaviruses arose in an ancestor common to mammals and birds,  suggesting that 
these viruses are approximately 200 million years old (Chan et a l,  1995b)  (Fig  3.1). 
Since  their  emergence,  papillomaviruses  appear  to  have  mutated  remarkably  slowly, 
making them a valuable tool  for tracking  animal  evolution and population migration 
(Ho  et  al,  1993;  Ong  et  al,  1993;  Scherneck  et  al,  1983).  Although  modern 
papillomaviruses display  very  limited abilities to jump  species  (productive  infections 
were achieved from chimp to pigmy-chimp cross infections and non-productive cross 
infections  from  cow  to  horse  (Lancaster  et  al,  1911;  Van  Ranst  et  al,  1992)), 
papillomaviruses appear not to have truly co-evolved with their hosts for two reasons. 
Virus phylogeny does not mirror host phylogeny accurately, breaking with Fahrenholz’s 
rule1,  and therefore indicating that cross infections may have occurred though history 
(Chan  et al,  1995a),  although re-classifications  may  change  this.  Selection  pressure 
exerted on a host by a parasite is negligible when compared to the  selective pressure 
exerted on the parasite by the host (Jermy, 1984). Therefore viral evolution should be
1  Cospeciation is the process whereby one population speciates in response to and in concert with another, 
and is a consequence of the associates dependence on its host for its survival.Chapter 3 Conservation of function between El  E4 proteins
*   Unclassified
*   alpha group
*   beta, gamma, pi, omikron and xi groups
*  delta group
mu, lambda, kappa and lotta,groups
Common ancestor
Mammals
Birds* /reptiles?
Marsupials?
Endenta
(armadillos, anteaters) 
-Langomorphia
(rabbits, hares)
— Roden tia *
(mice, rats, squirrels) 
■Primates  **
(humans, monkeys, gorillas, 
chimps)
-Carnivora
(dogs, cats, bears, raccoons, 
seals)
—Artiodactyla **
(pigs, cows, deer, goats, 
sheep)
-Cetaceans*
(whales, porpoises, dolphins) 
_Pcrissodactvla* *
(horses, rhinos)
I —Sirenia*
(manatee, dugong)
  Proboscidea*
(elephants)
Figure 3.1  Mammalian evolution
Diagram shows the evolution of mammals and birds from a common ancestor over 200 
million years ago.  The spread ofclosely related papillomaviruses (see Fig 1.1) 
identified throughout the animal kingdom is shown.  The branch containing the gamma, 
pi, omikron and xi viruses is the most divergent throughout the animal kingdom 
indicating that they may be the most ancient groups.  The distribution of viruses in the 
branch containing the mu,  lambda, kappa and lotta group viruses makes it possible to 
speculate an age of approximately  110 million years when hosts last shared a common 
ancestor (Benton and Ayala, 2003). Alpha group virus distribution is limited to 
primates, hinting at a more recent emergence.  Data from (Antonsson and Hansson, 
2002; Bossart et al., 2002; de Villiers et al., 2004; Jacobson et al.,  1982; Tachezy et al., 
2002; Villiers de, 2001).
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described as sequential evolution with the virus being forced to evolve to accommodate 
modifications in biochemical mechanisms in the host (Bernard et al,  1994; Chan et al, 
1997; Chan et al., 1995b).
3.2.3  The nature of Papillomavirus phylogeny
Papillomavirus isolates are currently classified into  118 distinct species and,  although 
genetic  drift does  occur within  species,  it  appears to  be  limited.  Misclassification  of 
papillomaviruses has occurred in the past,  for example,  HPV55  and HPV64 are now 
known to  be  variants  of HPV44  and  HPV35,  respectively.  Interestingly,  the  drift  in 
HPV 18 and 16 genomic sequences can be used to track prehistoric migrations of human 
populations  (Ho  et  al.,  1993;  Ong  et  al.,  1993).  Despite  these  variations, 
papillomaviruses appear to remain a relatively discrete phylogeny of viruses compared 
to  viruses  such as retroviruses which  show vast  diversification  due  to  high mutation 
rates (Alberdi Leniz et al., 2004; Bartolo et al, 2005; Ciccozzi et al., 2005).
3.2.3.1  Papillomavirus mutation rates
The discrete nature of papillomavirus phylogeny is likely due to them having a mutation 
rate comparable to that of their hosts,  (1 bp/several thousand years (de Villiers et al,
2004)).  This  low  mutation  rate  is  partly  due  to  papillomaviruses  lacking  any  viral 
polymerase  enzymes,  which  makes  them  reliant  on  high  fidelity  host  cell  DNA 
polymerases.  The  slow  mutation  rate  is  surprising  considering  that  viral  DNA 
replication  occurs  in  cells  expressing  E6  and  E7,  which  are  usually  associated  with 
genetic instability (Banks et al,  1987; Bedell et al,  1989; Brusa et al, 2003; Hawley- 
Nelson et al, 1989). This may suggest that viruses are under constant selective pressure 
from  sources  such  as  the  host  immune  responses.  Various  attempts  to  classify 
papillomaviruses in the past have used genes which show comparatively high levels of 
homology.  The  E4  gene  sequence  is  of little  use  to  taxonomists  due  to  the  lack  of
90Chapter 3 Conservation of function between E1A E4 proteins
homology shared between different virus subtypes. This suggests that the E4 gene may 
be  a  hotspot  for  the  accumulation  of  mutations  in  the  papillomavirus  genome 
(Narechania et al., 2005).
This work is part of an ongoing collaboration with other lab members (Woei Peh and 
Heather Griffin) whose aim is to characterise the function of the E1A E4 proteins from 
phylogenetically  diverse  papillomaviruses.  Protein  sequences  were  analysed  and 
compared using a protein alignment tool and by observing immunostaining patterns in 
cell culture. HPV 16, 18, 31, 35 and 45 are all high risk mucosal tropic a-group viruses 
and were detected with the TVG405  antibody.  HPV  2  is  a cutaneous tropic  a-group 
virus  detected  using  a  specific  polyclonal  antibody,  and  HPV  4  and  65  are  both 
cutaneous tropic y-group viruses, also detected using specific polyclonal antibodies.
3.3  Results
3.3.1  E1AE4 protein sequence alignments
E1A E4 gene sequences for HPV  1, 2, 4,  16,18, 31, 35, 45 and 65  were obtained from 
the  HPV  sequence  website  fhttp://hpv  web.lanl.gov/T  and  analysed  using  the  Edit 
sequence program (DNASTAR incorporated, USA) and Mult  Alin sequence alignment 
software  (http://prodes.toulouse.inra.fr/multalin/multalin.html.).  Alignments  were 
performed using the E1A E4 protein  sequences from the a or y  genus alone,  and also 
from the p genus sequence (Fig 3.2)
All a-group E1A E4 proteins investigated appear to share an N-Terminal leucine cluster 
(LLXLL) (Fig 3.2 A and C red arrows), which was previously shown to be required for 
cytokeratin association (Roberts et al., 1997; Wang et al., 2004). a-group proteins also
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HPV El A E4 sequences aligned using MultAlin software. (A.) a  group sequence 
alignments. Note islands of sequence homology at the C and N terminus (black arrows) 
and the YPLLXLL domain (red arrows) as well as a proline rich region (blue arrows). 
(B) y group sequence alignments show very high sequence homology throughout the 
entire protein length The red arrows indicate the region used in the charge distribution 
table. (C) There is considerable heterogeneity between the a, y and p group E1A E4 
proteins. The green arrows indicate the leucine cluster in HPV1  El A E4.B.
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share  a  proline  rich  region  and  a  hydrophobic  C-Terminal  region  thought  to  be 
involved in multimerisation (Bryan et a l,  1998; Wang et al, 2004). A leucine cluster 
(Fig  3.2  C,  green  arrows)  can  also  be  seen  in  HPV  1   E1A E4,  which  has  also  been 
demonstrated to bind keratin (Roberts et al,  1994). Interestingly, the leucine cluster is 
absent in other closely related viruses, COPV, ROPV and CRPV, and although “leucine 
rich regions” are present in these proteins, they have not yet been shown to be involved 
in  keratin  association  (Woei  Peh,  personal  communication).  The  y-group  E1A E4 
proteins lack a leucine cluster motif but do contain a proline rich region in the centre 
and hydrophobic motifs in the C-terminus. In addition to this, y-group proteins contain a 
glutamic acid cluster in their central region, the purpose of which is unknown.  HPV1 
E1A E4 shares sequence homology with both the a and y-group proteins depending on 
how alignments  are performed  suggesting that  it may  share  features  with  both types 
of E1A E4 proteins (Fig 3.2, C).
3.4  The  association  of  E1AE4  proteins  to  the  cytokeratin 
network
HPV  type  1   and  16  ElA E4s  have  all  previously  been  shown  to  associate  with  the 
cytokeratin  network  via  the  leucine  cluster.  HPV  16  (a-group)  cause  an  apparent 
collapse  of  the  keratin  network  whereas  HPV1  E1A E4  (p-group)  appears  to  bind 
keratins transiently  before  forming  large  cytoplasmic  and  nuclear  inclusion  granules 
(Roberts et al,  1994; Rogel-Gaillard et al,  1992b). To determine whether other HPV 
E1A E4 proteins have the ability to associate with and disrupt the keratin network, SiHa 
cells  were  transfected  with  E1A E4  expression  vectors  and  subsequently  analysed  by 
immunostaining. SiHa cells are a cervical cancer cell line and so were considered to be 
a  suitable  model  for  investigating  the  properties  of the  high  risk  a-group  E1A E4 
proteins. It is notable that the cutaneous tropic types 2, 4 and 65 may behave differentlyChapter 3 Conservation of function between E1A E4 proteins
when  expressed  in  differentiated  cutaneous  keratinocytes.  Attempts  to  express  the 
proteins in HaCat cells failed due to the difficulties encountered in transfecting the cells.
3.4.1  The  effect  of  fixation  on  E1AE4  and  cytoskeletal  filament 
networks
To determine the optimum fixation conditions for visualising E1A E4 and cytoskeletal 
filament,  SiHa cells were  fixed  with  either  ice  cold methanol  (2  min)  or  5  %  (w/v) 
paraformaldehyde  (5  min).  Cells were  subsequently  stained for keratins  (C2562  pan­
keratin antibody) or microtubules (B512) and DNA (DAPI) and analysed by confocal 
microscopy.  Cells  fixed  with  methanol  contained  sharp  and  clearly  defined  keratin 
filaments  and  microtubules  (Fig  3.3  B,  D  and  F).  No  clear  keratin  filaments  or 
microtubules could be observed in cells fixed with paraformaldehyde,  suggesting that 
this fixation process destroys filaments  (Fig  3.3  A,  C  and E).  Transfected  SiHa cells 
revealed that  all  the  a-group proteins tested were  able  to  produce  sharp  filamentous 
staining patterns when fixed with both methanol and paraformaldehyde (see Fig 6.14). 
Because  of the  differences observed  in keratin and  microtubule  staining  patterns,  a- 
group ElA E4’s were fixed with methanol in all experiments.  Fixation protocols had a 
significant  effect  on  the  staining  patterns  observed  for  y  type  E1A E4  proteins. 
Paraformaldehyde  fixation  resulted  in  a  sharp  E1A E4  filamentous  staining  pattern. 
Filaments  could  also  be  observed  after methanol  fixation but were  significantly  less 
apparent  (compare  Fig  3.4  D,  (methanol)  with Fig  3.7  S,  (paraformaldehyde)).  As  a 
result  of this  finding,  cells  transfected  with  y-group  proteins  were  fixed  using  both 
methods and the findings are discussed in the following sections.
3.4.2  Association of E1AE4 proteins to the cytokeratin network
SiHa cell transfected with a-group E1A E4 expression vectors were fixed with methanol
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Paraformadehyde  Methanol
Tubulin
Figure 3.3 The effect of methanol and paraformaldehyde fixation on keratin and 
microtubules
SiHa cells were fixed with either methanol (-22  C, 2 min) or paraformaldehyde (rt, 5 
min) and subsequently stained for keratins or microtubules (red) and DNA (DAPI, 
blue)  Paraformaldehyde fixation disrupted the filamentous appearance of both keratins 
and microtubules (A, C, E)  Both microtubules and keratin filaments remained intact 
after methanol fixation (B, D, F). Scale bars denote 5 pm.
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and stained for E1A E4, keratin (C2562) and DNA (DAPI). All a-group E1A E4 proteins 
investigated were  shown to  associate with the cytokeratin network in SiHa cells (Fig 
3.4).  E1A E4 staining had a variety  of different structures including  filaments bundles 
and aggregates.  The majority  of these  structures  colocalised with keratins  suggesting 
that  the  association  of a-group  E1A E4  proteins  to  the  keratin  network  induces  the 
collapse  of the  affected  network.  This  may  suggest  that  a  similar  keratin  bundling 
mechanism  is  conserved  throughout  a-group  E1A E4  proteins  regardless  of  tissue 
tropism.
Cells  transfected  with  HPV  4  or  65  E1A E4  were  fixed  with  either  methanol  or 
paraformaldehyde. Cells fixed with methanol contained weakly filamentous E1A E4 that 
partially colocalised to the keratin network in some cells (Fig 3.4 D-F, W-Y). Not all 
E1A E4 filaments co-stained with keratins (arrow Fig 3.4D-F),  suggesting that y-group 
E1A E4 proteins associated with a second filament network. Perinuclear keratin filament 
collapse was not observed to occur with 4 or 65 E1A E4. Cells transfected with HPV 4 or 
65 E1A E4 fixed with paraformaldehyde contained significantly sharper E1A E4 filaments 
(see Fig  3.5) that did not colocalise with keratins filaments  (data not  shown),  which 
were destroyed during the  fixation process  (see  Fig  3.3).  This  finding  suggests that 
keratin  association  may  be  a  feature  common  to  a-group  E1A E4  proteins  but  not 
necessarily y-group ElA E4’s.
3.4.3  The association of E1AE4 proteins to microtubules
Having  determined that y-group  E1A E4  proteins may  be  associated with  cytoskeletal
filaments  other  than  keratin,  the  association  of  E1A E4  filaments  to  actin  and 
microtubules was investigated (for further information on both see section 4.2.1).
972E1AE4  Merge I  E1AE4 DAPI Keratin
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Figure 3.4 HPV El AE4 proteins have the capacity to associate with and disrupt 
keratin filament networks.
SiHa cells transfected with HPV El AE4 expression vectors and stained for keratin (red), 
E1A E4 (TVG405, green) and DNA (DAPI, blue). All a-group E1AE4 proteins 
demonstrated the ability to associate to and disrupt cytokeratin filament networks. HPV 
4 and 65 E lA E4’s colocalised to keratin but to a lesser existent than the a-group. Non 
keratin-associated El AE4 filaments were visible with HPV 4 (arrow D-F). Scale bars 
denote 5 pm.
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Neither a nor y-group proteins were found to associate with actin filaments, which were 
visualised using phalloidin (Data not shown).  SiHa cells were transfected with E1A E4 
expression  vectors  and  fixed  as  described  in  section  3.4.1  before  being  stained  for 
E1A E4 and a-tubulin (B512).  High power confocal images were taken and individual 
optical slices closely examined, a-group E1A E4 proteins did not show any evidence of 
colocalisation with microtubules (Fig 3.5).
3.4.4  y-group proteins colocalise well with microtubules.
The y-group HPV 4 and 65 E1A E4 proteins were both observed to colocalise perfectly
with microtubules.  In  addition to  colocalisation, y-group  E1A E4  proteins  appeared  to 
cause an increase in microtubule filament thickness (up to 300 nm compared to 23 nm 
in  the  absence  of  E1A E4).  y-group  E1A E4  association  also  appeared  to  prevent 
disruption  of microtubules  by  paraformaldehyde  fixation,  since  intact  microtubules 
were  observed  in  ElA E4-containing  cells  but  were  not  detected  in  the  neighbouring 
ElA E4-negative cells (Fig 3.5 S-X). Unlike a-group proteins, which caused the collapse 
of the associated keratin network, no microtubule collapse was observed at time points 
up to 72 hours.
3.4.5  Association of E1AE4 proteins to mitochondria
In addition to associating with the cytoskeleton,  HPV  16 E1A E4 has previously been
reported to interact with mitochondria (Raj et ah, 2004). Healthy mitochondria appear 
as punctate structures in the cytoplasm, possessing either a concave shape or appearing 
as long interconnected tube-like structures. Mitochondria are highly dynamic organelles 
capable  of  undergoing  both  fusion  and  fission  events  in  response  to  changing 
intracellular  environments  (Otsuga  et  al.,  1998;  Yaffe,  1999).  It  was  reported  that 
mitochondria in HPV 16 ElA E4-expressing cells reorganise into a large perinuclear
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Figure 3.5 The association of E1AE4 proteins with inicrotubiiles
SiHa cells transfected with a-group HPV E1AE4 expression vectors fixed with 
methanol and stained for a-tubulin (red), El A E4 (TVG405, green) and DNA (DAPI, 
blue).  Images of a-group E1AE4 proteins with a filamentous appearance show that 
filaments do not colocalize (A-R)  Microtubules are unaffected by the expression of y- 
group E1A E4 proteins.  SiHa cells transfected with y-group El A E4 proteins were fixed 
with paraformaldehyde (S-X), y-group E lA E4 proteins colocalised with and protect 
microtubules against paraformaldehyde mediated disruption (note, no microtubules are 
observed in neighbouring cells)  Microtubule filament morphology is also altered by 4 
and 65 E1A E4 expressions.  Scale bars denote 5 pm.
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bundle.  ElA E4-associated  mitochondria  also  lose  membrane  potential,  which  may 
induce  apoptosis.  It  was  also  shown  that  the  leucine  cluster  is  essential  for 
mitochondrial  association.  As  the  leucine  cluster  is  conserved  throughout  a-group 
E1A E4  proteins,  it  was  decided  to  investigate  whether  other  E1A E4  proteins  also 
colocalise with mitochondria.
SiHa  cells  were  transfected  with  E1A E4  expression  vectors,  and  mitochondria  were 
labelled with mitotracker red  (Molecular Probes)  prior to  fixation with methanol  (a- 
group)  or  paraformaldehyde  (y-group),  and  staining  for  E1A E4  (different  fixation 
procedures  did  not  affect  mitochondrial  staining  patterns).  At  24  hours  all  a-group 
E1A E4 proteins were observed to  localise  with and cause  disruption of mitochondria 
(Fig 3.6).  All a-group ElA E4’s appeared to behave in a similar fashion and displayed a 
mixed  population  of  filamentous,  bundled  and  speckled  patterns.  Mitochondrial 
association was not observed in all cells but increased in frequency at later time points 
(Data not shown).  Both  small punctate  (mitochondrial  shaped)  and  larger perinuclear 
(presumably  keratin  associated)  E1A E4  structures  were  observed  to  co-stain  with 
mitochondria.  This finding may  suggest that on  some  occasions  E1A E4  associates to 
individual mitochondria, whereas on other occasions mitochondria become associated 
to the collapsed keratin bundles, y-group E1A E4 proteins did not display any detectable 
mitochondria associations,  suggesting  that these  proteins  lack the  ability  to  associate 
with mitochondria.
3.4.6  The association of E1AE4 with Cyclin B
HPV  16  E1A E4  has  previously  been  reported  to  induce  cell  cycle  arrest  (G2)  by 
sequestration of the cyclin B CDK 1  complex into the cell cytoplasm (Davy et al.,
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Figure 3.6 The association of El AE4 proteins with mitochondria
SiHa cells were transfected with a-group E1AE4 expression vectors and stained with 
mitotracker red (Molecular Probes, red) before being fixed with methanol and stained 
for E1AE4 (TGV405, green) and DNA (DAPI, blue). All a-group E1AE4 proteins were 
seen to colocalize with mitochondria (A-R). SiHa cells transfected with y-group E1AE4 
expression vectors were treated in the same way but fixed with paraformaldehyde (S- 
X). Differential fixation procedures did not affect mitochondria staining (compare A-R 
with S-X). No co-localization was seen to occur between 4 or 65 E1AE4 and 
mitochondria.  Scale bars denote 5 f.im.
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2005). The ability of the a and y-group E1A E4 proteins to associate with cyclin B was 
investigated. SiHa cells were transfected with E1A E4 expression vectors, and cells were 
fixed at 24 or 48 h post-transfection with methanol (a-group) or paraformaldehyde (y- 
group), and stained for E1A E4 and cyclin B (GNS11). HPV 16, 18, 31 35 and 45 E1A E4 
could all be observed to colocalise with cyclin B in SiHa cells (Fig 3.7 D-R). No HPV 2 
E1A E4 /cyclin B double positive cell could be located at either time point in SiHa cells 
(Fig  3.7  A-C).  This  result  may  suggest  that  the  association  with  HPV  2  E1A E4  is 
weaker or that HPV 2 E1A E4 may behave in a similar fashion to HPV  1   E1A E4 which 
has been reported to block cell cycle by preventing cyclin B accumulation in the cell 
(Knight et al.,  2004).  Although the association of type  16 E1A E4 to cyclin B  is well 
characterised further studies using synchronised cells may be required to determine the 
existence of the interaction between other a-group E1A E4 proteins and cyclin B.
HPV 4 and 65 E1A E4 proteins were not observed to colocalise with cyclin B (Fig 3.7 S- 
X). In cells that stained positive for both proteins, cyclin B accumulated in the nucleus. 
Weak colocalisation between  cyclin  B  and 4  E1A E4  was  observed  in  apoptotic  cells 
(determined by fragmented nuclei, observed in DAPI stain (see inlay Fig 3.7 T)). These 
results suggest that unlike a-group proteins, y-group E1A E4 proteins lack the ability to 
associate with or inhibit the build up of cyclin B.
3.5  Discussion
All  HPV E1A E4 proteins  investigated  in this  study  were  shown to  have  a conserved 
ability to associate with and disrupt the components of the cell cytoskeleton.  Whereas 
a-group proteins associated with the cytokeratin network, y-group proteins appeared to 
preferentially associate with microtubules although some evidence of partial keratin
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Figure 3.7 Association of E1AE4 proteins to cyclin B
SiHa cells transfected with a-group El A E4 expression vectors were fixed with methanol 
and stained for cyclin B (GNS-11, red) E1A E4 (green) and DNA (DAPI, blue). Cyclin B 
colocalisation could be seen with HPV  16,  18, 31, 35 and 45 (D-R). HPV 2 E1AE4 was 
not observed to colocalize with cyclin B and double positive cells could not be found 
(A-C). SiHa cells transfected with y-group E1A E4 expression vectors were treated in the 
same way but fixed with paraformaldehyde. No colocalisation between 4 or 65 El A E4 
was observed (except in apoptotic cells arrow S-T (inlay shows cells nucleus T)), cyclin 
B could be seen to accumulate in the nucleus of some cells HPV 4 or 65 E1AE4 
indicating that nuclear import was unaffected. Scale bars denote 5 |im
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colocalisation  was  observed.The  a-group  E1A E4  proteins  showed  no  sign  of 
colocalising to microtubules in SiHa cells, whereas y-group proteins showed preferential 
colocalisation to microtubules. It has since been discovered that when expressed in the 
NIKS cell line, (containing keratins 5, 14,  13), HPV 4 and 65 E1A E4 can associate with 
keratins  in  addition  to  microtubules  (personal  communication,  woei  Peh).  These 
findings  mean  that  cellular  factors  (most  probably  the  expression  of native  keratin 
subtypes) influence the ability of the y-group E1A E4 proteins to associate with different 
components of the cell cytoskeleton. The a group viruses are found in both mucosal and 
cutaneous sites, y-types only infect cutaneous sites, so in vivo are perhaps more likely to 
behave as they do in NIKS.
E1A E4  proteins  from  both  groups  caused  the  disruption  of  affected  cytoskeletal 
filaments,  and  to  filament  collapse  in  the  case  of  the  a-group  proteins,  which 
presumably  affects  filament  function.  HPV  4  and  65  E1A E4  were  shown  to  protect 
microtubules from paraformaldehyde induced disruption whereas 16 E1A E4 was able to 
protect  keratin  filaments  against  paraformaldehyde  diruption  (see  Fig  6.14).  These 
findings  may  suggest  some  form  of  stabilisation  or  cross-linking  between  E1A E4 
proteins  and  cytoskeletal  components.  Both  a  and  p-group  E1A E4  proteins  (HPV 
1,11,16) have previously been shown to have the ability to multimerise via a C-terminal 
motif (Ashmole  et al.,  1998;  Bryan  et al.,  1998;  Roberts  et  al,  1997;  Wang  et al., 
2004).  In  the  case  of  HPV 16  E1A E4  multimerisation  is  believed  to  aid  filament 
reorganisation (Wang et a l, 2004) and it is tempting to speculate that HPV 4  and 65 
El A E4 proteins may cause microtubules stabilisation by a similar process.
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All the a-group proteins investigated have demonstrated the  ability to  associate with 
and  aggregate  mitochondria  whereas  y-group  E1A E4  proteins  did  not.  To  determine 
whether this ability is unique to all a-group viruses and absent in all y group proteins 
would require the investigation of additional virus subtypes.  Although the purpose of 
this function remains unclear, it has been reported to induce apoptosis, which may aid 
virus release (Raj et a l, 2004).  a-group viruses are only found in primates suggesting 
that they may be a more recently evolved group. If this is the case then mitochondrial 
association  may  be  a  more  recently  evolved  function  that  offers  an  evolutionary 
advantage to this group of viruses.
HPV  16 is known to induce cell cycle arrest via its ability to sequester active cyclin B 
into the cytoplasm (Davy et a l, 2000; Davy et a l, 2005). This is the likely mechanism 
for E1A E4 induced cell cycle arrest, since active cyclin B/CDK complexes are required 
to enter the nuclease for cell cycle progression. In this chapter it has been shown that 
HPV  18, 31, 35, and 45 E1A E4 proteins also colocalise with cyclin B in the cytoplasm. 
This observation suggests that these proteins may be able to induce cell cycle arrest by a 
similar mechanism. This was not apparent in cells expressing the other a E1A E4 protein 
HPV 2 E1A E4. Instead HPV 2 E1A E4 expressing cells contained low levels of cyclin B. 
It  is  therefore  possible  that  HPV  2  E1A E4  inhibits  the  build  up  of cyclin  B  in  the 
absence  of colocalisation  as has been reported  for the p-group  HPV1  E1A E4  protein 
(Knight et al, 2004).
HPV 4 and 65 do not appear to colocalise with cyclin B. Cells that contain both E1A E4 
and  cyclin  B  showed  cyclin  B  accumulation  in  the  nucleus,  suggesting  that  these 
proteins did not inhibit cyclin B build up or cause cytoplasmic sequestration.  It is not
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known whether HPV4  and 65  E1A E4  cause cell  cycle  arrest,  however, both proteins 
were  shown to  affect microtubules,  which in itself may  disrupt the  cell cycle.  Cells 
arrested in this way by inhibitors such as taxol usually contain restructured chromatin 
(Barboule et a l, 1997; Jordan et al, 1996). Condensed chromatin could not be observed 
in cell expressing HPV 4 and 65 E1A E4, indicating that if cell cycle arrest has occurred, 
it may be through some other pathway.
In summary, these data suggest that ability to disrupt elements of the cytoskeleton is a 
conserved function that is common to all the E1A E4 proteins investigated. The a-group 
proteins were shown to localise selectively to the cytokeratin network, which is believed 
to  affect cell  integrity  and aid virion release.  The y-group protein have the  ability to 
affect both keratin and microtubules depending on the environment in which they are 
expressed,  which  gives  them  the  potential  to  affect  both  the  cell  cycle  and  the  cell 
integrity. These findings suggest that although E1A E4 functions appear to vary between 
different virus subtypes, the ability to interact and disrupt the cell cytoskeleton is highly 
conserved in distantly related viruses.
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4  The effect of 16 E1AE4 on keratins in SiHa cells
4.1  Aims
Although  the  association  between  the  HPV  E1A E4  proteins  and  keratins  has  been 
known for  some time,  the purpose  and outcome  of the  interaction is  still  not clearly 
understood. This work follows on from the study in Chapter 3, and aims to gain a better 
understanding and significance of the interaction between E1A E4 and keratins.
4.2  Introduction
4.2.1  The cell cytoskeleton
To  understand  the  purpose  of  the  ElA E4-keratins  interaction,  it  is  necessary  to 
understand how the cell cytoskeleton functions in order to comprehend how the systems 
are  being  targeted  by  the  virus.  Due  to  the  complex  way  in  which  the  different 
components of the cytoskeleton interact, a brief overview of cytoskeletal structures has 
been included.  The cytoskeleton is composed of a series of filament networks that are 
responsible for intracellular transport,  cell  motility  and protection against mechanical 
damage. The cytoskeleton is composed of three distinct filament networks, the macro 
filaments  (microtubules),  micro-filaments  (actin)  and  intermediate  filaments  (keratins 
and  others),  each  of which has  distinct properties  and perform  a variety  of different 
functions. Microtubules are composed of 2 subunits, a and (3 tubulins, that polymerise 
into hollow, cylindrical, polar filaments,  24 nm in diameter (Fig 4.1 A).  Microtubules 
originate from a single point in the cell referred to as the microtubule organising centre 
(MTOC), which is located in the centrosome, and are involved in intracellular transport. 
Microtubules  exist  in  a  state  of  flux  referred  to  as  dynamic  instability,  and  can 
polymerise  from  one  end  whilst  depolymerising  from  the  other,  producing  an  effect 
referred to as treadmilling, which can facilitate intracellular transport. Micro-filaments 
are  formed  from  actin  homo-polymers,  and  form  polar  filaments  5-7  nm
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Figure 4.1  Polymerisation of cytoskeletal filament networks
Figure shows the polymerisation of microtubules, actin and keratin filaments 
Microtubules dimerise before polymerising to form hollow polar filaments -24 nm in 
diameter (A), image taken from (www.cellbio.utmb.edu). Actin monomers form polar 
homopolymers after shedding profilin (B) image taken from
(www.academic.brooklyn.cuny.edu). Keratin filaments form non polar filaments by the 
dimerisation of type I and type II subunits. Type I and type IT keratin rod domains twist 
round one another to from dimers which spontaneously assemble into staggered 
tetramers. Protofibrils are 4 tetramers thick, four protofibils assemble into an 
intermediate filament (C)  Image taken from (www.biology.iupui.edu)
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in diameter (Fig 4.1).  Actin filaments form a network beneath the plasma membrane 
and function to  link membrane-bound/associated proteins to cytoplasmic proteins and 
play a key role in cell motility. Both micro and macro filaments utilise specific motor 
proteins and  can be targeted by various pharmacological agents that act to stabilise or 
destabilise/depolymerise filament networks (Alberts, 2002).
4.3  Intermediate filaments
The final components of the cytoskeleton are the intermediate filaments (IFs). IFs are 
distinct from the other two filament networks for a number of reasons.  IFs display  a 
remarkable level of heterogeneity; to  date over 50 different human IFs proteins have 
been identified.  Despite this,  individual  proteins are highly  conserved throughout the 
animal  kingdom  (Markl  et  al.,  1998a;  Markl  et  al.,  1998b).  IFs  appear  to  be  more 
recently  evolved  than  microtubule  or  actin  filament  systems,  and  can  be  found 
throughout metazoan phyla (Stuurman et al.,  1998).  Several different types of IF have 
so  far  been  identified.  These  include  acidic  and  basic  keratins,  desmin,  vimentin, 
lamins,  and  neurofilaments.  IFs  all  form  non-polar  polymers,  with  filaments  ~10nm 
thick.  Unlike  the  microtubule  and  actin  filament  networks,  IFs  have  no  known 
associated motor proteins and are not thought to be involved in intracellular transport 
although may be involved in cell migration (Long et al 2006). IFs are not housekeeping 
proteins and genes encoding cytoplasmic  IFs are  expressed in  a cell type  specific  or 
differentiation-dependent fashion  (Coulombe  et al.,  2000).  IFs  are  significantly more 
stable than microtubules and actin,  forming insoluble networks.  Cells lacking IFs are 
more  likely  to  undergo  apoptosis  or  rupture  when  exposed  to  mechanical  stress 
(Takahashi et al., 1999)
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4.3.1  Keratin polymerisation
All keratins contain head and tail domains connected by a long a-helical rod domain, 
-310  amino  acids  in  length,  comprised  of long  heptad repeats  containing  leucine  or 
hydrophobic  residues at positions “a” and “d” of the helix. Keratins form stable, non- 
covalent,  obligate heteropolymers with specific binding partners.  The type II  keratin, 
K8,  forms  a network  with  its  type  I  binding  partner,  keratin  18  in  hepatocytes  and 
simple  epithelium.  Keratins  K5  and  14  form  a  network  in  undifferentiated  basal 
epithelial cells, K4/13 in differentiated mucosal epithelium and Kl/10  in differentiated 
cutaneous epithelium (reviewed in (Coulombe et al., 2002). Polymers are formed when 
the rod domain of types I and II keratins twist round one another to form parallel coiled- 
coil dimers. Dimers assemble into staggered tetramers, which form the basic building 
blocks of filaments. Keratin intermediate filaments are composed of blocks of tetramers, 
8  units  thick,  forming  filaments  -lOnrn  in  diameter  (Fig  4.1C).  The  keratin 
polymerisation process results  in a very  flexible  fibre,  which  has tremendous tensile 
strength, giving cells the ability to resist damage. Experimental evidence suggests that 
head and tail  domains do  not play  a part in the  polymerisation process  (reviewed in 
(Fuchs,  1994)). Various conserved phosphorylation sites have been identified in both 
domains. It has been  suggested that the tail domain may make a significant contribution 
to the elasticity of keratin filaments (Coulombe et al., 2000).
4.3.2  Keratin filament organisation
The properties of the keratin filament network, is thought to be regulated in a number
of different ways. Rheological studies investigating the mechanical properties of keratin
filament suspensions have provided some interesting information about the nature with
which keratin filaments interact with one another.  The elastic properties of keratin IF
suspensions  cannot  be  entirely  explained  by  steric  forces  (a  simple  solution  of
tangled/overlapping  filaments  in  solution  would  not  behave  in  such  a  way).
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Interestingly the properties of keratin IF suspensions are very comparable to those of F- 
actin  filaments  in  the  presence  of  exogenous  cross-linking  proteins.  This  finding 
suggests that keratins filaments may be able to interact (cross-link) with one another in 
the absence of other proteins (Ma et al,  1999). An innate cross linking ability would 
significantly  increase  the  mechanical  strength  of the  network  formed.  Expression  of 
different keratin monomers also alters keratin filament network architecture (Coulombe 
et al,  1989). Keratin networks have demonstrated the ability to relocate and reorganise 
in cells during processes such as wound healing, cell migration and mitosis (Paladini et 
al, 1996).
4.3.3  Keratin-associated proteins
Unlike other filament networks, keratins appear to have no associated motor proteins. 
To  date  only  three  cellular  keratin-specific  binding  proteins  have  been  identified 
(Coulombe et a l, 2000). These are filaggrin and trichohyalin, both of which are found 
in differentiated epithelium. These proteins are believed to play a role in altering keratin 
network architecture as cells differentiate, in order to increase their mechanical strength 
(Hamilton et al,  1991). The  keratin network is reorganised during mitosis, the process 
is regulated by phosphorylation and the 14.3.3 protein is though to bind phosphorylated 
keratins modulateting  their  solubility  (Liao  et al,  1996).  Another  keratin-associated 
protein is plectin,  which acts  as a cytoskeletal  cross-linking protein that attaches the 
keratin network to microtubules and actin filaments (Seifert et al,  1992).  As well  as 
associating  with  structural  proteins,  keratins  have  been  reported  to  associate  with  a 
number of signalling proteins (reviewed in (Paramio et al, 2002)).
4.4  Biochemical modifications to keratins
Keratins  are  known  to  undergo  a  number  of  different  biochemical  modifications 
including  phosphorylation,  glycosylation  and  ubiquitination.  These  modifications  are
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involved  in reorganising  the  keratin  network  and  are  invoked  by  mitosis,  apoptosis, 
stress and differentiation-dependant stimuli.  Although 20 different keratins have been 
identified to date, the majority of research has focused on keratins 8 and 18 which are 
simple epithelial types.
4.4.1  Mitotic reorganisation of the keratin network
The phosphorylation of keratins was first shown by 2D gel electrophoresis (Gilmartin
et  al,  1980).  Mitotic  arrest  has  been  demonstrated  to  induce  phosphorylation  and 
glycosylation of keratin  8  and  18  in hepatocyes, during which time keratin filaments 
depolymerise and form numerous small inclusion bodies (Chou et al,  1993a). Type II 
keratins become  phosphorylated  during mitosis  at the  highly  conserved  motif Ser-73 
residue by p38 mitogen-activated protein kinase (MAPK) in tissues and cultured cells 
(Ku et al, 2002a; Liao et al,  1997; Toivola et al, 2002).  Phosphorylation of keratin 8 
at Ser 23 and 431  appears to occur upon stimulation of the EGF receptor  and during 
mitotic  arrest,  and  is  thought  to  be  facilitated  by  mitogen  activated  protein  kinase 
(MAPK), and CDC2 kinase (Ku et al,  1997b). A major physiological phosphorylation 
site on the type  1   keratin K18,  Ser  52,  is part  of a consensus  site for cyclic AMP- 
dependent protein kinase, calmodulin-dependent protein kinase, S6 kinase and PKC and 
becomes phosphorylated during interphase thereby  facilitating  filament reorganisation 
(Ku  et  al,  1994).  The  soluble  pool  of keratin  is  not  differentially  phosphorylated, 
suggesting that interaction with other cellular factors is responsible for the inhibition of 
keratin polymerisation in the cytosol (Chou et al,  1993b). It has since been discovered 
that the  14-3-3  protein bind to keratin  18  upon phosphorylation at  Ser-33,  and act as 
solubilzation co-factor (Ku et al, 1998; Liao et al, 1996). The binding of 14-3-3 to the 
cytokeratin network has been demonstrated to modulate keratin filament solubility and 
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4.4.2  Keratin modifications during apoptosis
Phosphorylation of Keratin 18 at Ser- 53 precedes cleavage by caspases 3, 6 and 7 in a 
conserved,  non-alpha-helical  region.  The  caspase  recognition  site  in  keratins  is 
conserved in lamins and other IF proteins, but interestingly, type II keratins seem to be 
remarkably resistant to  apoptosis induced proteolysis  (Caulin et a l,  1997).  The M30 
epitope  of keratin  18  becomes  exposed  upon  caspase  cleavage  resulting  in  a  26kDa 
fragment  becoming  apparent  in  apoptotic  cell  lysates  (Leers  et  a l,  1999).  Caspase 
cleavage of keratin  14 and  19  also produces low molecular weight fragments (Ku et 
a l, 2001). Keratin 10 appears to lack a caspase cleavage site, which may reflect its role 
in  terminally  differentiated  epithelia  where  the  integrity  of  the  Kl/10  network  is 
important. Despite being degraded during apoptosis, keratins have been shown to play a 
vital role in regulating cellular responses to pro-apoptotic signals.  Studies have shown 
that cells expressing a keratin 8/18 network are more resistant to TNF and Fas-mediated 
apoptosis than those that lack keratins. Resistance is thought to occur by the binding of 
downstream signalling molecules such as  TRADD and Raf-1  (Inada et a l, 2001; Ku et 
a l, 2004). Knock out/in studies have demonstrated that cells show greater sensitivity to 
pro-apoptotic signalling in the absence of keratins (Marceau et al 2004). This suggests 
that as well  as providing mechanical  strength to  cells,  keratins  also  allow the  cell to 
survive in stressful environments in which it would normally undergo apoptosis.
4.4.3  Keratin turnover and ubiquitination
The ubiquitination of keratins was first identified in Mallory bodies (see section 4.5.2)
formed in mice (Ohta et a l, 1988). Since then it has been demonstrated that keratins are
ubiquitinated and then degraded via the proteasome as part of keratin network turnover.
The ubiquitination of keratins  is thought to  be regulated in part via phosphorylation.
The phosphorylation of K8 at Ser-23, 73 and 431 protects against, but does not prevent,
ubiquitination  whereas  the  link  between  phosphorylation  of K18  and  ubiquitination,
118Chapter 4 The effect of E1A E4 on Keratins in SiHa Cells
remains unclear (Ku et al., 2000). Interestingly, herpes simplex virus type 2 (HSV 2), 
which also infects epithelial tissue, is believed to trigger the degradation of cytokeratins 
with a viral kinase US3. This kinase has been demonstrated to induce phosphorylation 
of keratin  17,  which  in  turn  leads  to  its  ubiquitination  and  degradation.  Knock  out 
studies have demonstrated a difference in cytopathic effects in the absence of the kinase 
(Murata et al, 2002).
4.5  Keratins and disease
Keratins are known to play a role in a number of diseases, with mutations in keratins 
causing skin and liver pathology. Studies of these conditions have lead to a much better 
understanding of overall keratin function.
4.5.1  Stress-stimulated phosphorylation of the keratin network
It has long been evident that the phosphorylation state of keratins can modulate keratin
function and may be involved in keratin associated diseases. An early study was able to 
show  the  dephosphorylation  of  keratins  in  cells  stressed  by  culturing  them  in  the 
presence of acrylamide (Eckert et al., 1988). Since then further studies appear to suggest 
that  the  opposite  is  true  and  that  keratins  become  increasingly  phosphorylated  in 
stressed  cells.  Experiments  in  mice  investigating  liver  damage  resulting  from  the 
ingestion of the hepatotoxin griseofulvin, have  shown that under these circumstances, 
keratins become hyper-phosphorylated and form Mallory bodies (Cadrin et al.,  1995; 
Chou et al.,  1993b).  Stress-mediated phosphorylation  of Ser-73  on keratin  8  byPKC 
delta has been shown to regulate disassembly of keratin intermediate filaments. Keratins 
have also been shown to be phosphorylated in cells that have been exposed to shear and 
hypoxic stresses, resulting in the collapse of the affected network (Omary et al.,  1998; 
Ridge, 2004; Ridge et al., 2005).
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4.5.2  Mallory bodies
A  number  of  different  stresses  can  lead  to  the  formation  of  perinuclear  keratin 
aggregates  referred  to  as  Mallory  bodies  (keratin  aggresomes).  Mallory  bodies  are 
characterised  by  the presence  of hyperphosphorylated  and ubiquitinated keratins that 
can  be  visualised  as  high  molecular  weight  keratin  “smears”  following  SDS  gel 
electrophoresis (Bardag-Gorce et al., 2002;  Ohta et al.,  1988); (Fausther et al., 2004; 
Nakamichi  et al.,  2005).  A number  of proteins that associate  with the  mis-folded  or 
collapsed  keratin  networks  in  Mallory  bodies  have  also  been  identified,  including 
Hsp70, Hsp25 and p62 (Fausther et al., 2004; Janig et al., 2005; Zatloukal et al., 2002). 
Mallory body formation can be mimicked by feeding mice the phosphatase  inhibitor, 
okadaic acid, which causes keratin networks to collapse into perinuclear aggregates that 
contain multiple phospho-keratin species. Mallory body formation can also be induced 
in  other  ways,  e.g.  by  feeding  mice  griseofulvin,  treating  cells  with  proteasome 
inhibitors  and  over-expressing  a  single  keratin  species  (Bardag-Gorce  et  al.,  2004; 
Cadrin et al.,  1995; Nakamichi  et al., 2002).  Mallory  bodies  are believed to  form  in 
order to clear misfolded and/or hyperphosphorylated,  ubiquitinated keratins when the 
proteasome system becomes  overloaded (Riley  et al.,  2003).  As part of this process, 
cells use microtubules to sweep up keratins into perinuclear aggregates located at the 
microtubule organising centres (Riley et a l, 2003). Aggresome formation  has also been 
reported to result in proteasome inhibition (Bence et al., 2001; Bennett et al., 2005).
4.5.3  Keratin mutations linked to disease
Mutations  in  specific  keratins  have  been  linked  to  a  number  of clinical  conditions.
Transgenic  mice  over-expressing  a human  keratin  18  with  a  mutation  in the  highly
conserved  arginine  89,  develop  chronic hepatitis  and  show  a predisposition to  drug-
induced liver damage (Ku et al., 1995; Ku et al., 1996). The phosphorylation of keratins
is believed to protect against hepatotoxicity hence  mutations  in keratins may render
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some individuals more susceptible to liver damage induced by toxic stress (e.g. binge 
drinking) (Ku et a l, 1996; Ku et al., 2005; Stumptner et al, 2000). The disfiguring skin 
disease  epidermolysis  bullosa  simplex  (EBS),  is  an  inherited  disease  caused  by  a 
mutations  in either keratin  5  or  14  (Coulombe  et al,  1991;  Lane  et al,  1992).  The 
mutations prevent correct keratin polymerisation resulting in a fragile epidermis that is 
prone to blistering and damage. EBS may provide some insight as to why the papilloma 
viruses  have  evolved  to  target  keratins  at  a  specific  point  in  the  virus  life  cycle 
(discussed later).
4.6  The association of E1AE4 with keratin
The  association  between  keratin  and  the  E1A E4  protein  was  first  observed  in 
keratinocytes expressing HPV 16 E1A E4, where it was noticed that the E1A E4 protein 
had  a  filamentous  staining  pattern.  ElA E4s  were  shown  to  colocalize  with  keratin 
filaments but not  actin,  microtubules  or nuclear lamins  (Doorbar et al,  1991).  Later 
work showed that HPV1 and 31  E1A E4 proteins also had the capacity to associate with 
cytokeratins (Pray et al,  1995b; Roberts et al,  1994). Whereas HPV  16 and 31  appear 
to  be  capable  of binding  to  and  collapsing  the  cytokeratin  network,  HPV  1   E1A E4 
appears to associate transiently with keratins before forming large cytoplasmic inclusion 
bodies with no resulting disruption of keratin networks  (Rogel-Gaillard et al,  1993). 
Mutational analysis was able to demonstrate that the conserved  N-terminal YPLLXLL 
motif present in HPV  16 and other a-group viruses (see Fig 3.2) is responsible for its 
association with keratins (Roberts et al,  1997). HPV 1   contains an N-terminal LLGLL 
motif which can be lost due to N-terminal processing (Doorbar et al,  1996; Roberts et 
al, 1994; Roberts et al, 1997; Roberts et al, 2003). The ability of HPV 16 to colocalize 
directly  to  keratin  filaments  has  also  been  observed  by  immunoelectron  microscopy 
(Sterling  et al,  1993b).  More  recent  work  has  demonstrated  that  a region at  the  C-
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terminus of 16E1A E4 may be responsible for modulating cytokeratin collapse (Roberts 
et a l,  1997;  Wang  et al.,  2004).  Coimmuno-precipitation  studies have  demonstrated 
that HPV  16 has the capacity to bind directly to keratin  18 but not its type II binding 
partner keratin 8. It has also been shown that the E lA E4-keratin association is not just 
an in vitro phenomenon but it also occurs in vivo (Doorbar et al.,  1997; Wang et al., 
2004). From this data it has been hypothesised that E1A E4 may induce keratin filament 
disruption in vivo by multimerising on keratin filaments in order to aid viral egress.
4.7  Results
4.7.1  Keratin association with E1AE4 in SiHa cells
E1A E4  has previously  been  reported  to  associate  with  keratin  networks  in  cells.  To
observe this, SiHa cells were infected using the recombinant adenovirus (rAD) HPV 16 
E1A E4 expression system (Doorbar et al., 2000) before the cells were fixed and stained 
with antibodies raised against keratins (C2562) and E1A E4 (TVG405) at 12, 24 and 48 h 
post transfection. The staining patterns observed varied in appearance depending on the 
time after infection, and could be divided into 3 distinct groups. At 12 h post infection 
most  cells  showed  a  distinct  filamentous  pattern  that  colocalised  almost  exclusively 
with keratin  filaments  (Fig  4.2  A-C).  At  24  h  E1A E4  is  observed to  colocalise  with 
keratins  in  a filamentous  pattern  in various  states  of collapse,  (Fig  4.2  D-F).  E1A E4 
association  caused  the  keratin  filaments  to  appear  bundled  together  into  thicker 
filaments,  an event that presumably precedes their collapse.  When collapse occurred, 
keratins were found to form perinuclear bundles or cage-like structures that can wrap 
around the nucleus. A third punctate staining pattern was manifested as multiple El A E4
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Figure 4.2 Effect of E1AE4 on keratin networks
Images show SiHa cells infected with the rAD E1AE4 expression system, fixed 24 h 
post infection and stained for DNA (DAPI-blue), keratin (C2562-red) and E1AE4 
(TVG405-green). E1AE4 displays three different staining patterns.  E1AE4 is commonly 
filamentous in appearance and colocalises with keratin filaments (A-C). E1AE4 
expression leads to the collapse of associated keratin networks into perinuclear bundles 
(D-F). Cells also commonly contain non filamentous E lAE4 bodies which are not 
always keratin associated,  keratin networks appear intact in some of these cells (G-I). 
Scale bars denote 5  pm.
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structures,  including  condensed  perinuclear  aggregates  as  well  as  more  discreet 
cytoplasmic structures. This staining pattern increased in frequency at later time points 
(Fig  4.2  G-I).  The  perinuclear  E1A E4  structures  always  co-stained  with  keratins, 
whereas the  smaller more  diffuse  structures  did  not.  It is known that E1A E4 has the 
capacity  to  associate  with mitochondria so  it was  decided to  investigate  whether the 
diffuse  E1A E4  structures  colocalise  with mitochondria (see  section 4.8).  When taken 
together,  these  data  suggest  that  E1A E4  is  capable  of  forming  multiple  keratin- 
associated structures, not all of them being filamentous.
4.7.2  E1AE4  can  collapse  multiple  types  of  keratin  network  when 
expressed in HaCat cells.
It is not known whether  E1A E4  can disrupt or  induce  modifications to  other keratin
networks such as 5/14 or 4/13, which are encountered in vivo. To determine whether 16 
E1A E4 could interact with and disrupt these keratins E1A E4 was expressed HaCat cells. 
HaCat cells  express a keratin network that contains keratins 5,  14  8, and 18, as well as 
the  differentiation-dependent  4,  13,  1   and  10  keratins  (Breitkreutz  et  a l,  1991; 
Breitkreutz et a l, 1993).
HaCat  and  SiHa  cells  were  infected  with  rAD  E1A E4,  fixed  and  stained  for  E1A E4
(TVG405)  and  specific  keratins  (antibodies  from  Novocastra).  SiHa  cells  stained
positive for keratin 8 and 18; were negative for keratins 4, 5,  10 and 14;  approximately
10% of SiHa cells were found to express keratins 4 and 13 (not shown); and HaCat cells
stained positively for keratins 4,  5,  8,  10,  13,  14 and  18.  All keratins in HaCat cells
appear  to  colocalize  with  E1A E4  and  be  remodelled  in  the  same  fashion  following
E1A E4  association  (Fig  4.3).  This  data  must  not however  be  over-interpreted  as the
different  keratins  form  a  single  inter-connected  network.  In  addition  to  this,  the
differentiation-dependent keratins 4, 13,1 and 10 may not be modified in the same way
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Figure 4.3 El AE4 expression in HaCat cells
HaCat cells infected with rAD E1A E4, were fixed 24 h after infection and stained for 
E1A E4 (TVG405-Green), keratin specific antibodies (Novacastra, red) and DNA 
(DAPI-Blue). Keratin staining shows that E1A E4 appears to have the capacity to 
associate with and disrupt keratins 4, 5, 8,10,13,14 and  18 (A-U).  Scale bars denote 5 
pm.
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as networks at the surface of terminally differentiated epithelium.  These observations 
suggest that 16 E1A E4 may associate with multiple keratin subtypes.
4.7.3  E1AE4  expression  patterns  in  the  presence  of  multiple 
different keratin polypeptides
HaCat and SiHa cells were infected with rAD E1A E4, fixed  12, 24, 48, and 72 h post
infection and  stained  for  E1A E4  (TVG405)  and keratin  (C2562).  E1A E4  co-localised 
with keratin in both cell types and produced similar staining patterns. E1A E4 expressed 
in SiHa cells induced keratin 8/18 networks to collapse rapidly, leading to the formation 
of perinuclear bundles by 24 h. This is apparent from the rapid decrease in filamentous 
E1A E4 staining and the corresponding rapid increase in collapsed and aggregate staining 
patterns  observed  at  24  h  (Fig  4.4  A).  HaCat  cells  appear  to  be  significantly  more 
resistant to keratin network collapse due to the expression of greater keratin levels or 
different  keratin  subtypes.  Unlike  SiHa  cells,  intact  filament  networks  could  be 
observed in HaCat cells 72 h post infection (-35% of cells) (Fig 4.4 B). Both cell lines 
contained keratin-associated E1A E4 aggregates that increased  in frequency  with time. 
The graphs for both cell lines indicate that the frequency of collapsed keratin bundles 
levels off with time, whereas aggregates continue to increase in frequency  suggesting 
that they may be at the end point for the collapsed structures (Fig 4.4).
4.8  The association of E1AE4 with mitochondria and keratin 
in SiHa cells
HPV 16 E1A E4 has previously been shown to associate with mitochondria, although the 
purpose of the E1A E4 mitochondrial interaction is as yet unknown (Raj  et al.,  2004). 
Using  keratin  and  E1A E4  antibodies  in  conjunction  with  a  mitochondrial  stain  the 
relationship  between  E1A E4  aggregates,  keratin  and  mitochondria  was  investigated. 
SiHa  cells  were  infected  with  rAD  E1A E4  or  rAD P-gal,  treated  with  mito-tracker 
(Molecular Probes), fixed with methanol 24 h post infection, and stained for E1A E4
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Figure 4.4 The temporal distribution of different El AE4 structures in HaCat and 
SiHa cells.
Cell count data for SiHa and HaCat cells infected with rAD E1A E4 and stained for 
E1A E4 and keratin (100 cells counted / time point) for filaments, bundles and aggregates 
for examples refer to Fig 4.2. Graph A shows a decrease in the number of SiHa cell with 
filamentous E IA E4 over time, cells with filamentous El A E4 drop to 2% by 72 h  In 
contrast 30% of HaCat cells maintain filamentous E1A E4 at 72% indicating a greater 
resistance to network collapse. Both populations show and increase in collapsed keratin 
bundles at later time points with curves flattening at ^48 h, with SiHa cells peaking at 
50 % and with HaCat only 36% (A-B)  Cells containing El A E4 associated keratin 
aggregates continue to increase up to 72 h indicating E1AE4 aggregates to be at an end 
point.
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(TVG405)  and  keratin  (C2562).  Cells  were  examined  using  high  power  confocal 
microscopy. In the absence of E1A E4, keratins form a filamentous network throughout 
the  cytoplasm,  with  mitochondria  existing  as  punctate  structures  (Fig  4.5  A-C). 
Triple-stained  cells  show  that  E1A E4  frequently  causes  mitochondria  and  keratin  to 
collapse together  (Fig  4.5  D-G),  All  cellular keratins  appear  to  be  bound by  E1A E4 
although not all E1A E4 is keratin associated (Fig 4.5 H arrow). Non keratin-associated 
E1A E4 was observed to colocalize with mitochondria (Fig 4.5 compare H with I). The 
binding  of E1A E4  to  mitochondria  and  keratins  resulted  in  the  reorganization  and 
colocalisation of mitochondria to  keratin bundles.  Furthermore,  all  detectable  E1A E4 
was  observed to  localise  to  either  mitochondria  or  keratin,  with  very  little  unbound 
protein  being  present.The  examination  of SiHa  cells  containing  filamentous  E1A E4 
showed that E1A E4 can selectively bind to keratins without affecting mitochondria (Fig 
4.6 A-D) as previously reported (Raj et al, 2004). Conversely in cells containing E1A E4 
aggregates (Fig 4.6 E-K), E1A E4 associates with both keratin and mitochondria and in 
some  cases  these  aggregates  can  be  observed  in  the  absence  of  keratin  network 
saturation or collapse.  It is thought likely that keratin saturation and network collapse 
occur  prior  to  aggregate  formation  allowing  E1A E4  to  associate  with  mitochondria. 
E1A E4 production may possibly cease allowing keratin networks to reform. The higher 
frequency of cells exhibiting  aggregate  staining  at later time points makes this  seem 
probable (see Fig 4.4).
4.9  E1AE4 association induces the phosphorylation of 
keratins
Keratin  networks  become  highly  phosphorylated  as  a  result  of  normal  cell  cycle 
progression during  mitosis  and apoptosis,  and reorganise  into  multiple aggregate  like 
structures  (Ku  et a l,  1994;  Ku et al,  1998;  Ku et al,  2002b).  The  observation  of 
similar structures in ElA E4-expressing cells prompted us to investigate the
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Figure 4.5 The association of E1AE4 to keratin and mitochondria
Example of a SiHa cell stained for keratin (C2562) and mitochondria (Mitotracker-red), 
the two systems do not colocalize, keratins form cytoplasmic filament networks and 
mitochondria exist as punctuate structures (A-C). In the presence of E1AE4 (TVG402- 
blue) mitochondria and keratin collapse together, (D and J). All keratin is bound by 
E1A E4 although not all E1A E4 is keratin associated (H arrow). E1A E4 not associated to 
keratin is be bound to mitochondria (I arrow).  Scale bars denote 5 pm.
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Figure 4.6 E1AE4 associated to keratin and mitochondria selectively
SiHa cells infected with rAD E1A E4, fixed 24 h after infection and stained for keratin 
(C2562-green), mitochondria (Mitotracker-red) and E1A E4 (DAPI-blue). E1AE4 can be 
seen to associate to keratin without affecting mitochondria (A-D)  Cells containing 
E IA E4 aggregate structures (E-K) E IA E4 can be observed to associate to both keratin 
(inlay J) and mitochondria simultaneously (arrows E-K) in the absence of keratin 
network saturation or collapse (E-K).  Scale bars denote 5 pm.
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phosphorylation state  of keratins in the presence  of E1A E4.  SiHa cells were infected 
with  rAD  16  E1A E4,  fixed  24  h  after  infection  and  stained  with  one  of  four 
phospho-specific  anti-keratin  antibodies  (LJ4  [K8,  ser-73],  2D6  [K8,  ser-431],  3055 
[K18,  ser-52]  and  8250  [K18,  ser-33]).  Cells  infected  with  a  p-gal  recombinant 
adenovirus expression vector were used as a negative control. The population of P-gal 
infected  cells  showed  a  small  percentage  of strongly  phospho-keratin  positive  cells. 
This subset of cells could be divided into two populations consisting of apoptotic and 
mitotic cells (identified though DAPI  staining) (Fig 4.7)  (Ku et al.,  1997b;  Ku et al., 
1998;  Ku et al,  2002a;  Liao  et al.,  1997;  Toivola et al.,  2002).  The  3055  antibody 
exhibited  a  low  level  of mitochondrial  background  staining  in  SiHa  cells  (data  not 
shown).  At 24 h post  infection ~  50%  of ElA E4-positive  cells  reacted  strongly  with 
phosphor-specific  keratin  antibodies  (Fig  4.8).  E1A E4  associated  with  both  collapsed 
keratin bundles  and  filamentous  keratin  but the majority  of these  cells  did  not  cross 
react with phospho-specific  keratin  antibodies.  Cells that  contained  E1A E4  aggregate 
structures,  all  stained  strongly with phospho-specific keratin antibodies (see Fig 4.9). 
The  observation  that  keratin  bundle  formation  can  occur  in  the  absence  of 
phosphorylation  (not  shown)  and  that  filament  phosphorylation  is  not  necessarily  a 
consequence  of keratin collapse  (see  Fig 4.8),  may  suggest that phosphorylation is  a 
stress  response  induced  by  the  association  of  E1A E4  to  filaments.  These  findings 
suggest that the formation of keratin associated E1A E4 aggregates may occur as a direct 
result of keratin phosphorylation.
4.9.1  E1AE4 and Cyclin B1 colocalise in aggregates
It is known that HPV16 E1A E4 has the ability to sequester the cyclin B/CDK 1  complex
into the cytoplasm (Davy et al, 2005). It is also know that the cyclin B/CDK 1  complex 
can phosphorylate keratin 18 (K18-Ser33) during M phase (Zhou et al., 1999). In
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Figure 4.7  Phospho-specific keratin antibodies react with mitotic and apoptotic 
SiHa cells
SiHa cells infected with P-gal rAD were stained for phosphorylated keratin, (K8 P04 
ser-431(2D6), P04 ser-73 (LJ4), or K18 P04 ser- 33 (8250) (red) and DNA (DAPI- 
blue). Apoptotic/mitotic status of cells was determined by DAPI stain (see inlays A-C). 
(A-B) LJ4 and 2D6 reacted strongly with cytoplasmic structures in both mitotic and 
apoptotic cells. (C) 8250 produced strong cytoplasmic staining in mitotic cells. Cells 
with normal nuclei showed little reactivity with the phospho-specific keratin antibodies. 
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Figure 4.8 E1AE4 binding induces multi-site phosphorylation of type I and II 
keratins
SiHa cells infected with rAD E1AE4 were fixed 24 h post infection and stained for 
E1AE4 (TVG405-green), phospho specific keratin antibodies (K8 PO4 ser-431  (2D6), 
P04 ser-73 (LJ4), K18 P 04 ser- 33 (8250) P 04 ser-52 (3055)) (red) and DNA (DAPI- 
Blue). The keratin  18 PO4 ser-52 antibody (3055) appeared to cross react with 
mitochondria (J-L). The association of E1A E4 to keratin filaments resulted in the 
phosphorylation of affected keratin structures. Scale bars denote 5 pm.
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addition  to  being  phosphorylated  during  the  cell  cycle,  the  accumulation  of  this 
phospho-keratin isoforms has also been observed during toxin induced Mallory body 
formation  (Fausther  et  al.,  2004).  Double  staining  for  E1A E4  and  cyclin  B, 
demonstrated that less than 10 % of cells with filamentous E1A E4  showed visible  co­
localization (not shown). By contrast, cyclin B could be seen to colocalize with -90 % 
of E1A E4  aggregates.  These  structures were  also  observed to  contain phosphorylated 
keratin (Fig 4.9). The collapse of keratins may concentrate cyclin B staining making it 
easier to visualise. Conversely sequestration of cyclin B to keratin filaments by E1A E4 
may result in keratin phosphorylation promoting aggregate formation.
4.9.2  Is  the  recruitment  of  the  cyclin  B/CDK1  complex  to  keratin 
responsible for keratin phosphorylation?
Having established that both keratin phosphorylation and cyclin B-E1A E4 colocalisation
predominate  on  ElA E4-keratin  aggregates,  it was  decided  to  investigate  whether  the 
association of the cyclin B/CDK 1  complex was involved in keratin phosphorylation. To 
examine this, a mutant E1A E4 (T22A, T23A) which is unable to sequester cyclin B into 
the cytoplasm was utilised.  This mutation is not predicted to affect the association of 
E1A E4 with keratins (Davy et al, 2002).  It was hypothesized that if cyclin B/CDK  1  
was involved in the phosphorylation of El A E4-associated keratin, this mutant would be 
unable  to  sequester  cyclin  B  and  may  therefore  affect  cyclin  B-dependent  keratin 
phosphorylation. Immunostaining using the panel of phospho-specific keratin antibodies 
revealed that all four keratin sites still underwent phosphorylation including keratin  18 
ser-33, which is a known in vitro substrate of the cyclin B/CDK 1   complex (Ku et al, 
1998). These data indicate that recruitment of the cyclin B/CDK1  complex by E1A E4 is 
not  essential  for  the  phosphorylation  of these  sites  in  the  ElA E4-associated  keratin 
networks (Fig 4.10).
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Figure 4.9 E1AE4 aggregates contain highly phosphorylated keratin and Cyclin B
SiHa cells infected with rAD E1AE4 were fixed 24 h post infection and stained for 
E1AE4 (TVG405, green) keratin (C2562, red) and DNA (DAPI, blue). E1AE4 
aggregates contain keratin (A-C). Cells stained for Cyclin B (GNS11-red) reveal that 
almost 100 % of E1AE4 aggregates also contain Cyclin B (D-F). E1AE4 aggregates also 
react strongly with phospho-specific keratin antibodies (K8 P 04 ser-431 (2D6), P 04ser- 
73 (LJ4), and K18 P 04 ser-33 (8250), (red) (G-I).  scale bars denote 5 pm.
136Figure 4.10 An E1AE4 mutant with a reduced affinity for Cyclin  B maintains the 
ability to induce keratin phosphorylation
SiHa cells transfected with a mutant (T22A, T23A) El A E4 expression vector were 
fixed 24 h post transfection and stained for El AE4 (TVG405-green), keratin (C2562- 
red) and DNA (DAPI-Blue)  The mutant El A E4 maintained its ability to bind and 
disrupt keratin filament networks as previously reported (A-C)  Staining with phospho 
specific keratin antibodies (K8 P04 ser-431   (2D6), P04 ser-73 (LJ4), K18 P04 ser- 33 
(8250) P04 ser-52 (3055)-(red)) showed that (T22A, T23A) E1A E4 maintained the 
ability to induce multiple keratin phosphorylation events (D-O). 3055 produces 
background mitochondrial staining (M-O).  Scale bars denote 5 pm.
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This  finding  was  further  supported  by  a  second  experiment  that  looked  at  E1A E4 
expression  in  SiHa  cells  held  under  aphidicolin  block  using  an  established  protocol 
(Davy  et  al,  2005).  SiHa  cell  were  synchronised  at  Gl/S  using  low  serum  and 
aphidicolin and then infected with rAD E1A E4. One population was then released from 
the aphidicolin block 6 h post infection whereas the other remained under the block. 
The  cells were  fixed  and  stained  for E1A E4  and keratin,  at 24  h post infection.  The 
population released  from  the  aphidicolin  block had  twice  as  many  of ElA E4/keratin 
aggregates when compared to the blocked population. Despite the difference in ElA E4’s 
appearance, ElA E4-associated keratin structures in both populations stained positively 
with all four phosphor-specific keratin antibodies suggesting that the  Gl/S phase cell 
cycle arrest did not prevent ElA E4-induced keratin phosphorylation of these sites. The 
increased  frequency  of E1A E4/Keratin  aggregates  in  the  released  population  may  be 
attributable to higher levels of kinase activity at later points in the cell cycle (reviewed 
in (Stark et al., 2004), which may promote aggregate formation. These findings suggest 
that keratin phosphorylation may be  a stress  induced response to  E1A E4  binding and 
that it is not necessarily linked to the proteins ability to disrupt the cell cycle.
4.9.3  Unking keratin Phosphorylation to E1AE4 binding
To investigate the relationship between keratin phosphorylation and E1A E4 binding, a
second mutant (M2  E1A E4),  lacking the  LLKLL  motif,  which has been  shown to  be 
involved  in  E1A E4  binding  keratin,  was  utilised  (Roberts  et  al,  1994;  Wang  et  al, 
2004). M2 E1A E4 has a greatly reduced ability to bind to and collapse keratin networks 
and is unable to associate with mitochondria (Raj et al, 2004). SiHa cells infected with 
an  M2  rAD  E1A E4  expression  vector  (Doorbar  et  al,  2000)  were  fixed  24  h  post 
infection  and  stained  for  E1A E4  and  Keratin.  M2  E1A E4  formed  large  irregular 
condensed structures that showed almost no keratin (Fig 4.11  A-C) (see next section).
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Figure 4.11 M2 E1AE4 a keratin binding mutant show very little keratin 
phosphorylation.
SiHa cells infected with rAD M2 E1A E4 were fixed 24 h post infection and stained for 
E1A E4 (TVG405-green) keratin (C2562-red) and DNA (DAPI-blue). M2 E 1A E4 did not 
form filamentous structure commonly observed with wild type E1A E4 although, a few 
partially filamentous globules were observed (arrow F). No keratin reorganisation was 
observed to occur in cell expressing M2 E1A E4 at 24 h (A-C).  Staining of cells with 
TVG405 (Green) and phospho specific keratin antibodies (K8 PO4 ser-431  (2D6), PO4 
ser-73 (LJ4) and K18 PO4 ser- 33 (8250) red) overlay images show that expression of 
M2 E1A E4 did not induce phosphorylation of cytokeratin networks (D-F).  Scale bars 
denote 5 pm.
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Phosphorylated  keratin  was  not  observed  using  any  of  the  four  phospho-specific 
antibodies  in cells  expressing  M2  E1A E4  (Fig 4.11  D-F).  These  data indicate that  a 
direct  interaction  between  keratin  and  E1A E4,  or  that  the  resultant  network 
reorganisation is required for keratin phosphorylation to occur.
4.9.4  M2 E1AE4 maintains a weak affinity for keratin network
Having noticed during the earlier experiment that M2 appeared to have a very limited
ability to  localise to  keratins  in  SiHa cells,  it was  decided to perform  a time  course 
experiment to see if the association altered over time. SiHa cells were infected with rAD 
M2 E1A E4, fixed at 12, 24, 48, 72 h after infection and stained for keratin (C2562) and 
E1A E4 (TVG405) (Fig 4.12). At 12 h very little M2 E1A E4 could be seen in the cells. 
By 24 h visible levels had built up, with cells comprising of a mixed population that 
showed both diffuse and condensed staining patterns (Fig 4.12 A-C). Interestingly a few 
stretched-globular  structures  that  weakly  colocalize  with  keratin  were  also  observed 
(Fig 4.12 D-F). Between 48-72 h keratin colocalisation increased resulting in disruption 
and bundling of keratins (Fig  12  G-I). Unlike wild type E1A E4,  M2 never displays a 
purely filamentous pattern and forms condensed structures which displays weak keratin 
colocalisation  which  increases  over  time,  eventually  resulting  in  network  disruption 
only at late time points.
4.10Characterisation of E1AE4 and keratin complexes
4.10.1  Western blot analysis of the wild type and mutant 2 E1AE4
SiHa cells were infected with rAD p-gal, wild type or M2 E1A E4 expression vector and
harvested  at  12,  24  or  48  h  post  infection.  The  lysates  were  separated  on  a  15% 
SDS/PAGE gel and transferred to a nitrocellulose membrane then probed for E1A E4 and 
glyceraldehhyde-3-phosphate  dehydrogenase  (GAPDH)  (used as loading control)  (Fig 
4.13). P-gal infected extracts did not contain ElA E4-reactive bands. Wild type E1A E4
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Figure 4.12 Build up of M2 E1AE4 in SiHa cells results in keratin filament 
disruption
SiHa cells infected with rAD M2 El A E4 were fixed 24, 48, and 72 h after infection and 
stained for E1A E4 (TVG405-Green), keratin (C2562-red) and DNA (DAPl-Blue). M2 
E1A E4 displays a variety of different patterns. At early time points cells contain both 
diffuse and globular M2 E1A E4 with few filamentous structures and little keratin 
colocalisation (A-F). Keratin staining builds up in M2 E1A E4 structures and by 72 h M2 
E1AE4 the majority of cellular keratin is found to localise with M2 E1AE4 resulting in 
the disruption of networks (G-I). Scale bars denote 5 j^m
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Figure 4.13 Western blot characterisation of wild type and M2 El AE4 expression 
and keratin species in SiHa cells  over a 48 h time course
A shows the build up of wild type and M2, E1AE4 in rAD infected SiHa cells 12, 24 and 
48 h post infection (probed with TVG402). Wild type E1AE4 expression can be detected 
12 h post infection and continues to build up between 24 and 48  h. M2 expression 
cannot be detected at 12 h, but by 48 h expression has dramatically increased and is 
approximately comparable to that ofwild type protein.  The right most lane contains p- 
gal infected SiHa extract and demonstrates that TVG402 does not react with other 
cellular proteins. Blot B shows extracts probed for keratin 18 (CY-90). Low exposures 
show high molecular weight keratin 18 species in the wt El AE4 lanes, higher exposures 
reveal the presence of keratin ladders.  At 48 h, high levels of M2 El AE4 expression do 
not result in the formation of keratin ladders, and are comparable to the P-gal 
population.  C shows extracts of SiHa cells infected with wt or M2 El AE4 or p-gal rAD 
at 12, 24 and 48 h post infection probed for keratin 8 (Cam 5.2).  Low exposures of the 
blot reveal little difference between the three groups. Higher exposures show high 
molecular weight keratin 8 species present in the w t-ElAE4 lanes. Keratin 8 and  18 
blots of extracts from M2 and p-gal infected cells appear comparable at all time points. 
All blots were re-probed with GAPDH as a loading control
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could be detected at  12 h and ran as 2 bands.  The top band has been shown to result 
from the phosphorylation of E1A E4 (Wang et a l, 2004). At later time points, the levels 
of protein increased significantly  with additional E1A E4  species also being observed. 
These are believed to be caused by multimerisation of the protein (Wang et a l, 2004). 
By comparison M2 E1A E4 was not detectable at  12 h post infection,  and levels were 
only comparable to wild type at latter time points. By 24 h M2 can be detected at low 
levels and appears as a single band, however by 48 h M2 levels have increased greatly 
and  additional  high  molecular  weight  species  are  also  detectable.  This  observation 
suggests  that the  association  of E1A E4  to  keratin  may  stabilise  the  protein  allowing 
levels to accumulate.
4.10.2  E1AE4  expression  in  SiHa  cells  induces  high  molecular 
weight keratin ladders
SiHa extracts  (as  used  in  section  4.10.1)  were  separated  on  a  10%  SDS/PAGE  gel,
Western blotted and probed for either a keratin 8 or  18 and GAPDH. The keratin blots 
showed that all three cells extracts were comparable at 12 h (Fig 4.13 B and C). At later 
time points additional high molecular weight keratin 18 species are clearly visible in the 
E1A E4 extracts (Fig 4.13 B) as previously reported (Wang et a l, 2004). No increase in 
high molecular weight keratin 18 species is observed in the M2 E1A E4 or p-gal extracts 
at  these  time-points.  The  emergence  of high  molecular  weight  keratin  18  species 
coincided with an  increase  in E1A E4  levels (Fig 4.13A),  suggesting that the  two  are 
linked. Despite high expression levels at 48 h (Fig 4.13  A) abundant M2 E1A E4 does 
not result in the formation of keratin ladders.  Extracts were also probed for keratin 8 
(Fig 4.13 C). High molecular weight keratin 8 species were also observed in wild type 
E1A E4 extracts at 24 h but not P-gal or M2 E1A E4 extracts. However, they were much 
less intense than the keratin 18 species and could not be detected at 48 h due to loss of 
cells (Fig 4.13 C).
144Chapter 4 The effect of E1A E4 on Keratins in SiHa Cells
A build up of low molecular weight keratin 8 and 18 species was observed in both M2 
and  P-gal  extracts  over  this  time  period.  These  species  were  less  intense  in  E1A E4 
extracts. At late time points wild type ElA E4-expressing cells undergo keratin collapse 
and apoptosis both of which cause cells to float off the plate (the extent of cell loss can 
be determined by strength of GAPDH bands) (also see Fig 4.18). Low molecular weight 
keratins bands observed in M2 E1A E4 and p-gal at late time points may be caused by 
caspase  cleavage  of keratin  (Caulin  et  a l,  1997;  Ku  et  al,  1997a;  Oshima,  2002; 
Schutte et al, 2004). The lack of low molecular weight keratins (see arrows Fig 4.13 B 
and  C)  may  indicate  that  E1A E4  expressing  cells  detach  from  the  plate  prior  to  the 
initiation of apoptosis. Alternatively apoptosis may only be initiated in cells which have 
lost their keratins as mitochondrial association (previously linked to apoptosis (Raj  et 
al,  2004))  is usually  observed  after  keratin  collapse.  High  molecular weight  keratin 
species may be induced by glycosylation or ubiquitination.
4.10.3  Keratin specific western blots of HaCat cell lysate
To  examine  whether  ElA E4-association  could  induce  biochemical  modifications  to
keratins other than K18/8, HaCat cells were infected with either wild type or M2 E1A E4 
rAD.  Cells were harvested  12, 24, 48,  72 and 96 h post infection. Expression of wild 
type  and  M2  E1A E4  in  HaCat  cells  was  comparable  to  SiHa  cells  with  M2  levels 
building  up  more  slowly  over time  (Fig  4.14  A).  Lysates  were  separated  on  a  10% 
SDS/PAGE gel and probed with keratin specific antibodies. Keratin 8 and 18 blots were 
comparable to those from SiHa cells with high molecular weight species being observed 
in both (Fig 4.14  B).  Keratin  10 blots  were  weak and  it is possible that this  keratin 
species is not abundant in HaCat (data not shown). No high molecular weight keratin 
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Figure 4.14 Affect of wild type and M2 E1AE4 or different keratin subtypes in 
HaCat cells
HaCat cell infected with wild type or M2 E1A E4 rAD were harvested  12, 24,48 and 72 h 
(24,48, 72 and 96 h for M2) post infection. Extracts were separated on a  10% SDS 
PAGE gel probed for E1AE4 (TVG402). Blots revealed that M2 builds up more slowly 
than wild type protein. Extracts separated on 10% SDS/Page gels were probed with 
subtype specific keratin antibodies (K8 cam5.2, KI8 Cy-90, KI4-LL001, KI3- 
NCLCK13.  An increase in high molecular weight keratin 8 and  18 species was 
observed in El A E4 extracts. Levels of M2 E1A E4 are low at 24 h time points but greatly 
increase by 48 hr (A). M2 E1A E4 does not cause an increase in keratin high molecular 
weight keratins species (B)  Keratin  13 blots revealed no, differences between wild type 
and M2 E IA E4 extracts with not detectable high molecular weight keratin  Both the 
keratin 4 and  14 blots showed some evidence of additional high molecular weight 
species by 72 hr  in the E1A E4 lanes
146Chapter 4 The effect of E1A E4 on Keratins in SiHa Cells
and  14 bands could be detected at late time points in wild type E1A E4 extracts (Fig 
4.14C), apparent loss of K14 in M2 lanes was due uneven loading (loading control not 
shown). Although the data are inconclusive it does not rule out the possibility of E1A E4 
inducing  biochemical  modifications  to  the  more  robust  differentiation-dependent 
keratins.
4.10.4  E1AE4 association increase levels of keratin phosphorylation
Earlier  immunofluorescence  experiments  were  able  to  show  that  the  association  of
E1A E4 to keratin resulted in the multi-site phosphorylation of the affected network (see 
section 4.9).  This result was confirmed by western blot analysis of the  SiHa extracts 
used  in  section  4.10.1.  Extracts  probed  with  the  four  phospho-specific  antibodies 
(described in section 4.9), revealed that cells infected with E1A E4 show elevated levels 
of keratin phosphorylation at 24 h (Fig 4.15). At 24 h post infection M2 expressing cells 
did not show elevated levels of keratin phosphorylation and were comparable to the 13- 
gal population.  By 48 h post-infection phosphorylation levels in all populations were 
elevated  (data not  shown).  This  may  be  due  to  apoptosis/cell  stress  associated  with 
adenovirus  infection.  These  data  confirm  that the  association  of E1A E4  with  keratin 
facilitates keratin phosphorylation.
4.10.5  The effect of E1AE4 keratin-binding on the solubility of both 
proteins
We  have  shown  that  M2  maintains  an  ability  to  associate  with  and  disrupt  keratin 
filaments although the rate of disruption was significantly reduced. In addition to this its 
expression  does  not  induce  biochemical  modification  to  keratins.  Fractionation 
experiments were conducted to determine whether M2 had the capacity to affect keratin 
solubility  as has previously  been reported  for wild type  E1A E4  (Wang  et a l 2004). 
Wild type E1A E4, M2 and p-gal infected SiHa cells were harvested from the plate using
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Figure 4.15 E1AE4 expression increases levels of phosphorylated keratin 8 and  18
SiHa cells infected with P-gal, wild type or M2 El A E4 rAD were harvested at  12 and 
24 h post infection (same extracts used in fig 4.13). Extracts were probed with phospho 
specific keratin antibodies IB4 [K18, P04 ser 33], 3055  [K18, P04 ser 52], LJ4 [K8, 
P04 ser 73] and 2D6 [K8, P04 ser 431]  Blot A shows extracts probed for K8, P04 ser 
73 the antibody reacts  with E1A E4 extracts at  12 h the signal increases at 24 h, M2 and 
P-gal extracts are negative. Blot B shows E lA E4 extracts contain significantly more K8, 
P04 ser 431  at 24 h than P-gal or M2 extracts. Blot C shows extracts probed for K 18, 
P04 ser 33 the lower band which corresponds to keratin  18 is significantly stronger in 
E1A E4 extracts  Blot D shows extracts probed for K18, P04 ser 52 two bands are 
detected the lower band corresponding to keratin  18 is only present in the E1A E4 
extracts (upper bands in C and D may be antibody reacting with an unidentified cellular 
protein).
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PBS/EDTA,  these  cells  were  then  pooled  with the  media  from the  plate,  containing 
detached and apoptotic cells, cells were subsequently pelleted by centrifugation. Pellets 
were then resuspended, and incubated at 4°C for one hour with agitation sequentially in 
1%  NP40  (soluble  fraction),  1%  empigen  (partially  soluble  fraction)  and  9  M  urea 
(insoluble fraction). The fractions were then analyses by SDS Page (see Fig 4.16)
No reduction in keratin solubility was observed with M2 E1A E4 population which were 
comparible with the P-gal control population, where keratin levels are low in the urea 
fraction at all time points. These findings suggest that despite associating with keratins a 
later time points M2 E1A E4 does not effect their solubility in the same manner as wild 
type E1A E4.
In  cells  expressing  wild  type  E1A E4,  keratin  18  solubility  distribution  shifts,  being 
weaker in the NP40 fraction and higher in the urea fraction when compared to the p-Gal 
and M2 expressing populations. The higher molecular weight keratin species are found 
exclusively in the insoluble (urea) fraction (Fig 4.16.B).
The  way  in  which  the  experiments  were  conducted  (1  h  incubations)  may  have 
exaggerated the solubility of each fraction, as keratin is usually seen predominantly in 
the empigen fractionation. This data show that keratin solubility is reduced, in E1A E4 
epressing cells but is not affected by M2 E1A E4.
Wild type E1A E4 fractionates predominantly to the empigen fraction (Fig 4.16 A). At 
early time points the phosphorylated form of the proteins is present exclusively in the 
empigen fraction however at later time points it is also observed in the urea fraction.
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Figure 4.16 Fractionation of El AE4, M2 and keratins from SiHa cells
SiHa cells infected with wild type and M2 E1AE4 or P-gal were harvested. Proteins was 
extracted sequentially in  1%NP40,  1% empigen and 9 M urea and probed for keratin  18 
or E1A E4. E1A E4 is predominantly found in the empigen fraction  High molecular 
weight (phosphorylated) E1A E4 is predominantly found in the empigen fraction. M2 
El A E4 is more soluble and expressed at very low levels at 24 h, at later time points M2 
is evenly distributed through the three fractions (A)  Wild type E1A E4 expression 
induces a solubility shift in keratin causing a decrease in the NP40 fraction and a 
significant increase in the urea fraction. High molecular weight keratin species are only 
found in the urea fraction. M2 E1A E4 does not cause a shift in keratin solubility and is 
comparable to the P-gal fractionation (B ).
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This distribution contrasts dramatically with M2 E1A E4. At 72 h despite associating to 
keratins,  M2  is  distributed  equally  between  the  three  fractions  and  significantly  the 
phosphorylated form of the protein (see 4.10.1) exhibits no fraction preference (Fig 4.16 
A). These data suggest that keratin binding reduces E1A E4 solubility,  furthermore the 
phosphorylated form of E1A E4 is exceptionally insoluble, in the presence of keratin.
4.11  Does the association of E1AE4 to keratins induce their 
ubiquitination
It has previously been shown that keratins become ubiquitinated during Mallory body 
formation  and  as  part  of  normal  protein  turn-over,  resulting  in  their  subsequent 
degradation via a proteasome-dependent pathway (Ku et al., 2000). Experiments using 
proteasome inhibitors demonstrated a build up of both phosphorylated and ubiquitinated 
keratins suggesting that proteasome mediated degradation plays a role in the turnover of 
cytokeratin  networks  in  vivo  (Ku  et  ah,  2000).  The  accumulation  of 
hyperphosphorylated  and  ubiquitinated  keratins  is  also  seen  during  some  disease 
processes  resulting  in  the  formation  of Mallory  bodies  (see  section  4.5.2).  Previous 
experiments have shown that expression of E1A E4 induces keratin phosphorylation (Fig 
4.8) and the formation of multiple high molecular weight keratin species (Fig 4.13). A 
series  of  experiments  were  carried  out  to  determine  whether  E1A E4  induces  the 
ubiquitination  of  keratins  in  a  manner  similar  to  that  seen  during  Mallory  body 
formation.
4.11.1  The ubiquitin- proteasome system
The proteasome is a large cytosolic proteolytic complex that is involved in the selective 
degradation of proteins which are selectively targeted for degradation by the covalent 
conjugations  of  multiple  ubiquitin  molecules.  Proteasome-mediated  degradation  is 
involved  in  multiple  cellular  processes  including  protein  turnover  as  well  as  the
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degradation of cell cycle regulators and misfolded proteins.  The ubiquitin proteasome 
system  is  commonly  subverted  by  viruses,  which  override  cellular  processes  by 
targeting  specific  proteins  for  proteasome  mediated  degradation  (reviewed  in 
(Shackelford et al., 2005). To target a substrate for degradation, an activating enzyme, 
El, transfers ubiquitin to a carrier E2 enzyme, and this in turn tags ubiquitin on to the 
targeted  substrate  with  the  help  of E3  enzymes.  Substrate  recognition  is  primarily 
carried out by E3 enzymes. Ubiquitin is usually conjugated onto a lysine on the target 
protein and can perform several different functions depending on the manner in which 
the  poly-ubiquitin  chain  is  constructed.  Conjugation  of  ubiquitin  molecules  to  an 
existing ubiquitin chain at lysine 48 or 29 signals degradation (a minimum chain length 
of  four  is  required  for  proteasome  mediated  degradation)  whereas  the  addition  to 
ubiquitin lysine 64 on certain proteins has been demonstrated to trigger DNA repair and 
transcription  factor  activation  (reviewed  in  (Pickart,  2001).  Mono-ubiquitination  of 
proteins has been linked to endocytosis, histone regulation and virus budding (reviewed 
in  (Hicke,  2001).  The  ubiquitination  of  misfolded  proteins  can  serve  to  recruit 
chaperones in an attempt to rescue them. If proteins are successfully refolded ubiquitin 
chains  are  removed  by  the  enzyme  isopeptidase,  but  if  unsuccessful,  proteins  are 
degraded,  and  it  has  been  suggested  that  ubiquitinated  keratins  may  undergo  this 
process (Janig et al., 2005).
The proteasome is composed of 2 separate components, a 19S regulatory domain, and 
the 20S proteolytic domain.  The  19S  regulatory  domain consists of a base  and  a  lid 
domain  and  is  located  at  either  one  or  both  ends  of the  20S  proteolytic  complex 
producing  the  26  or  30S  proteasome,  respectively.  The  19S  regulatory  domain 
recognises  target  proteins  by  way  of their  poly  ubiquitin  chains,  which  it  removes
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before  unfolding  proteins  and  directing  them  to  the  pore  of the  20S  subunit  where 
proteolysis occurs. The proteolytically active sites are located within the lumen of the 
cylindrical 20S complex to (reviewed in (Dahlmann, 2005)).
4.12  E1AE4 aggregates colocalize with ubiquitin.
The  first  experiment  was  designed  to  determine  whether  any  E1A E4  structures 
colocalised  with  ubiquitin.  SiHa  cells  infected  with  E1A E4  were  double  stained  for 
E1A E4 and ubiquitin.  In cells containing E1A E4  with a filamentous pattern, ubiquitin 
staining was diffuse and did not colocalize with E1A E4 (Fig 4.17 A-C).  This staining 
pattern was also observed in neighbouring E1A E4 negative cells (Fig 4.17 D-G). Cells 
containing  E1A E4  collapsed  keratin  bundles/aggregates  contained  diffuse  ubiquitin 
staining, however, the dense E1A E4 structures reacted strongly with ubiquitin antibodies 
(Fig 4.17 D-J). Interestingly this pattern is similar to that observed in figure 4.9 where 
dense E1A E4 structures also reacted strongly with phospho-specific keratin antibodies 
(Fig  4.6).  This  observation  suggests  that  dense  ElA E4/keratin  structures  may  have 
characteristics  in  common  with  Mallory  bodies,  which  also  contain 
hyperphosphorylated and ubiquitinated keratins (Cadrin et al.,  1995; Ohta et al.,  1988; 
Stumptner et al., 2000)
4.13Proteasome  inhibitors  enhance  E1AE4  induced  keratin 
laddering
To establish whether high molecular weigh keratin species were indeed ubiquitinated 
experiments  were  conducted  with  a  proteasome  inhibitor  which  prevented  the 
degradation  of ubiquitinated  proteins.  SiHa  cells  were  treated  overnight  with  either 
ALLN (an inhibitor of the chymotryptic-like activity of the proteasome) (10 pM in 5 pi 
of DMSO) or with vehicle (5 pi DMSO). Cells were harvested and lysate separated on a 
12% SDS/PAGE gel western blotted and probed for ubiquitin (Sc-8017) (Fig 4.18). The
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Figure 4.17 Dense E1AE4 structures colocalise with ubiquitin
SiHa cells infected with rAD E1AE4 were stained for E1AE4 (TVG405-green), ubiquitin 
(Z0458- red) and DNA (DAPI-Blue). E1AE4 with a filamentous staining patterns does 
not colocalise well with ubiquitin (A-C), in contrast dense bundles and El A E4 
aggregates react strongly with ubiquitin antibodies (D-J). Neighbouring E1AE4 negative 
cells show a diffuse ubiquitin staining pattern (D-G).  Scale bars denote 5 pm.
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Figure 4.18 Affects of proteasome inhibitors on E1AE4 and Keratin
SiHa cells treated overnight with the proteasome inhibitor ALLN, or vehicle (DMSO) 
overnight extracts were probed for ubiquitin (Sc-8017). Blot A shows an increase in 
high molecular weigh ubiquitin species in the treated population, suggesting inhibition 
of the proteasome.  SiHa cells infected with El A E4 or P-gal and treated with ALLN or 
vehicle were harvested by collecting supernatant (S) and plate (P) fractions and SDS 
lysates were probed for keratin  18 (CY-90), E1A E4 (TVG402) and GAPDH (loading 
control). High molecular weight keratin species were significantly enhanced by the 
addition of proteasome inhibitors in both P and S El A E4 fractions. Higher exposures of 
the blots also revealed the presence of high molecular weight keratin species in the 
ALLN treated P fraction of P-gal cells (photoshop enhanced panel B*).  Treatment of 
cells with ALLN was also observed to increases high molecular weight E1A E4 species 
although no laddering was observed (top panel B).
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treated lysate showed an increase in high molecular weight ubiquitinated species (Fig 
4.18  A).  This result  suggested  that  as  expected,  the  ALLN  was  inhibiting the  break 
down  of high  molecular  weight  ubiquitin  reactive  protein  species.  The  proteasome 
inhibitor ALLN was employed to determine whether E1A E4 association induced keratin 
ubiquitination. SiHa cells were infected with either E1A E4 or p-gal rAD, and harvested 
24 h after infection, one population was treated overnight with the proteasome inhibitor 
ALLN,  and the  second  population  was treated  with vehicle  (DMSO).  Culture  media 
from  plates  was  collected  and  centrifuged  to  produce  a  pellet  from  the  supernatant 
population (S) which was subsequently lysed in 1%SDS/PBS; cells adhering to the plate 
were  then  harvested  by  direct  lysis  in  1%SDS/PBS  (fraction  P).  Cell  lysate  was 
separated on a 12 % SDS/PAGE gel and probed for keratin, E1A E4 and GAPDH (Fig 
4.18B). Loading controls revealed that the P-gal population contained more cells in the 
P fraction than the S fraction. Whilst the E1A E4 population contained an even number 
of cells in the P and S fractions due to the properties of E1A E4 (apoptosis induction and 
keratin disruption) which can cause cells to float off. The blots revealed a significant 
increase  in  high  molecular  weight  keratin.  Species  in  both  ALLN  treated  E1A E4 
fractions. The emergence of a weak high molecular weight keratin species can also be 
seen in the ALLN treated p-gal P population (Fig 4.18.B*). Due to the large number of 
ubiquitin reactive species, in these cell extracts (Fig 4.18A) it was not possible to use 
ubiquitin blots to identify different ubiquitin reactive bands in E1A E4 and P-gal samples 
(see Fig 4.21).  These experiments were repeated using a second proteasome inhibitor 
MG 132, and similar results were observed (data not shown).
It has previously been reported that treatment with proteasome inhibitors induces the 
formation of high molecular weight keratin 18 species formed by ubiquitination (Ku et
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al., 2000). This data supports the hypothesis that the E lA E4-induced keratin ladders are 
caused by  ubiquitination.  In addition to  seeing  an increase  in high molecular weight 
keratin species, both of the ALLN-treated fractions contain an additional E1A E4 band 
pointing  to  the  stabilisation/reduced  turnover  of  E1A E4  multimers.  These  high 
molecular  weight  species  have  previously  been  demonstrated  to  be  caused  by 
multimerisation (Wang et al,  2004),  although the possibility  of E1A E4 ubiquitination 
cannot be ruled out.
4.13.1  Immunoprecipitation of keratin, ubiquitin and E1AE4
To determine if any of the high molecular weight E1A E4 or keratin species enhanced by
the  addition  of  proteasome  inhibitor  were  ubiquitinated;  immuno-precipitation 
experiments  were  conducted.  The  aim  was  to  determine  if any  immuno-precipitated 
E1A E4  or  keratin  bands  reacted  with  ubiquitin  or  whether  ubiquitin  immuno- 
precipitations could pull down any E1A E4 or keratin species. Initial experiments failed 
to pull down anything due to excessive levels of SDS, and it was also noticed that heavy 
and  light  chain  antibody  contamination  in  the  regions  of interest  could  hinder  the 
identification of ubiquitinated proteins.  Samples lysed in  1%  SDS or 9 M urea/ 0.1% 
NP40  contained  insoluble  species  of  interest  (data  not  shown),  without  inhibiting 
antibody  binding  (Fig  4.19.A).  To  reduce  antibody  contamination,  antibodies  were 
covalently  cross-linked  to  beads  using  dimethyl  pimelimidate  (DMP).  Cross-linking 
antibodies to beads significantly reduced heavy and light chain contamination making 
IP blots easier to interpret (Fig 4.19.B).  Using  samples lysed in  1   %  SDS and cross- 
linked antibodies,  it was possible to  successfully  IP  E1A E4,  keratin  18  and ubiquitin 
from E1A E4 infected SiHa cell lysates (Fig 4.19 see below).
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Figure 4.19 Imniunoprecipitation of E1AE4, ubiquitin and keratin
E lA E4-infected SiHa cell were harvested in  10% SDS,  1% SDS or OM urea. Proteins 
could be IP’ed from  1% SDS or urea extracts but contained significant heavy and light 
chain antibody contamination when probed for E1A E4 (A). Cross-linking antibodies to 
beads with DMP resulted in a significant decrease in the presence of heavy and light 
chain released from beads as shown by coomassie stain (B). E lAE4-probed E IA E4 IP 
shows that 4 species were pulled down. In the absence of antibody no E1A E4 was 
present, whereas in the absence of sample, only antibody contamination is observed (C). 
E IA E4, keratin and ubiquitin  IP’s probed for keratin  18, demonstrate that keratin  18 was 
only present in keratin IP lane (D.)  El A E4, keratin and ubiquitin IP’s probed for 
ubiquitin showed ubiquitin IP’s capture multiple high molecular weight ubiquitin 
species (E  )  The E1A E4 IP lanes does not contain any ubiquitin cross reactive bands 
The keratin IP lane contains high molecular weight ubiquitin cross reactive bands 
(keratin IP E).
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4.13.2  E1AE4  and  keratin  can  be  immuno-precipitated  from  E1AE4 
infected SiHa cells
SiHa cell  lysate,  ElA E4-IPs  and  controls were  separated  on  a  15  %  SDS/PAGE  gel 
western blotted and probed for E1A E4 using TVG402 (Fig 4.19 C).  In addition to the 
main  band  at  ~12  kDa  multiple  high  molecular  weight  E1A E4  species  were  also 
observed.  Some  of these  species have previously  been  shown to be  enhanced by the 
addition  of proteasome  inhibitors  (Fig  4.18).  This  experiment  showed  that  E1A E4 
species can be immuno-precipitated using this approach.  The control lanes (no sample 
or no antibody) showed that in the absence of antibody no E1A E4 is present, and that in 
the absence of sample additional bands present were due to antibody contamination (Fig 
4.19.C).
The L2A1  antibody precipitated keratin  18, however, neither the ubiquitin nor E1A E4 
IPs  contained  keratin  cross-reactive  species  (Fig  4.19  D).  Although  keratin  has 
previously been reported to co-IP with E1A E4 (Wang et al., 2004), it is unlikely that the 
interaction  is preserved  in the  1%  SDS  required to  solubilise  high  molecular keratin 
species.  Antibody  contamination  prevented  identification  of  keratin  cross-reactive 
species in the ubiquitin IP.
4.13.3  Ubiquitin probed IPs
To establish if any E1A E4 or keratin species were ubiquitinated, E1A E4 and keratin IPs
were  probed  with  a  ubiquitin  antibody.  The  ubiquitin  blot  demonstrates  that  the
ubiquitin  IP  was  successful  and  had  pulled  down  multiple  high  molecular  weight
ubiquitin-reactive  proteins.  No  clear  ubiquitin  reactive  species  was  identified  in the
E1A E4 IP lane. The high molecular weight E1A E4 species present in the ElA E4-probed
E1A E4 IP ( Fig 4.19C) were not detected by the ubiquitin antibody, confirming that they
are probably caused by multimerisation as previously suggested (Wang et al., 2004) and
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not E1A E4 ubiquitination. Several ubiquitin reactive bands were detected in the keratin 
IP lanes. This result strongly suggested that ubiquitinated keratin species were present 
in  E1A E4  expressing  SiHa  cell  lysate.  High  molecular  weight  keratin  species  have 
previously  been  demonstrated  to  be  induced  by  wild  type  but  not  M2  E1A E4  (Fig 
4.13).Furthermore,  high  molecular  weight  species  were  enhanced  by  the  addition  of 
proteasome  inhibitors  (Fig  4.18).  These  data  suggested that they  may  be  induced by 
ubiquitination.
4.13.4  Keratin IPs from E1AE4 and p-Gal infected SiHa cells
Having  generated  evidence  to  suggest  that  the  high  molecular  weight  keratin  bands
induced by the expression of E1A E4 are caused by ubiquitination (Fig-4.19E), the extent 
of ubiquitination  of both  K8  and  18  was  further investigated  using  ubiquitin probed 
keratin IPs. Extracts from both P-gal and E1A E4 infected SiHa cells harvested 48 h post 
infection  were  immuno-precipitated  using  both  L1A2  and  the  pan  keratin  antibody 
(C2562). Due to the problems encountered in earlier experiments with high molecular 
weight  antibody  contamination,  the  amount  of  antibody  used  for  each  immuno- 
precipitation was  further  reduced.  Lanes  containing  antibody  and  no  sample  showed 
that  antibody  contamination  had  been  virtually  eliminated.  IPs  were  probed  for 
ubiquitin (Fig 4.20 A  and C)  and then re-probed for keratin  18  (Fig 4.20  B  and D). 
Control lanes revealed a number of low molecular weight ubiquitin species adhering to 
the beads (Fig 4.20 C). These ubiquitin contamination bands were of lower molecular 
weight than those observed in the keratin immuno-precipitations. In addition to this, low 
molecular weight ubiquitin bands were not present in the keratin immuno-precipitation 
lanes suggesting that the coupling of antibodies to beads reduced this background.
GAPDH blots of extracts showed that comparable amounts of proteins had been used in 
each IP (Fig 4.20B). Keratin blots of extracts showed that comparable amounts of
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Extracts from SiHa cells infected with p-gal and E1A E4 rAD and harvested 24 h post 
infection were IP’ed for keratin (C2562 (A) and L2AI  (C)) and probed for ubiquitin (A 
and C). Blots were then re-probed for keratin  18 (B and D)  The lane containing 
antibodies and no sample shows negligible heavy and light chain antibody 
contamination  Only the E1A E4 keratin IP lane contains detectable ubiquitin reactive 
species (3 min exposure)  E1A E4 and p-gal extracts were also probed for keratin 8 and 
18 species (A).  The same membrane was re-probed for keratin  18 demonstrating keratin 
IP’s were successfiil but that only the E1A E4 IP lane contained high molecular weight 
keratin species (10 s exposure)  Keratin 8 and  18 blots were also re-probed for GAPDH 
to demonstrate sample equal loading (B)  A second keratin IP was performed on the 
same extracts using the L2A1  keratin antibody and probed for Ubiquitin  The lane 
containing no sample showed little, heavy or light chain antibody contamination.  IP's 
preformed without antibodies produced weak low molecular weight background bands 
but were clear in the region of interest  Ubiquitin reactive keratin species were only 
present in the E1A E4 keratin IP lane and not the p-gal lane (3 min exposure). E1A E4 
sample was also run on the same gel and probed for keratin 8 and  18 to aid the 
identification of bands (C). The membrane was re-probed for keratin  18 which was only 
present in IP lanes not the control lanes (10 s exposure). High molecular weight keratin 
18 species were only present in the E1A E4 lane with bands matching some ubiquitin 
reactive species (D). Ubiquitin blots (3 min exposure) were aligned with keratin  18 re­
probes (10 s exposure) preformed on the same membrane, some bands aligning 
perfectly (arrows). E1AE4 samples probed for keratin 8 and  18 are included for 
reference (E).
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keratin were present in each IP and that keratin ladders were only present in E1A E4 
extracts (Fig 4.20 A-B). p-gal IP lanes contained virtually no ubiquitin-reactive bands 
(Fig 4.20 A and C). Multiple ubiquitin reactive species (ladders) were present in E1A E4 
keratin IP  lanes.  Both L2A1  and the  pan keratin  antibody  IPs produced  comparable 
bands.  In particular when using the L2A1  antibody several prominent bands could be 
clearly observed in the ubiquitin-probed E1A E4 extracts (Fig 20 C). Ubiquitin-reactive 
bands were an identical size as prominent high molecular weight keratin 18 species (Fig 
4.20 A and C).
Both blots were washed and re-probed for keratin  18.  The re-probe showed that both 
L2A1  and  C2562  antibodies  had  pulled  down  keratin  18  (below  ubiquitin  reactive 
ladders) from p-gal and E1A E4 extracts. Keratin IPs from E1A E4 extracts also contained 
multiple high molecular weight keratin  species.  When the keratin  and ubiquitin blots 
were overlaid, bands matched perfectly (Fig 4.20 E). Furthermore, ubiquitin bands had 
to be exposed for 3 min to visualise, when re-probed for keratin, blots only required 10 
s exposures to visualise bands. Very high molecular weight keratin species/ladders were 
more apparent when blots were probed for ubiquitin than when probed for keratin. This 
finding  is  likely  due to the  fact that high molecular weight keratin  species are poly- 
ubiquitinated  so contain multiple ubiquitin reactive  epitopes.  These  data have clearly 
identified  a  number  of  keratin  species  present  only  in  E1A E4  expressing  cells, 
suggesting  that  keratin  18  may  be  significantly  more  ubiquitinated  than  its  type  2 
binding partner keratin 8. This finding is interesting when it is considered that HPV  16 
E1A E4 has been shown to bind specificity to keratin 18 (Wang et al, 2004).
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4.13.5  Cleavage of ubiquitin chains by isopeptidase
Having identified ubiquitinated keratin species by immuno-precipitation, we decided to
confirm  the result  using  an  alternative  approach.  Instead  of purifying  the  species  of 
interest  it  was  decided  to  try  and  deplete  them  using  the  enzyme  isopeptidase.  The 
enzyme  cleaves  isopeptide  bonds  and  liberates  ubiquitin  chains  from  proteins,  so 
rescuing them from proteolysis (see section 4.11.1).  SiHa cell were infected with wild 
type E1A E4 rAD and treated for 12 h with the proteasome inhibitor, ALLN, in order to 
prevent  turnover  of ubiquitinated  species  prior  to  harvesting  with  PBS/EDTA.  Cell 
pellets were resuspended in 200 pi of isopeptidase buffer and gently lysed using 0.5 % 
(v/v) NP40 and 1   pi of benzonase. To determine the activity of the isopeptidase, 2 pi of 
sample was treated with vehicle (buffer),  or  1   or 2  pi of activated isopeptidase, with 
sample volumes being adjusted using isopeptidase buffer,  prior to incubation at room 
temperature for 20 min. Samples were mixed with loading buffer, separated on a 10 % 
SDS/PAGE  gel  and  probed  for ubiquitin  (Fig  4.21 A).  The  blot  showed that  1   pi  of 
enzyme had very little effect on the sample, whereas 2 pi appeared to cause a significant 
reduction in the number of high molecular weight ubiquitin species suggesting that the 
enzyme had cleaved ubiquitin chains  from proteins  (Fig 4.21).  To probe the keratin 
species of interest present in El A E4 expressing cells, 2 pi of lysate was incubated with 3 
pi  of enzyme  or  buffer  and  treated  as  previously  described.  Membranes  were  then 
probed  for  keratin  18.  Low  exposures  of the  blot  revealed  that  keratin  loading  was 
comparable  for  both  samples.  Higher  overnight  exposures  were  required  to  show  a 
detectable reduction in high molecular weight keratin species in the treated sample. This 
result shows that the treatment of cellular extracts with the ubiquitin cleaving enzyme 
isopeptidase removes high molecular weight keratin bands produced in the presence of
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Figure 4.21  Isopeptidase cleavage of ubiquitin from keratin
SiHa cells were infected with E1AE4 rAD, harvested in isopeptidase buffer and treated 
with vehicle (buffer),  1  or 2 pi of isopeptidase, and probed for ubiquitin. Lysate treated 
with 2 pi of enzyme show reduced high molecular weight ubiquitin species (A).  Lysate 
treated with vehicle (-) or 3  pi isopeptidase (+) and probed from keratin  18 revealed that 
treated extract contain fewer high molecular weight keratin species (B top panel), short 
exposure demonstrated comparable keratin loading (B lower panel).
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E1A E4. This result further supports the argument that the keratin laddering observed in 
E1A E4 positive cells is caused by the ubiquitination of keratin.
4.13.6  Build  up  of E1AE4  induced  ubiquitinated  keratins  results  in 
proteasome inhibition
E1A E4  expression  induces  the  build  up  of phosphorylated  and  ubiquitinated  keratin 
species, these keratin modifications have also been observed in conditions that lead to 
Mallory body  formation (keratin aggresomes)  (Ohta et al,  1988;  Yuan et al,  1998). 
Aggresome formation has previously been reported to result in proteasome inhibition 
(Bence et al, 2001). Using both wild type, and M2 E1A E4 that does not modify keratin, 
the  activity  of  the  proteasome  was  monitored  by  looking  at  levels  of  protein 
ubiquitination over time. Lysates from SiHa cells infected with wild type or M2 E1A E4 
were harvested at  12,  24,  48  and 72  h post infection  (24, 48,  72  and 96 h  for M2), 
before  being  separated  on  a  12%  SDS/PAGE  gel  and  probed  for  ubiquitin.  Blots 
contained  multiple  high  molecular  weight  ubiquitin-reactive  species.  High  molecular 
weight species increased in strength at 48 and 72 h post infection in E1A E4 but not the 
M2  lanes,  with  the  band  at  ~8  kDa  corresponding  to  free  ubiquitin,  indicating 
comparable sample loading. Due to the number of high molecular weight species it was 
impossible to identify individual ubiquitinated keratin species in the 60-100 kDa region 
of interest (Fig 4.22 C). The dramatic increase in the number of high molecular weight 
ubiquitin species is  comparable to  what is  observed  after the  addition of proteasome 
inhibitors (see Fig 4.18). The data presented here suggests that E1A E4 expression may 
cause  the  build  up  of ubiquitinated  keratins  and  result  in  the  formation  of keratin 
aggresomes.
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Figure 4.22 E1AE4 induced  ubiquitinated keratin accumulation results in 
Proteasome inhibition.
Blots of extracts from wild type and M2 El AE4 rAD infected SiHa cells harvested  12 24 
48 and 72 h post infection (24, 48, 72 and 96 h in the case of M2).  Blots show that both 
El A E4 and ubiquitinated keratin species increase with time blots A and B. The same 
extracts probed for ubiquitin reveal an increase in high molecular weight ubiquitin 
species 48 and 72 h post infection in wild type El A E4 lanes C.
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4.14Discussion
The aim of this study was to determine the effect of the E1A E4 keratin interaction on 
keratin. The data generated suggest that HPV16 E1A E4 has the capacity to bind to and 
reorganise  multiple  types  of keratin  network  in  monolayer  cell  culture.  It  was  also 
possible to demonstrate that the association of E1A E4 with keratin induces biochemical 
modifications that include phosphorylation and ubiquitination.
Immunofluorescence  experiments  demonstrated  that  the  association  of  E1A E4  with 
multiple  types  of keratins  can  cause  their  collapse  into  various  types  of structures. 
E1A E4  appears  to  selectivity  target  keratin  networks,  and  when  keratins  become 
saturated, the excess E1A E4 then associates with mitochondria, which appears to result 
in their colocalisation with keratin bundles as previously reported (Raj  et al., 2004). In 
addition to bundles, E1A E4 formed aggregates that interacted simultaneously with both 
keratin and mitochondria in some cases in the absence of keratin network collapse. This 
may  be  explained  by  the  hypothesis  that  keratin  networks  have  collapsed  and  then 
reformed, and that E1A E4 expression may have ceased. This is supported by the finding 
that E1A E4 aggregates are observed more frequently at later time points. In addition to 
this, E1A E4 aggregates were shown to contain Cyclin B, hyperphosphorylated keratin 
and ubiquitin.
Phosphorylation  of keratin  filaments  is  known  to  promote  the  formation  of keratin 
aggregates and it was hypothesised that the recruitment of the cyclin B/CDK1  complex 
by  E1A E4  may  be  partly  responsible  for  keratin  phosphorylation.  Experiments  with 
mutant  ElA E4s  demonstrated  that  phosphorylation  of  keratin  required  a  direct 
association with E1A E4 but was not necessarily dependent on the ability of E1A E4 to
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sequester cyclin B to keratins. E1A E4 aggregates were observed less frequently in cells 
arrested at Gl/S with aphidicolin, suggesting that their formation may be promoted by 
S-G2 progression through cell cycle, this may be due to a elevated kinase activity later 
in the cell cycle (reviewed in (Stark et a l, 2004).
Western blot analysis confirmed the presence of highly phosphorylated keratins and the 
formation of high molecular weight keratin ladders.  Keratin laddering has previously 
been  shown  to  be  caused  by  ubiquitination  (Ku  et  al.,  2000).  Attempts  to  observe 
biochemical modifications to keratins 1/10, 5/14 and 4/13 were only partially successful 
with  possible  modification  observed  in  K4  and  K14.  This  may  not  be  a  significant 
finding as relative  levels of keratins were  not  determined.  HaCat cells  are  known to 
down regulate keratin 10 when grown in low calcium media (Kee et a l, 2001). Keratin 
10 is known to induce cell cycle arrest (Paramio et al,  1999), so it is possible that cells 
down-regulate  other  differentiation  dependant  keratins  making  it  hard  to  identify 
modified species.
Fractionation  experiments  showed  that  E1A E4  expression  decreases  the  solubility  of 
keratin and demonstrated that high molecular weight keratin species are very insoluble. 
Furthermore, it was noticed that there may be a connection between the increase in high 
molecular weight keratin species and a depletion of soluble keratins: it still remains to 
be determined which is the cause and which is the effect.
Several  different  approaches  were  taken  to  identify  ElA E4-induced  ubiquitination  of 
keratins.  Immuno-staining  demonstrated  that  ubiquitin  colocalises  with  E1A E4 
aggregates.  Treatment  of ElA E4-infected  cells  with  proteasome  inhibitors  caused  a
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significant build up of high molecular weight keratin species. Proteasome inhibition has 
previously been shown to induce a build up of ubiquitinated keratins  (Ku et al., 2000). 
In addition to this, proteasome inhibition induced a build up of high molecular weigh 
(presumably multimeric) E1A E4 species, suggesting that the two may connected.
Immuno-precipitation of ubiquitin and E1A E4 was able to show that the E1A E4 protein 
itself appears  not to  be  targeted  by  the  ubiquitin  system  whereas  keratin  is.  Keratin 
immuno-precipitation  demonstrated  that  significantly  higher  levels  of  ubiquitinated 
keratins were present in E1A E4 cells than p-gal infected control cells. The identification 
of ubiquitinated keratin was further supported by the finding that keratin ladders could 
be depleted by enzymatic cleavage of ubiquitin chains by isopeptidase.
The previously identified, highly conserved LLXLL domain that has been reported to be 
essential for keratin association appears to have a more complex function (Roberts et 
al., 1994; Wang et a l, 2004). Experiments showed that E1A E4 has a reduced affinity for 
keratin in the absence of this domain, but still maintains a limited ability to bind to and 
reorganise  keratin  networks.  Interestingly,  in  the  absence  of the  LLXLL  motif,  the 
E1A E4  protein  loses  its  ability  to  induce  a  keratin  solubility  shift,  or  biochemical 
modifications.  The  finding  that  M2  E1A E4  had  little  effect  on  keratin has  additional 
significance as it demonstrates that biochemical modifications to keratin are induced by 
E1A E4 as a result of the direct association of the protein to keratin. The M2 protein is 
predicted  to  maintain  its  cell  cycle  arrest  ability  (Nakahara  et a l,  2005)  for  which 
keratin association is not required (Davy et a l, 2005),  suggesting that ElA E4-induced 
cell  cycle  arrest  is  not  responsible  for  the  observed  modifications  to  keratin.  This
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finding  suggests  that  the  mechanisms  for  targeting  keratin  networks  may  be  highly 
conserved though out a-group E1A E4 papillomavirus proteins.
These data when combined,  suggest that E1A E4 expression in monolayer cells induces 
the formation of keratin aggresomes, with proteasome inhibition appearing to occur as a 
result  of  accumulation  of  ubiquitinated  keratin.  Protein  aggresome  formation  has 
previously been reported to induce proteasome inhibition (Bence et al, 2001; Bennett et 
al, 2005), although this has not been experimentally demonstrated for Mallory bodies. 
The  mechanism  by  which  E1A E4  induces  biochemical  modifications  of keratin  still 
remains to be identified.  Some evidence  suggests that E1A E4 multimerises on keratin 
filaments  (Wang  et  al,  2004).  Although  E1A E4  multimerisation  has  been  linked  to 
keratin network collapse (Wang et a l, 2004) it has been previously demonstrated that 
monomeric Fab antibodies can associate with keratins  and also induce network collapse 
(Waseem  et  al,  2004),  suggesting  that  other  mechanisms  cannot  be  ruled  out.  In 
addition to this, it is known that a variety of non-specific cell stress events can collapse 
keratins inducing the formation of Mallory bodies (Cadrin et al,  1995; Nakamichi  et 
al, 2002; Yuan et al,  1998).  Because of this it is important to further understand the 
mechanisms  behind  ElA E4-induced  keratin  aggresome  formation,  in  order  to  better 
understand  how  the  protein  affects  keratin  networks  in  vivo.  It  remains  to  be  seen 
whether  keratin  network  collapse/reorganisation,  phosphorylation  and  subsequent 
ubiquitination,  observed  in undifferentiated  cells  grown  in  monolayer  culture  can be 
observed in vivo.
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5  The association of E1AE4 with keratin in vivo 
5.1 Aims
Previous work has shown that the expression of E1A E4 in undifferentiated cells grown 
in monolayer culture results in its association to the cytokeratin network, which in turn 
causes the reorganisation and collapse of the affected network (Doorbar et al.,  1991). 
Work presented in the previous chapter was able to show that E lA E4-induced keratin 
collapse causes the phosphorylation and ubiquitination of keratins resulting in formation 
of  Mallory  body-like  aggregates.  Keratins  expressed  at  the  surface  of  terminally 
differentiated  epithelium  are  already  highly  modified  and  so  it  remains  to  be  seen 
whether any of these ElA E4-induced effects can be observed in vivo. This chapter aims 
to  identify the effects  of E1A E4  on keratin  in vivo  and to  determine  whether E1A E4 
maintains the capacity to associate with and disrupt keratins networks.  It also aims to 
establish  whether  E1A E4  can  induce  biochemical  modifications  such  as  the 
phosphorylation and ubiquitination of native keratins.
5.2lntroduction
5.2.1  Effects of epithelial differentiation on keratins networks
As cells move up the epithelium they undergo the process of terminal differentiation,
during  which  time  keratins  are  modified  in  several  ways.  Keratin  5/14  networks 
expressed in basal cells are down-regulated, and the differentiation-dependent keratins, 
4/13 in mucosal epithelium, or 1/10 in cutaneous epithelium are expressed. Towards the 
surface  of  the  tissue,  keratins  undergo  additional  modifications  which  make  the 
networks  even  more  robust.  These  form  a  mechanical  barrier  which  protects  the 
underlying tissue from external  insult.  Keratin filaments have been  shown to become 
disulphide  bonded  to  one  another  in  the  upper  layers  of the  epithelial  tissue  as  it 
undergoes terminal differentiation (Sun et al.,  1978). Another differentiation dependent
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protein,  filaggrin,  exists  as  a  polyprotein  precursor  and  is  activated  by  proteolytic 
cleavage.  The filaggrin monomers bind and cross-link keratin filaments thus forming 
aggregated keratin fibres that provide additional strength to the networks (reviewed in 
(Presland et a l, 2000)).
5.2.2  Reasons for studying HPV2 and HPV16 in parallel
Due  to  the  small  size  of HPV  16  lesions,  their  limited  E1A E4  expression,  and  the
difficulty  in acquiring frozen HPV  16  lesions that are required for later experiments, 
HPV 2 (verrucas) and HPV  16 lesions have been examined in parallel. HPV 2 lesions 
are considerably larger, and express significantly more E1A E4, making them easier to 
work with. Frozen HPV 2 lesions (obtained from Northampton chiropody school) were 
used  for  western  blot  analysis,  as  formalin-fixed  proteins  cannot  be  resolved  by 
SDS/PAGE (due to the covalent bonds that result from formalin treatment). Both type 2 
and type  16 are a-group papillomaviruses, whose E1A E4 proteins contain the LLXLL 
motif required for keratin targeting. In Chapter 3 the proteins were shown to behave in a 
broadly  similar  fashion,  both  disrupting  keratin  networks  and  so  HPV2  E1A E4  was 
predicted to be a suitable substitute model for HPV 16E1A E4 in vivo.
5.3Results
5.3.1  Types 2 and 16 E1AE4 can be seen to colocalize with keratins 
in vivo
It was decided to investigate whether type 2 E1A E4 associates with keratins in vivo as 
has previously been reported to occur for type  16 (Doorbar et al.,  1997;  Wang et al, 
2004). Types 2  and  16  lesions were triple  stained  for DNA,  E1A E4 and keratin.  The 
association of both HPV  16 (Fig 5.1) and 2 E1A E4 (Fig 5.2) with keratin filaments was 
observed in a sub-set of cells in lesions. Furthermore this ability of keratin antibodies to 
recognise ElA E4-associated keratin filaments suggests that E1A E4 association does not
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E1A E4 &  DAPI
Figure 5.1  HPV 16E1AE4 and keratin colocalisation can result in the disruption of 
keratin networks  in cervical epithilium.
Paraffin-embedded, formalin-fixed, normal (A-C) and HPV 16-infected (D-F) cervical 
epithelia, were stained for keratin (C2562, red),  DNA(DAPI, blue) and HPV 16 E1AE4 
(TVG405, green). (A-C) Normal cervical epithelium does not cross-react with El AE4- 
specific antibodies and contains a solid, unbroken keratin stain in the upper layers of the 
tissue.  (D-F) Infected tissue expressing E1AE4 displays a damaged keratin stain (see 
arrows in D-F). (G-I) Cells expressing filamentous El AE4 could be found as previously 
reported (Wanget al., 2004).  High magnification images (J-L) of cells containing 
filamentous El AE4 (large arrow in G-I) reveals that individual El AE4-associated keratin 
filaments can be identified, showing that El AE4 association to filaments does not mask 
keratin antibody epitopes. Reorganisation of keratins to the edge of the cells can also be 
observed in some cells (small arrows G-I). Scale bars denote 5 jam
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Figure 5.2 HPV 2E1AE4 and keratin colocalisation results in the disruption of 
keratin networks in cornified tissue.
Paraffin-embedded, formalin fixed, normal (A-C) and HPV 2-infected (D-R) foot skin, 
was stained for keratin (C2562, red), DNA (DAPI, blue) and HPV2 E1A E4 (rabbit 
polyclonal, green). (A-C) Normal cornified foot skin (20 X objective) does not react 
with HPV2 E1A E4 antibodies and contains an unbroken keratin stain throughout the 
tissue  (D-F) Image of HPV 2-infected skin shows El A E4 expression in an HPV2 
lesion  Image produced by stitching together multiple images (using 20 x objective). (G- 
I) High power images reveal that HPV 2 can be observed to associate with keratin 
filaments in tissue, without masking keratin antibody epitopes (arrows G-I)  The 
cornified layer of an HPV 2 lesion  (40 x objective) displays  perforated keratin staining 
in regions expressing E lA E4  (J-L) El A E4 colocalises with keratin “holes”
Neighbouring regions lacking ET E4 expression display a solid unbroken keratin stain 
(G-I) Keratin staining is commonly found to be reduced in intensity and reorganised to 
the edge of the cell in E 1  A E4-positive cells. Note that E 1  A E4-negative regions of the 
cell do not stain with keratin (arrows M-O)  (P-R) Regions towards the surface of 
infected tissue appeared to be torn and damaged, which frequently contain high levels of 
ET E4 (arrows, P-R).  Scale bars denote 5 pm
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necessarily mask keratin antibody epitopes (see Fig 5.1G-L).  These data indicate that 
keratin  association  is  a  strategy  employed  by  both  mucosal-and  cutaneous-tropic 
a-group papillomaviruses. Although it was possible to identify cells in which E1A E4 
and keratin colocalised, there was little evidence of cytokeratin collapse occurring,  in 
contrast to the  situation found in  vitro.  A few cells lower down in the  epithelium of 
some  lesions  could  be  found  showing  some  signs  of  partial  reorganisation  (not 
shown)(Doorbar  et  al.,  1997;  Wang  et  ai,  2004)  but  no  keratin  aggregates  were 
observed.  A  sub-population of both HPV  2  and  16  cells appeared to  show relatively 
bright fluorescent ring-like keratin structures,  suggesting that the keratins have partly 
reorganised to the edge of cells (see Fig  5.1  G-I,  5.2 M-O).  Unlike cells  in vitro,  no 
E1A E4 aggregate structures were observed in tissue. These data suggest that although 
keratin  collapse  may  occur  infrequently,  its  rarity  suggests  that  it  is  unlikely  to  be 
ElA E4’s primary mode of action.
5.3.2  Types 2 and 16 E1AE4 proteins may reduce levels of keratin in 
vivo
Although type 2 and  16  E1A E4 proteins could be observed to localise with keratin in 
some cells, the absence of strong keratin staining in cells expressing abundant E1A E4 
was  observed  significantly more  frequently.  HPV  16  lesions with gaps in the  keratin 
staining  were  frequently  observed.  Keratin  “holes”  colocalised  with  areas  of  high 
E1A E4  expression  (Fig  5.1  D-F).  Normal  cervical  epithelium  did  not  react  with  16 
E1A E4 antibodies and displayed solid keratin staining throughout (see Fig 5.1 A-C). The 
same  was  observed  in  HPV  2-infected  E1A E4  positive  tissue  where  keratin  staining 
appears to be reduced or absent from the tissue in regions with high levels of E1A E4 
expression (Fig 5.2 J-O) (also see Appendix I). In a region of cornified tissue expressing 
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keratin stain (Fig 5.2 J-O). In the adjacent ElA E4-negative region the keratin staining is 
continuous and unbroken.  These data show that in regions with high levels of E1A E4 
expression, keratins appears to be reorganised giving the tissue a perforated appearance, 
suggesting an E1A E4 induced effect on the keratin integrity.  It is conceivable that the 
apparent reduction in keratin is caused by E1A E4 masking of keratin epitopes. Although 
this theory cannot be ruled out, the same reduction is observed in HPV 16 tissue when a 
rabbit  polyclonal  pan-keratin  antibody  (Novocastra)  was  used  (data  not  shown). 
Furthermore,  the  C2562  pan  keratin  antibody  contains  a  cocktail  of  pan-specific 
monoclonal antibodies and should be able to recognise multiple keratin epitopes. That 
ElA E4-associated keratin filaments can be observed in some cells in lesions,  suggests 
that binding does not result in keratin epitope masking. In addition to this observation, 
E1A E4  association  to  keratin  filaments  in  vitro  does  not  result  in  keratin  epitope 
masking  (see  Fig  4.2  J-L  and  4.3  G-I).  It  was  also  observed  that  nucleated  cells 
containing E1A E4 structures at the periphery of cells did not contain keratin staining in 
ElA E4-negative regions towards the centre of the cell as observed in the neighbouring 
tissue,  (see  Fig  5.2  M-O).  In  addition  to  these  observations,  expression  of HPV16 
E1A E4 was shown to be able to induce polyubiqutination of keratins (see  Chapter 4), 
which is known to promote their degradation (Ku et al., 2000).  When combined these 
data suggest that the observed E1A E4 effect on keratin staining is caused primarily by 
the reorganisation and/or loss of keratin rather than epitope masking.
5.3.3  E1AE4 may induce keratin phosphorylation in vivo
Although  E1A E4  could  be  seen  to  induce  keratin  phosphorylation  in  vitro,  it  is  not
possible to say for certain if this is not a stress response that results from E1A E4 build­
up, or whether it is in some other way related to keratin collapse or reorganisation.  To 
determine if E1A E4 association induced phosphorylation of keratins in vivo, normal and
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infected cervical epithelium was stained with the panel of phospho-specific antibodies 
(described in section 4.9).
The phospho-specific antibodies used in earlier experiments were raised against keratins 
8 and 18 , not keratins 4 and 13 that are expressed at the surface of cervical epithelium, 
and so it was not certain that they would react with tissue. However both the 8250 [K18 
P04 ser-33]  and 2D6  [K8 P04 ser-431]  antibodies did react with  16 E1A E4 -positive 
sections of infected epithelium (Fig 5.3  and 5.4).  The 3055  [K8 P04 ser-52] and LJ4 
[K8 P04 ser-73] antibodies did not react with proteins in formalin fixed cervical tissue 
(data not  shown).  Neither  of the  antibodies  reacted  with normal,  uninfected  cervical 
epithelium (Fig 5.3 and 5.4 A-C). A subset of cells containing high level E1A E4 reacted 
with  the  phospho-specific  antibodies  (Fig  5.3  and  5.4,  D-F).  Furthermore,  phospho- 
specific antibody staining was observed to colocalise with E1A E4 (Fig 5.3 and 5.4, G-I) 
as previously reported to occur in vitro (see section 4.9). These data suggest that E1A E4 
association  with  keratin  networks  in  infected  epithelium  may  result  in  the 
phosphorylation of keratins in a subset of cells  in vivo.  These  data must not be over 
interpreted as it has not yet been proven that these antibodies will react with keratin 13. 
Despite this it is thought that the staining may be genuine as sections were restained and 
found to express keratins 8 and 18 (not shown). Keratin 8/18 network has been reported 
to be expressed in cervical tissue, with increasing frequency as tissue differentiation is 
lost  during  neoplastic  progression,  and  are  commonly  found  in  cervical  tumours 
(Martens et al, 1999; Smedts et al., 1990).
5.3.4  E1AE4 expression induces altered ubiquitin localization in vivo
The association of HPV  16 E1A E4 to the keratin network in SiHa cells causes affected
keratin network to become highly phosphorylated and ubiquitinated (see Chapter 4). At
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Figure 5.3 HPV  16 E1AE4 expression may induce type  1   keratin phosphorylation 
in cervical epithelium
Normal or HPV  16-infected, cervical epithelium was stained for  16 El  E4 (TVG405, 
green) and DNA (DAPI, blue) type  1   keratin phospho Ser-33 (8250, red). Normal 
cervix did not react with TVG405 or 8250 (A-C) (tissue surface marked by line)  8250 
(K18-P04ser 33) reacted with a subset of E 1  A E4-positive cells towards the surface of 
infected tissue (D-F)  High magnification images taken on a confocal microscope 
showed that 8250 staining colocalises with E1A E4 (G-I). Scale bars denote 20pm
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Figure 5.4 HPV  16 E1AE4 expression may induce type 2 keratin phosphorylation 
in cervical epithelium
Normal or HPV  16-infected, cervical epithelium was stained for  16 E1A E4 (TVG405, 
green) and DNA (DAPI, blue) type 2 keratin phospho-Ser-431(2D6, red)  Normal 
cervix did not react with either TVG405 or 2D6 (A-C) (tissue surface marked by line). 
2D6 (K8- P04ser-431) reacted with a subset of E1A E4 positive cells towards the surface 
of infected tissue (D-F)  High magnification images taken on a confocal microscope 
showed that 2D6 staining colocalises with E1A E4 (G-I).  Scale bars denote 20pm
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present  it  is  unclear  whether  these  biochemical  modifications  are  linked  to  keratin 
network collapse, which is rarely observed in vivo. It was decided to investigate whether 
E1A E4 disruption of keratins in vivo results in their subsequent ubiquitination, as a first 
step lesions were double stained for E1A E4 and ubiquitin. Previous studies investigating 
the location of ubiquitin in epithelia have shown that mitotically active cells in the basal 
layer are strongly immunopositive for ubiquitin, (Sato et al, 1997).  Immunostaining of 
normal cervical epithelium with ubiquitin antibodies produced a discreet pattern which 
reduced  in  intensity  towards the  surface of tissue  (Fig  5.5  A-C).  In HPV  16-positive 
cervical  tissue  this  pattern  is  also  observed  and  continues  during  low  level  E1A E4 
expression (Fig 5.5 D-F). Closer to the surface in a sub-set of cells with high levels of 
16 E1A E4, a cytoplasmic build up of ubiquitin was observed (Fig 5.5 D-F). Furthermore 
some ubiquitin staining was observed to colocalize with E1A E4 (Fig 5.5 G-I). The same 
pattern was observed with two ubiquitin antibodies; a polyclonal (DAKO, not shown) 
and a monoclonal (Santa-Cruz, used in Fig 5.5). Sections were also stained with rabbit 
serum,  and  no  staining  was  observed  (data  not  shown).  This  finding  supports  the 
hypothesis  that  ElA E4-expression  induces  increased  ubiquitination  of  certain 
cytoplasmic proteins or a relocation of certain nuclear proteins.
HPV  2  E1A E4  expression was  also  observed to  alter ubiquitin  expression  in vivo.  In 
normal tissue ubiquitin staining was predominantly nuclear but could be detected in the 
cytoplasm of cells in the basal layer. Cytoplasmic ubiquitin staining is lost in the mid­
layers of the epithelium (Fig  5.6 A-C),  and staining could not be detected in E1A E4- 
negative  regions  of the  cornified  layer  (Fig  5.6  O-R,  see  phase  image(P)  for  tissue 
borders)  as has been reported previously  (Sahin.,  2001).  E1A E4  expressed in the mid 
and lower layers coincided with a cytoplasmic build up of ubiquitin in a sub-set of cells,
182Chapter 5______________________________The association of E1A E4 with keratin in vivo
Merge  I  E1AE4  I  Ubiquitin
Normal I B
Figure 5.5  16 El AE4 expression induces a build up of cytoplasmic ubiquitin
In normal cervical epithelium stained for  16 E1A E4 (TVG405, green) and ubiquitin (Sc- 
8017, red) (A-C), ubiquitin has a discreet staining pattern, reducing towards the surface 
of the tissue.  In infected tissue ubiquitin staining is initially nuclear (small arrows). 
Towards the surface in regions expressing high levels of El A E4, ubiquitin staining 
appears in the cytoplasm of a sub-population of cells (big arrows D-F)  Higher 
magnification images reveal that the cytoplasmic ubiquitin colocalises with E1E4 
staining (G-I). Scale bars denote 20pm
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Figure 5.6 Type 2 El AE4 expression induces ectopic  ubiquitin expression
Normal and HPV2-infected foot skin was stained for E1AE4 (green), ubiquitin (Sc- 
8017, red) and DNA (DAPI, blue).  (A-C) Nuclear and cytoplasmic ubiquitin staining is 
seen in mitotically active cells towards the basal  layer. (D-I) Cells expressing E1AE4 in 
the lower layers also contain cytoplasmic ubiquitin which colocalises with E1AE4 in 
some cells (white line indicates basal layer D-F). (J-N) In the mid layers ubiquitin 
staining decreases and becomes nuclear, but some E lAE4-positive cells maintain 
elevated levels of cytoplasmic ubiquitin. (N) A quantitative image (blue pixels denote 
region of greatest intensity, green the lowest) shows E1AE4 positive cells contain higher 
levels of ubiquitin than surrounding cells. (O-R) Multiple 20 x images were stitched 
together to produce a composite image of the cornified layer of an HP V 2 lesion. 
Ubiquitin staining is normally absent from the cornified layer but is maintained in some 
regions when E1AE4 is present.
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with E1A E4 and ubiquitin colocalising in most but not all of these cells (Fig 5.6 D-N). 
E1A E4  induced  cytoplasmic  build  up  of ubiquitin  did  not  inhibit  nuclear  ubiquitin 
staining, but could also be detected in cells lacking nuclear staining (large arrows Fig 
5.6 J-N).  Quantitative confocal  images of ubiquitin showed that E lA E4-positive  cells 
generally  had  higher  ubiquitin  levels  than  surrounding  cells  (Fig  5.6  N).  Ubiquitin 
staining in the cornified layer varied between lesions, with some containing few E1A E4 
and  ubiquitin-positive  cells  (see  Appendix  II).  In  some  lesions  however,  ubiquitin 
staining extended into the cornified layer colocalised strongly with E lA E4-positive cells 
(Fig 5.4 O-R).  These findings suggest that both HPV 2 and  16 E1A E4 expression may 
induce ectopic localisation of ubiquitin in lesions. This may be due to E1A E4 induced 
ubiquitination  of keratins,  although this  is  not the  only  explanation.  Virus  infections 
commonly subvert the ubiquitin system (reviewed in (Shackelford et al., 2005), with the 
E6 protein being a good example, and it may be that other  HPV proteins are involved. 
In addition to this, events such as wound healing (due to infiltration of immune cells) 
(Kondo et al., 2002) and UV stress  (Sahin., 2001) can alter the ubiquitin reactivity of 
the  epithelium,  indicating  that  there  may  be  several  explanations  other  than  the 
ubiquitination of keratins that may be the cause of these observations.
5.4  E1AE4  induced  effects  on  keratin  and  ubiquitin  in  the 
virus life cycle
So  far  this  work  has been  able  to  show an  apparent  loss  or redistribution of keratin
which  coincides  with  E1A E4  expression  (section  5.3.2).  Furthermore,  it  has  been
possible  to  show  an  altered  ubiquitin  staining  pattern  in  lesions,  which  suggest  that
E1A E4 expression may be inducing the ubiquitination of cytoplasmic proteins.  It was
decided to use other markers of virus-life  cycle progression  in order to  determine  at
what  stage  these  events  were  occurring.  Loss  of  the  proliferation  marker,  mini
chromosome maintenance 7 (MCM-7), was used to identify the end of early life-cycle
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events (Middleton, 2003), and an LI  antibody was to used identify the cells that have 
established  capsid  protein  production  (Doorbar  et  al.,  1997;  Peh  et  al,  2002).  The 
objective of this was to determine the point in the virus life-cycle where the high-level 
expression of E1A E4 that is necessary for keratin reorganization occurs.
5.4.1  Elevated  levels  of  E1AE4  coincide  with  the  loss  of  MCM 
staining and the onset of L1 expression
The onset of E1A E4 staining has previously been reported to coincide with the loss of
MCM staining. The overlapping layers containing E1A E4-MCM double positive cells is 
believed to be where viral genome amplification occurs (Middleton, 2003; Peh et al.,
2004).  HPV  16  lesions  stained with MCM  and E1A E4  at low exposures  show a few 
double positive cells at the  lowest points  of E1A E4  expression  (Fig  5.7  A-D).  Over­
exposing the images (E1A E4 sill does not appear in adjacent regions (Fig 5.7E)) reveals 
low-levels of E1A E4 penetrating deeper into the tissue and shows a significant number 
of  double  positive  cells  (Fig  5.7  F).  MCM-E1A E4  double  positive  cells  generally 
contain  lower  levels  of  E1A E4  than  those  with  keratin  loss  and  altered  ubiquitin 
distribution, suggesting that these events may occur after viral DNA amplification has 
occurred.
To  determine at what point in the  epithelium the viral  capsid proteins are expressed,
tissue sections were stained for LI. The antibody produced clean staining and did not
react with normal tissue (data not shown). In HPV  16 lesions, LI  expression could be
detected  in  the  upper  layers  of the  tissue,  with  the  exact  location  depending  on  the
timing  of E1A E4  expression,  which  typically  preceded  LI  expression  by  a  few  cell
layers  as previously  reported  (Doorbar et al.,  1997;  Peh et al.,  2002).  LI  expression
begins in cells with moderate levels of E1A E4 and was confined to the nucleus (Fig 5.8
A-F). Towards the surface of the tissue, coinciding with high levels of E1A E4, LI can
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Figure 5.7 Low levels of E1AE4 can be detected extending well into MCM positive 
regions, whereas very  high lev els are expressed at the surface of the tissue.
HPV 16-positive cervical lesions were stained for DNA (DAPI, blue) E1AE4, (TVG405, 
green) and MCM7 (47DC141, red)  (A-B) MCM staining is nuclear; expression is lost 
towards the middle of the lesion. (C-D) Low exposures suggest E1A E4 and MCM 
double positive cells are rare, with only a few cells being visible  (E-F) However longer 
exposures of the image suggest that E1A E4 may be expressed closer to the basal layer 
and may extend several layers into the MCM-positive region. Very high levels of 
E1A E4 are expressed at the surface of the tissue (above the white line) moderate levels 
extend deeper into the tissue (between the white and yellow lines) and very low levels 
are detectable deeper in the tissue and extend several cell layers into MCM positive 
regions (between the yellow and red lines).
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Figure 5.8 HPV 16  E1AE4 expression precedes  LI staining, and very high levels of 
E1AE4 coincide with cytoplasmic  build upofL l
HPV 16-positive Cervical lesions were stained for E1AE4 (TVG405, green) and LI 
(CamVirl, red) and DNA (DAPI, blue).  Images show that E1AE4 staining is exclusively 
cytoplasmic (A & D) and precedes LI  expression by several cell layers (A-C). LI 
staining is initially nuclear but becomes increasingly cytoplasmic in the final few layers 
of the tissue, coinciding with elevated levels of E1AE4 (D-F). Close up of area shown by 
box in E (G-l) clearly shows particulate LI  staining in cytoplasm (large arrows, G-l) at 
the cell surface whereas LI  is located in the nucleus in underlying cells (small arrow G-
I).
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Figure 5.9 HPV2  E1AE4 staining precedes LI expression
HPV 2 lesions were stained forHPV2 E1AE4 (polyclonal, green), LI  (Cam Vir 1,  red) 
and DNA (DAPI, blue).  E1AE4 expression preceded LI  expression by several layers (A- 
C). High magnification images of cells in the lower layers (small arrow A-C) reveal that 
LI  expression was initially nuclear (G-I).  In cells towards the surface of the tissue (big 
arrow A-C), LI  expression becomes cytoplasmic and can be observed to colocalize with 
El AE4 (D-F).
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be observed in the cytoplasm where it may colocalize with E1A E4 (Fig 5.8 D-I). These 
data suggest that very high levels of E1A E4 are only initiated when virion assembly is 
complete and mature virions are released from the nucleus ready for release.  As with 
HPV 16, HPV2 tissue stained for LI indicated that E1A E4 expression precedes LI 
(Fig 5.9 A-C) (also see Appendix III) as previously reported (Peh et a l, 2002). In the 
lower regions of the HPV2 lesion LI  is expressed in the nucleus and does not localise 
with E1A E4  (Fig  5.9  G-I).  In higher layers  of HPV2  lesions,  LI  can be  observed to 
localize with El A E4 in the cytoplasm (see Fig 5.9 D-F).
The observations made in this section suggest that in HPV 16 lesions, E1A E4 expression 
levels  are  altered  towards  the  surface  of the  tissue,  allowing  the  protein  to  perform 
different tasks at specific points of the virus lifecycle. Low level expression appears to 
be sufficient for genome amplification whereas higher E1A E4 levels coincided with LI 
expression.  Interestingly,  type  16 E1A E4  levels appear to  elevate towards the  surface 
after completion of virion assembly (coinciding with altered LI  localisation). In HPV 2 
and  16  lesions,  LI  expression was  also  observed to  move  from  the  nucleus  into  the 
cytoplasm where it colocalises with E1A E4 towards the surface of the tissue.
5.4.2  Quantitative  analysis  of  HPV  16  E1AE4  levels  by  confocal 
microscopy
Earlier  experiments  appeared  to  show  a  gradual  build  up  of  16  E1A E4  through  the 
epithelium,  with keratin  loss  and  ubiquitin  relocation  only  being  observed  in  a  sub­
population  of cells  with  high  levels  of E1A E4  expression towards the  surface  of the 
infected  tissue.  In  order to  quantify  levels  of E1A E4  expression,  confocal  images  of 
lesions double  stained for E1A E4  and keratin,  ubiquitin or LI  were  analysed using  a 
quantitative function in the Leica confocal software. Lines starting at, and perpendicular
to, the surface of the tissue were drawn across each image; the fluorescence intensity for
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each  channel  was  then  plotted  along  the  line  (Fig  5.10).  Plots  revealed  significant 
increase  in  E1A E4  levels  close  to  the  surface  of the  tissue.  The  point  at  which  the 
fluorescence increase occurred depended on the depth of E1A E4 expression in the tissue 
and varied in thickness. In addition to this, a decrease in keratin levels was observed to 
coincide with the elevation of E1A E4 levels (Fig 5.10 A) no such decrease was observed 
in normal tissue (Fig 5.10 B). Furthermore, an increase in ubiquitin also coincide with 
elevated levels of E1A E4 (Fig 5.10 C). LI  staining showed that LI  expression precedes 
the elevation in E1A E4 levels and that the relocation of LI  appears to coincide with a 
further increase in E1A E4 (Fig 5.10 E). These data suggest that a significant increase in 
E1A E4  levels  may  be  linked  to  the  reorganisation  of  keratin,  ectopic  ubiquitin 
expression and relocation of the LI  viral capsid protein in the upper regions of lesions. 
These data add weight to the hypothesis that E1A E4 expression is not just a simple on or 
off process, but that expression is purposefully regulated by the virus as it approaches 
the  surface  of infected  tissue,  and  that  this  follows  viral  genome  amplification  and 
virion  production.  If these  findings  are  correct  then  this  indicates  that  E1A E4  may 
perform  a  final  function  in  the  terminal  phase  of viral  life  cycle  following  virion 
assembly to aid virion release.
5.5  Western Blot analysis of HPV2 lesions
In order to determine whether E1A E4 induces biochemical modifications to cytokeratins 
in vivo,  proteins extracts from HPV2 infected and normal foot tissue were analysed by 
western blot. Frozen, HPV2-infected tissue (verrucas), surgically removed from patients 
with  problematic  lesions,  was  used  for  the  study.  Frozen,  normal  skin  taken  from 
patients post-mortem, was used as a negative control. Frozen tissue was sectioned from 
top to bottom using  a cryostat.  Proteins extracted  from the  sections  were probed  for 
E1A E4, keratins 10 and 14, and ubiquitin. Eighteen lanes of verruca tissue were loaded
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expression coincide with specific events in the virus lifecycle.
Confocal images of HPV  16 lesions stained for E1A E4 (TVG405, green), DNA (DAPI, 
blue) and either keratin (C2562, A and B), ubiquitin (Sc-8017, C and D) or LI  (camvir 
1. E) (red), were analysed quantitatively using the area quantitate function in the Leica 
confocal software  Eight lines were drawn from the surface of the tissue to the lowest 
point and the fluorescence intensity measured (on a 250-point grey scale) of the green 
(graphs A 1-El) and red (graphs A2-E2) channels along the lines  Graphs Al, C l, and 
El  show levels of E1A E4 increasing towards the surface of the tissue, before spiking at 
the surface (EIA E4 spikes denoted by black arrows). Graph BI  and Dl  show very low 
levels of florescence in E1A E4 negative tissue with no increase in fluorescence towards 
the surface (note y-axis scale bar max of 30).  A reduction in keratin fluorescence 
coincides with the onset of high levels of E1A E4 (A1-A2)  No decrease in keratin levels 
is observed towards the surface in normal tissue (B2)  A peak in ubiquitin fluorescence 
is observed towards the surface and coincides with the elevated El A E4 levels (C1.-C2). 
No surface increase in ubiquitin is observed in E1A E4 negative tissue (D1-D2)  E1AE4 
expression precedes LI  expression (E1-E2), but LI  expression (*) precedes the 
elevation in E1A E4 levels (**).
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(from lowest layer to surface) whilst just 9 lanes of normal skin were loaded, due to the 
differences  in  thickness  of the  two  samples.  Successful  top  to  bottom  sectioning  of 
lesions was determined by expression profiles of keratins 10 and 14. Increasing keratin 
10, which coincided with decreasing levels of keratin  14, was taken to indicate surface 
tissue.  To refer to the lowest layers as the basal  layer would be inaccurate due to the 
folds in the tissue (papillae) caused by the virus, and this causes the distance between 
the surface and basal layer to vary significantly throughout the tissue (see Fig 5.2 D-F) 
(for expression profiles of E1A E4, keratin, ubiquitin and LI  in the lesion used in these 
experiments see Appendix I-III). Loading controls also presented a significant challenge 
as protein levels generally alter with differentiation. Proteins known to be expressed at 
significant levels at the surface of terminally differentiated epithelium are either viral 
(and hence cannot be used in normal tissue) or are known or suspected to be affected by 
viral gene expression (e.g. filaggrin, keratin, loricrin) (Brown et al., 2000; Lehr et al, 
2002;  Lehr  et  al,  2003).  Because  of this,  these  experiments  aimed  to  look  at  the 
presence or absence of different keratin species (specifically keratin ladders), in relation 
to the presence of E1A E4, and by comparing the relative strength of individual keratin 
bands to the major keratin band which, would be used as a crude indicatior of loading.
5.5.1  The differential processing of HPV2 E1AE4 in lesions
Protein extracts from normal tissue did not contain any HPV2 E lA E4-reactive bands
(not shown).  Slices from the lower layers of HPV2 lesions did not contain detectable 
levels of the E1A E4 protein. E1A E4 became visible in lane 5 and appeared as one band 
~15kDa  in  size  (Fig  5.11  A).  A  second  lower  band  began  to  appear  in  lane  7  and 
increased in strength for a further two lanes, then remained present to the surface of the 
tissue.  Lane  10  contained  a  further  band  ~28kDa  in  size,  which  also  appeared  to 
continue to be present to the surface of the tissue. A possible fourth band ~17 kDa in
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Figure 5.11  El AE4 expression in tissue coincides with altered keratin  14 species
A top-to-bottom sectioned HPV2-lesion was analysed by western blot for expression of 
HPV 2 E IA E4 and keratin species. (A) E1AE4 cannot be detected in the lowest layers, 
but is initially expressed as a single band in lane 5.  A second lower band appears in lane 
7, a third band -28kDa in size becomes visible in the middle of the tissue in lane  10  (B) 
Blots performed on lysates of a second lesion suggest the presence of a fourth lower 
molecular weight El AE4 species  10 kDa in size  (C-D) Keratin  14 (C9097-14B) blots 
show multiple bands in both normal (C) and infected tissue (D)  Little variation in low 
molecular weight (less than 51  kDa) keratin species was observed between normal and 
infected tissue. A high molecular weight band (-88 kDa) is observed in both normal and 
infected tissue and appears to increase in strength relative to total keratin in lanes 6-13 
coinciding with the build up of E1A E4 levels (see blot A).
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size  is also observed  in  lanes  12  and  16.  Earlier experiments that failed to  correctly 
orient the tissue, conducted on a larger lesion revealed a fifth lower band ~10kDa in size 
(see Fig  5.11  B).  Although specific E1A E4 bands were not identified, it is speculated 
that if HPV 2 processing is similar to HPV 16 it is possible that the major doublet may 
be caused by phosphorylation (Wang et a l, 2004). The lower band may be caused by 
N-terminal truncation as has previously been reported for HPV 1   and HPV  16 (Doorbar 
et al., 1988b; Doorbar et al., 1996; Doorbar et a l, 1997). The upper band may be due to 
multimerisation as has been reported to occur to HPV  1   and  16 E1A E4 (Doorbar et a l, 
1996; Wang et al., 2004). Although increasing E1A E4 levels may allow identification of 
minor  species,  these data indicate that HPV2  E1A E4  may  be  differentially  processed 
towards the surface  of the tissue,  supporting the hypothesis that the protein performs 
different roles that may be linked to the various stages of the virus life cycle.
5.5.2  Keratin species found in normal and HPV 2 infected epithelium
Protein extracts from verruca and normal skin were probed for keratin 10 and 14 to look
for  evidence  of  E lA E4-induced  biochemical  modifications.  Keratin  14  blots  from 
normal and infected tissue show a major band at ~51kDa. A number of additional lower 
molecular  weight  bands  were  also  found  in  normal  and  infected  tissue.  Close 
examination of multiple exposures of the blots could not distinguish a difference in low 
molecular  weight  species between normal  and  infected  tissue.  Keratin  14  expression 
weakened  towards  the  surface  of  the  tissue  indicating  top-bottom  sectioning  was 
successful. Two high molecular weight species -61  and -88 kDa in size were observed 
in infected and normal tissue (Fig 5.11C-D). A 92 kDa species (possibly a type I and II 
keratin dimer), was also observed in keratin 10 blots (Fig 5.12 C), the band was stronger 
in relation to the main (51  or 58 kDa) band in infected tissue. Interestingly the observed 
increase in strength of this band in lane 5 coincided with the onset of E1A E4 expressionChapter 5 The association of E1A E4 with keratin in vivo
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Figure 5.12 Keratin 10 and silver stain analysis of HPV 2-infected and normal skin
Top to bottom sectioning was performed on normal (A) and HPV 2-infected (B) skin, 
and extracts were probed for keratin  10 (K0199-12). Keratin levels increase towards the 
surface of normal tissue.  An increase was less apparent in the infected issue due to folds 
in the tissue (A-B). Multiple low molecular weight keratin 10 species were detected in 
both normal and infected tissue. Higher exposures of the blots show a ~92 kDa band 
(arrow C) present in infected tissue, which could not be detected in normal tissue.
Silver-stained gels of mid and surface regions from normal and infected tissue shows a 
90kDa band (D*) is picked up in verruca but is absent from normal tissue, despite more 
tissue being loaded in the normal lane (D).
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(see Fig5.11  A). Skin and verruca samples were processed simultaneously by boiling in 
laemmli buffer and DTT suggesting the increase was not due to a difference in sample 
preparation. Keratin  10 was expressed at increasing levels towards the surface of both 
infected and normal tissue. Three major bands could be detected in the keratin 10 blots, 
the major band being ~58 kDa in size the weaker bands were smaller, possibly break 
down products. Infected tissue also contained a band ~ 92 kDa in size which was more 
apparent  in  HPV2-infected  tissue  (Fig  5.12  A-C).  This  finding  was  supported  in  a 
silver-stained  gel,  which  contained  a  band  in  the  90k  region  that  was  significantly 
stronger in HPV 2 samples (Fig 5.12 D).  Keratin western blots were unable to identify 
a  significant  difference  in  keratin  species  between  normal  and  infected  tissue.  A 
possible increase in strength of the -88 and 92 kDa bands was observed in keratins  14 
and 10 blots respectively, between infected and normal tissue, although the significance 
of this is as yet unclear.
5.5.3  Ubiquitin Western blots from tissue
In  order to determine  if any  of the  keratin  species  described  in the previous  section 
could  be  attributed  to  ubiquitination,  extracts  from  normal  and  infected  tissue  were 
probed for ubiquitin. Ubiquitin blots were predicted to be easier to interpret than keratin 
blots due to the abundance of keratin and the relative scarcity of ubiquitinated proteins 
in epithelial tissue. However, ubiquitin blots proved to be problematic and were difficult 
to optimise,  suggesting that very low levels of ubiquitin are present in samples.  Free 
ubiquitin (8kDa) bands were observed in both samples, however due to the low levels of 
ubiquitin no other specifies could be detected before antibody background burnt out the 
blots (data not shown). On one occasion it was possible to identify a single band -  60 
kDa in size in HPV2 extracts, (see next section). Although this may represent a mono- 
ubiquitinated keratin species, it was not possible to draw significant conclusions fromChapter 5 The association of E1A E4 with keratin in vivo
these experiments.  Some of the problems encountered during theses experiments were 
subsequently resolved and are discussed in the next section.
5.5.4  Ubiquitin-keratin coimmunoprecipitation from lesions
In a final attempt to identify ubiquitinated keratin species in vivo, immunoprecipitations
were attempted on protein extracts of slices taken from the mid  layers  of the tissue. 
Slices were boiled in  1   % (w/v)  SDS/PBS and immunoprecipitations performed using 
the pan keratin antibody (C2562) and a keratin  14-specific antibody (C9097-14B). To 
reduce light chain antibody contamination samples were subsequently boiled in laemmli 
buffer without DTT. The keratin 14 antibody was shown to have pulled down keratin 14 
(Fig  5.13  D),  where  as the  C2562  antibody  did not (data not  shown).  Lanes  without 
antibody  demonstrated  that  uncoupled  beads  bound  protein,  producing  background. 
Interestingly earlier ubiquitin blots were restricted by the amount of protein that could 
be loaded into wells. Non-specific binding of protein to beads allowed the concentration 
of protein from samples,  producing good ubiquitin blots.  These control  lanes  lacking 
antibody,  show  low  molecular  weight  ubiquitin  species  present  in  both  normal  and 
infected  tissue  (more  low  molecular  weight  ubiquitin  was  observed  in  the  verruca 
sample Fig  13  A).  In addition to this a possible  ubiquitin  smear  starting  at -60 kDa 
(which is consistent with a ubiquitinated keratin 14 ladder) was observed in verruca but 
not  in  normal  skin.  Ubiquitin  reactive  bands  were  not  observed  in  the  pan  specific 
keratin IP lanes indicating that the coupling of antibodies to beads inhibits non specific 
binding  (Fig  5.13  A).  Keratin  14  blots  performed  on  samples,  suggested  that  more 
protein had been loaded into the normal skin lane (see Fig 5.13  B) indicating that the 
verruca sample may contain elevated levels of free and conjugated ubiquitin (or reduced 
keratin levels). In addition to this, lanes containing sample blotted for keratin revealed 
that the low molecular weight keratin species described in section 5.5.3 were not presentPan Keratin 
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Figure 5.13 In vivo keratin-ubiquitin co-immunoprecipitation
Keratin was immunoprecipitated from a protein solution produced by boiling 
microtome sections from the mid layers of normal and infected skin in 1% (w/v) 
SDS/PBS.  IPs were performed using a pan specific keratin antibody (C2562) (A) or a 
keratin 14-specific antibody (KOI99-12) (B) and probed for ubiquitin (Sc-8017). Lanes 
containing antibody only reveal that the high molecular weight bands observed in IP 
lanes are caused by antibody contamination (A and B). Un-conjugated beads incubated 
with sample produced low molecular weight ubiquitin bands that were not observed on 
antibody-conjugated beads (A*).  Verruca samples also contained a second ubiquitin 
reactive species -60 kDa (A**).  The pan-keratin antibody did not IP any detectable 
ubiquitin reactive species from either sample (A).  The keratin 14 antibody may have 
pulled-down species from both samples (arrows B).  Verruca sample probed for 
ubiquitin shows bw  levels of ubiquitin present in the sample (verruca lane, blot B). 
After image enhancement (C) the verruca sample could be seen to contain an additional 
band (B).  Extracts probed for keratin 14 reveal multiple high molecular weight species. 
Although normal skin extracts contained more keratin  14, a -60 kDa band (same as 
IPed ubiquitin-reactive species) is stronger in the verruca sample (B*). Blot B was re­
probed for keratin  14; verruca and normal IP lanes both contained keratin  14, although 
significantly more protein had been pulled down from the normal sample (D).
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in the absence of DTT indicating them to be disulphide linked species (see Fig 5.11 B). 
Weak ubiquitin reactive bands may have been pulled down by the keratin 14 antibody. 
Bands were absent in both controls lacking sample and C2562 IP lanes which, failed to 
pulled  down  keratin.  Furthermore,  low  molecular  weight  (8  kDa)  ubiquitin-reactive 
background bands (Fig 5.13 A) were not present in either immuno-precipitation, which 
may suggest that the ubiquitin reactive bands in keratin  14 immuno-precipitation lanes 
were  pulled  down  by  antibody  and  were  not  caused  by  non  specific  binding.  An 
additional  high molecular weight ubiquitin reactive band was detected  in the verruca 
lane  (Fig  5.13  C).  While  these  experiments  have  failed  to  conclusively  identify 
ubiquitinated keratins in vivo,  initial data suggest further investigations may be worth 
while. Optimisation of immunoprecipitations or more sensitive techniques such as mass 
spectroscopy may be required to provide a definitive answer.
5.6  Discussion
The data generated in this study suggest that E1A E4 maintains its capacity to associate 
with and disrupt keratins in vivo. Despite this finding, several differences were observed 
between  ElA E4-positive  cells  in  vivo  and  in  vitro.  Firstly  ElA E4-expression  in  vivo 
rarely  leads  to  perinuclear  collapse  of keratin  networks  or  the  formation  of E1A E4 
aggregates  as  seen  in  vitro,  suggesting  that  this  is  not  its  primary  mode  of action. 
However,  E1A E4  association  to  keratins  in  vivo  does  appear  to  result  in  the 
disruption/reorganisation  of networks,  possibly  leading  to  the  loss  or  degradation  of 
affected networks. Although epitope masking cannot be ruled out, it is thought to play a 
minor  role  for  a  number  of reasons  as  discussed  earlier  in  this  chapter  (see  section 
5.3.2).
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In addition to causing the loss of keratin staining, a subset of HPV  16 E1A E4 positive 
cells  near  the  surface  of  lesions  cross-reacted  with  the  phospho-specific  keratin 
antibodies,  8250 and 2D6.  These data must be viewed with some  caution as keratins 
4/13  and 5/14 do not contain identical epitopes to those to which the antibodies were 
raised,  although  this  does  not  rule  out  the  possibility  of  E lA E4-induced  keratin 
phosphorylation occurring  in vivo.  Interestingly both of the  sites  on keratins that  are 
observed to become phosphorylated in the presence of E1A E4 are linked to cell cycle 
arrest (Ku et al.,  1997b; Ku et al.,  1998), suggesting that E lA E4’s role in G2 arrest by 
cytoplasmic  sequestration  of the  cyclin  B1/CDK1  complex  (Davy  et al.,  2005)  may 
promote keratin reorganisation.
Furthermore,  cells  expressing  high-levels  of HPV  16  E1A E4  were  found  to  contain 
altered ubiquitin profiles, with ubiquitin staining appearing in the cytoplasm of E1A E4 
positive cells at the surface of tissue, whereas normal tissue only contained low level 
nuclear  staining  in  the  upper  epithelial  layers.  HPV  2  lesions  also  contain  altered 
ubiquitin profiles, with cells close to the basal layer containing cytoplasmic ubiquitin as 
has  been  previously  reported  (Sahin.,  2001;  Sato  et  al.,  1997).  Levels  of ubiquitin 
appeared  to  be  especially  high  in  E1A E4  positive  cells.  In  addition  to  this  in  some 
lesions,  E1A E4  positive  cells continued to  stain for ubiquitin  into the  cornified  layer 
where  no  ubiquitin  staining  is  detected  in normal  skin  (Sahin.  2001).  Although  it  is 
tempting to speculate that this is due to E lA E4-induced ubiquitination of keratins, there 
are also  a number of other possible explanations for these observations including the 
activity of other viral proteins, cell stress and infiltration of immune cells (Kondo et a l, 
2002; Sahin., 2001; Shackelford et a l, 2005).
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Data generated in this study also pointed to multiple levels of HPV  16 E1A E4 being 
present in tissue, which may correspond to different events in the virus lifecycle. Work 
on mRNA transcripts suggests that HPV 16 E1A E4 may be expressed in the basal layer 
of cells (Baker et a l,  1996;  Sherman et a l,  1992b;  Wilson et al, 2005). If this is the 
case, then initial levels are too low to be detected by immuno-fluorescence. The onset of 
detectable levels of E1A E4 occurs shortly before MCM expression is lost, allowing viral 
genome  amplification  to  occur  in  a  sub-population  of cells  (reviewed  in  (Doorbar,
2005)). Loss of MCM expression is followed by an elevation in E1A E4 levels, which in 
turn was shown to coincide with LI  expression, this may signify the onset of genome 
packaging.  Only  after this  has  occurred  does  E1A E4  expression  move  into  the  final 
stage, with protein levels building up further. In this population of cells E1A E4 can be 
seen to  induce  keratin  loss  and to  colocalize with ubiquitin.  In addition LI  relocates 
from the  nucleus to the cytoplasm  (possibly  following  nuclear envelope  breakdown), 
suggesting that matured virions may  be  ready  for release.  This  indicates that  keratin 
disruption  only  occurs  at  the  final  stage  of the  virus  lifecycle  perhaps  in  order  to 
facilitate egress of newly assembled virions. Keratin disruption must be carefully timed, 
as premature initiation could result in an EBS-like condition (Ishida-Yamamoto et al, 
1991; Lane et al, 2004; Werner et al, 2004), with infected epidermis being shed prior 
to  the  completion  of the  virus  lifecycle.  The  hypothesis  of multiple  functions  of  16 
E1A E4 is supported by parallel observations made in HPV2 lesions.
HPV2 E1A E4 is differentially processed in different regions of the tissue, although the 
identity  of each  band  was  not  confirmed,  if processing  is  similar  to  16  E1A E4  it  is 
possible to  speculate  as to the  identity  of each  band.  These  data would  indicate that 
HPV2 El A E4 may initially be expressed as a doublet containing a phosphorylated form.
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In higher layers of the epithelium, multimerisation occurs possibly instigating keratin 
disruption as previously suggested (Wang et al., 2004). An N-terminally cleaved form 
may also exist. Although its locations is uncertain, it may appear towards the surface of 
the tissue as previously seen with HPV 1E1A E4 (Breitburd et al, 1987).
Western blot analysis of keratins from normal and HPV 2-infected tissue proved to be 
challenging.  Because  of  the  great  abundance  keratin  in  terminally  differentiated 
epithelia tissue, the heterogeneous nature of HPV2 infections and the diffuse nature of 
E1A E4  expression  in  lesions,  western  bots  are  not  a  suitable  method  for  confirming 
ElA E4-induced drop in keratin levels. Both keratin 10 and 14 appeared to contain high 
molecular  weight  species  (possibly  a  dimer)  that  may  have  been  enhanced  by  the 
presence of E1A E4. This observation is interesting when compared with data generated 
in chapter 6 which suggests that E1A E4 may stabilise keratin filaments. Despite the use 
of several  different  approaches  no  conclusive  evidence  of ubiquitination  of keratin 
species  was  found.  Although this  does not rule  out this  as  a possible  mechanism  of 
action of E1A E4 in vivo, more sensitive approaches such as mass spectroscopy  may be 
required to resolve this issue.
5.6.1  Future experiments
In  order  to  identify  keratin  and  ubiquitin  reactive  species  of interest,  bands  from  a 
silver-stained  gel  could  be  sent  of  for  analysis  by  N-terminal  sequencing  or  mass 
spectroscopy analysis. It is hoped that the results would show whether E1A E4 induces 
biochemical  modifications to  keratins  in  vivo.  It  is  also  hoped  to  be  able  to  acquire 
frozen  HPV  16  sections  expressing  sufficient  E1A E4  to  perform  top-to-bottom 
sectioning so as to look for modified keratin species. In addition to this it is hoped that
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use  of  a  laser  dissection  microscope  may  also  be  used  to  conclusively  determine 
whether E1A E4 induces keratin loss.
Finally, in order to establish the true effect of E1A E4 on epidermal integrity, it is hoped 
to use HPV raft cultures and E1A E4 knockout viruses currently under development in 
the  lab.  If raft cultures  can be produced  expressing  high  levels  of E1A E4  it may  be 
possible  to  stress  the  surface  of  the  tissue  and  quantify  tissue  fragility.
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6  The  effect  of  E1AE4  on  cytokeratin  network 
dynamics
6.1  Introduction
Having  established  that  E1A E4  is  able  to  disrupt  keratins  and  induce  biochemical 
modifications  in  vitro  and  potentially  in  vivo  (see  chapters  4  and  5),  time  lapse 
experiments were conducted to better understand the mechanism by which this process 
occurs. The association of E1A E4 to keratin networks in vitro results in their collapse to 
the perinuclear region, a phenomenon that is rarely observed in vivo. This study aimed 
to analyse the effect of E1A E4 on individual processes involved in the formation and 
turnover of the keratin network.
6.2  Keratin dynamics
Keratins provide  mechanical  strength to  the  cell  whilst remaining  highly  dynamic  in 
order to avoid interference with cellular processes such as mitosis, migration and wound 
healing.  Cytokeratins  were  initially  believed  to  form  relatively  stable  cytoplasmic 
filament networks, but  the possibility of a dynamic cytokeratin network was suggested 
when it was noticed that filaments disassemble during cell division (Aubin et a l,  1980; 
Lane et al.,  1982). The dynamic nature of keratin filament networks was first shown in 
the early nineties in a study that monitored the incorporation of biotin-labelled keratins 
microinjected  into  living  cells.  Incorporation  of biotinilated  keratins  was  observed 
within  15  min of injection.  By  1.5-2 hours post infection extensive network labelling 
was observed  suggesting that complete network turnover had  occurred (Miller et al., 
1991; Miller etal, 1993).
6.2.1  Time-lapse studies of keratin dynamics
Keratin  network  dynamics  have  been  extensively  studied  by  time-lapse  microscopy, 
which has been able to identify individual processes involved in the turnover of keratin
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networks. Keratin movement is an ATP-dependent process that can be inhibited by the 
addition  of  sodium  azide  and  2-deoxy-D-glucose  (Windoffer  et  al.,  1999).  Work 
investigating the recovery  of dismantled  filament networks after mitosis  showed that 
network  formation  is  energy  dependent,  occurs  at  the  cell  cortex  (Fig  6.IB),  and 
requires both the actin and microtubule filament networks (Windoffer et a l, 2001). The 
phosphorylation state of keratins plays an important role in regulating network stability. 
Keratin  network  disintegration,  which  mimics  mitotic  disruption  can  be  induced  by 
treating  cells  with  phosphatase  inhibitors.  This  network  disintegration  is  rapid  and 
reversible, and recovers after the removal of inhibitors (Stmad et al., 2002).
6.2.2  Keratin network formation and turnover is dependent on both 
microtubules and actin networks
Recent  studies  have  demonstrated  that  keratin  filament  assembly  occurs  almost
exclusively  at  the  cell  cortex  and  that  from  here,  the  assembled  filaments  migrate 
towards the  centre  of the  cell  (Fig 6.1  A).  The  inward  directed  movement  of newly 
formed keratin filaments and their precursors occurs at a rate of  -0.05-0.3  pm/min 
depending on the cell  line being studied (Windoffer et al,  1999;  Yoon et al.,  2001). 
This movement is dependent on the actin cytoskeleton and can be inhibited by treating 
cells  with  cytochalasin  (Werner  et  al.,  2004;  Woll  et  al.,  2005).  It  has  also  been 
demonstrated that very  few subunit exchanges occur along  filaments as they  migrate 
inwards (see Fig 6. IB). Once filaments migrate into the central region of the cell, they 
fuse with keratin bundles, where they are dismantled, the subunits are then transported 
back  to  the  edge  of  the  cells  (Windoffer  et  al.,  2004).  This  movement  is  rapid 
(~18pm/min) and involves the transport of keratin particles to the edge of cell, which is 
facilitated  by  microtubules  (Woll  et  al.,  2005).  This  outward-directed  movement  of 
keratin  particles  can  be  inhibited  by  microtubule  depolymerising  agents  such  as 
nocodazole. Analyses of multiple keratin subtypes (K5, 8, 13, 14 and 18) has
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Figure 6.1 Mechanisms  behind keratin filament formation and dynamics.
Diagram A shows the simplified two step model which highlights the major aspects of 
cytokeratin filament network assembly (from left to right), and disassembly (right to 
left) during mitosis. Granules at the centre of the cell are not depicted they do not 
directly contribute to network formation. Granule extension and ligation occurs during 
assembly vs.  filament fragmentation and aggregate formation which occurs during 
disassembly. Radial filament extension and filament thinning occurs during network 
formation conversely filament retraction and thickening occurs during disassembly, 
(image taken from (Windoffer and Leube, 2001)). FRAP analysis on keratin filaments 
of PK18-5 cell demonstrates the differential recovery of central and peripheral 
cytokeratin filaments (white line indicates cell edge) (B).  The first image shows the 
region prior to bleaching (green line indicates path of laser). Note the recurrence of 
fluorescence predominantly at the peripheral region where inward moving filaments can 
be distinguished.  Image taken from (Windoffer et al., 2004).
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revealed that basic keratin dynamics appear to be neither subtype-specific or cell type 
dependent (Woll et al, 2005; Yoon et al., 2001).
6.3  Green florescent protein (GFP)
GFP was isolated from the crystal jelly fish Aequorea victoria in the  1960’s and first 
cloned  in  the  mid  eighties  (Charbonneau  et al,  1985).  GFP  does  not  itself produce 
fluorescent light; this role is performed by the enzyme luciferase, which produces ATP- 
dependent chemiluminescence with a wavelength of 369-475 nm. GFP functions to alter 
the  fluorescence  emissions  spectrum,  allowing Aequorea  victoria to  emit  green  light 
with a wavelength of  508nm (reviewed in (Shimomura, 2005).  In the laboratory GFP 
functions as a biological fluorophore and can be observed by excitation with an artificial 
light source such as a UV lamp or laser. The GFP protein contains a chromophore at its 
centre (Fig 6.2B) that has the ability to absorb light energy of specific wavelengths, this 
energy  is then re-emitted by the molecule at a longer wavelength (fluorescence).  The 
GFP protein catalyzes the formation of its own chromophore, which is contained within 
the  centre  of a beta-barrel  structure  formed by  11  beta  strands  (Fig  6.2A)  (Phillips, 
1997;  Yang  et  al,  1996).  Since  its  discovery,  GFP  has  been  an  invaluable  tool  in 
biological  research,  allowing  the  labelling  and  real-time  monitoring  of  biological 
molecules in their natural environments. Many different GFP mutants have since been 
produced  conferring  various  properties  on  the  protein  e.g.  enhanced  GFP  (EGFP) 
fluoresces  at a higher  intensity  and resists photobleaching when compared with wild 
type GFP.  Monomeric and pH sensitive variants have also been produced. In addition, 
single amino acid mutations resulting in shifts in the absorbance and emission spectra 
have been generated resulting  in yellow florescent protein (YFP)  and cyan florescent 
protein  (CFP) (reviewed by(Chudakov et al, 2005).
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Figure 6.2 The structure of the Green florescent protein (GFP)
GFP exists as a dimer in solution at low ionic strengths.  The protein is formed from 
eleven strands of p-sheet (green) which form the walls of a cylinder (A). Short segments 
of helices (blue) cap the top and bottom of the 'P-cari and provide a scaffold for the 
fluorophore (B) held near geometric centre of the can.  Images taken from (Yang, Moss, 
and Phillips,  1996)
212Chapter 6 The effect of E1A E4 on cytokeratin network dynamics
6.4  Basis of time-lapse imaging
To collect valid time-lapse data several factors must be taken into consideration. These 
include the depth of focus required, the duration of the experiment and the brightness of 
the  subject.  The  frequency  and  duration  of events  determines  the  interval  between 
frames.  Some  events  occur  frequently  and  rapidly,  and  are  relatively  easy  to  image. 
Events that occur rapidly but infrequently are much more challenging to film.  It can be 
difficult  to  keep  individual  filament  structures  in  focus,  especially  in  rounded  cells, 
where there  is  a lot  of scope  for movement in the Z-plane  (Windoffer et al.,  1999). 
Dynamic objects are more likely to drift in and out of the plane of focus and require a 
greater  depth  of focus,  which  is  obtained  by  increasing  the  number  of Z  sections, 
followed  by  merging  to  form  a  composite  image.  Subjects  with  low-intensity 
fluorescence require longer exposures times.  Conversely, bright subjects can be imaged 
using shorter exposure times and by using neutral density filters to further reduce light 
intensity.  Increasing the  intensity,  duration  and  frequency  of exposure  of samples to 
light increases the chances of corrupting the data by inducing phototoxic cell damage. 
The  selection  of  fluorophore  can  also  influence  the  phototoxicity  incurred  during 
imaging.  For  example,  blue  fluorophores  such  as  CFP  require  shorter  wavelength 
(higher  energy)  excitation  sources  resulting  in  more  rapid  accumulation  of  photo 
damage. Time-lapse imaging using multiple fluorophores requires a greater number of 
exposures and hence will increase phototoxic cell stress. All these factors must be taken 
into account when designing time-lapse experiments in order to generate valid data. As 
many  of these  factors  are  initially  unknown  and  time-lapse  experiments  require  a 
considerable amount of optimisation in order to establish a practical system.
6.4.1  Phototoxicity
Phototoxicity  is  a  problem  that  is  commonly  encountered  during  time-lapse
experiments.  Phototoxicity  and  photobleaching  are  two  distinct  phenomena.
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Phototoxicity  results from the  generation of free radicals by the  exposure  of cells to 
high energy light sources.  Free radicals are chemically reactive species with lone pair 
electrons  that  are  produced  by  the  breaking  of  chemical  bonds  by  high  energy 
ultraviolet light. As free radicals accumulate in cells they react with bio-molecules and 
disrupt  biological  processes  and  this  in  turn  can  alter  cellular  dynamics  leading  to 
apoptosis,  and  distorts  experimental  data  (Juven  et  al.,  1985).  Phototoxicity  can  be 
minimised  by  reducing  the  duration  and  intensity  of the  light  pulses  used  to  excite 
fluorophores  (Black,  2004;  Juven  et  al.,  1985;  Neumann  et  a l,  1999;  Satoh  et  al.,
1996). Addition of antioxidants such as ascorbic acid, which mop up free radicals can 
also be used to reduce phototoxicity (Neumann et al., 1999).
6.5  Results
6.5.1  Production  and  characterisation  of  a  16AE1AE4  YFP  fusion 
protein
The  YFP-E1A E4  fusion  protein  was  produced  by  cloning  E1A E4  from  the  existing 
MV11  vector, and ligating it into the pEYFP-Cl vector (Clonetec, see appendix IIII for 
vector map). This resulted in a YFP protein with E1A E4 attached to its C-terminus. The 
PCR reaction produced a 300 bp E1A E4 fragment (Fig 6.3 A), which was ligated into 
the vector and transformed into bacteria.  Clones were screened by both endonuclease 
restriction  digestion  and  PCR  (Fig  6.3B).  To  ensure  that  the  pYFP-ElA E4  construct 
expressed  a  functional  protein,  SiHa  cells  were transfected  with  the  construct.  Cells 
lysates  were  analysed  by  western  blots,  which  were  probed  with  an  ElA E4-specific 
antibody  (TVG  402).  Extracts  were  shown  to  contain  an  E1A E4  reactive  band  of 
approximately 40 kDa which is consistent with a fusion between E1A E4 (12 kDa) and 
YFP  (27kDa)  (Fig  6.3  C).  Separation  on  a  10  %  gel  showed  that  the  band  was 
composed of a doublet,  suggesting that phosphorylation may occur as with wild type 
protein.
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Figure 6.3 Cloning and identification of the YFP-E1AE4 fusion protein
The YFP-E1A E4 fusion protein was produced by cloning E lA E4 from pMVl 1   HPV  16 
El A E4 vector (Raj, 2004). PCR products were -300 bp in size and only present in lanes 
containing template (A.). PCR products were ligated into the pEYFP-Cl  vector 
(Clonetech) and electroporated into DH5aT:ells. Positive colonies were identified by 
PCR screening (B)  Wild type and YFP-E1A E4 clones were transfected into SiHa cells 
and lysates analyzed by western blotting. Blots were probed with the E1A E4 specific 
antibody (TVG402). Wild type E1A E4 produced 2 bands -12 kDa in size as previously 
reported. The YFP-fiision protein was -40 kDa in size (C) and found to contain 2 bands 
when separated on a  10 % gel (arrow)
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6.5.2  YFP-E1AE4 analysis by confocal microscopy
The behaviour of the YFP-E1A E4 protein was compared to wild type E1A E4 by high
resolution  confocal  microscopy.  SiHa  cells  were  transfected  with  pYFP-ElA E4  and 
fixed 24 h post transfection with methanol. Transfected cells were stained for keratin, 
mitochondria, or cyclin B (Fig 6.4).  Cells expressing YFP-E1A E4 contained the same 
E1A E4  structures found  in cells expressing wild  type protein  (filaments,  bundles and 
aggregates)  which  fluoresced  without  being  stained,  indicting  that  conjugation  to 
16E1A E4 did not disrupt the function of the YFP protein (Fig 6.4 A-C). In addition, the 
various  YFP-E1A E4  structures  all  colocalised  with  keratin  (Fig  6.4  D-F).  SiHa  cells 
transfected with the empty YFP vector showed that when not bound to E1A E4, YFP was 
diffuse throughout the cell and did not colocalise with keratin (Fig 6.4 G-I). YFP-E1A E4 
also colocalised with cyclin B, with colocalisation being more frequently observed in 
E1A E4 aggregates (Fig 6.4 M-O) as seen with wild type E1A E4.  YFP-E1A E4 did not 
colocalize with mitochondria, even in cells where E1A E4 displayed a mitochondria-like 
pattern (Fig 6.4 J-L). This data suggests that YFP-E1A E4 behaves in a similar manner to 
the wild type protein, except for its inability to associate with mitochondria.
6.5.3  Expression of YFP-E1AE4 in SW13 cells
To  confirm  that  YFP-E1A E4  was  incapable  of  associating  with  mitochondria;  the 
construct  was  expressed  in  cells  lacking  cytokeratin  networks.  YFP-E1A E4  was 
transfected into  SW13  T7K and  SW13  C2  cell  lines (C2  lack  keratin networks,  T7K 
cells express a K8/18 network).  In SW13  T7K cells YFP-E1A E4 expression produced 
results similar to those in SiHa cells, producing filaments, bundles and aggregates that 
co-stained with keratin (see Fig 6.5 G-L). Expression of YFP-E1A E4 in SW13 C2 cells 
resulted in a diffuse pattern that did not appear to colocalize with mitochondria (see Fig 
6.5 A-F).
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SiHa cells
SiHa cells were transfected with pYFPAEl AE4 and fixed with methanol 24 h post­
transfection before being stained for DNA (DAPI, blue) and either keratin (C2562), 
cyclin B (GNS  11) or mitochondria (mitotracker, used prior to fixation) (red).  YFP- 
16E1AE4 produced a variety o f structures including filaments bundles and aggregates 
(A-C). YFP-EI AE4 associated to and disrupted keratin filaments (D-F)  SiFla cells 
transfected with empty YFP vector, demonstrated that YFP was diffuse and did not 
associate to keratin (G-I). YFP- 16E1AE4 could  not be observed to associate with 
mitochondria (J-L).  YFP-16E1AE4 maintained the ability to associate with cyclin B (M- 
O).  Scale bars denote 5 pm.
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Figure 6.5 Expression of YFP-16E1AE4 in SW13 cells demonstrates that it is 
unable to associate with mitochondria
The ability of YFP El A E4 to associate with mitochondria was established by 
transfecting pYFP-16A E IAE4 into C2 (K-ve) and T7K (keratin 8 &  18) SWI3 cells. 
Cells were fixed 24 h post-transfection and stained for DNA (DAPI, Blue) and either 
keratin (C2562) or mitochondria (mitotracker added prior to fixation) (red). In the 
absence of keratin (SW13 C2 cell line) YFPA  E1A E4 was unable to bind mitochondria 
or form solid structures resulting in a diffuse cytoplasmic pattern (A-F)  When 
expressed in SW13 T7K cells YFP E1A E4 was exclusively located to keratin (G-L) 
Scale bars denote 5 pm.
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This data suggested that the fusion protein was incapable of forming solid structures in 
the absence of keratin.
6.6  Initial time-lapse strategies
Initial time-lapse experiments were carried out to observe both YFP-EIA E4 and CFP- 
keratin simultaneously using the AK-8 cell line expressing a CFP-tagged keratin 8/18 
network (kindly provided by Rudolph Leube). The aims were to determine how robust 
the cells were, to observe E1A E4 behaviour in cells, and to determine the rate at which 
E1A E4  accumulates  on  keratin  networks.  Initial  experiments  showed  that  cells 
frequently drifted out of the plane of focus, suggesting that long duration movies may 
not produce usable data.  Although YFP-EIA E4 was exclusively  localised to the  CFP 
keratin filaments, the network in the AK-8 cell line could not be clearly visualised, and 
only  poor  resolution  images  were  obtained  (this  was  also  noted  by  Rudolph  Leube, 
personal  communication).  Over  the  time  frame  required  to  observe  ElA E4-induced 
keratin collapse,  significant phototoxic effects were observed despite increasing time- 
lapse  intervals.  Cells  were  observed  to  ball  up  and  fluorescent  keratin  formed  into 
aggregates in the absence of E1A E4, indicating the initiation of apoptosis (Caulin et al,
1997). The narrow margin between YFP-EIA E4 and phototoxicity-induced cytokeratin 
network collapse, meant that it was not possible to distinguish between the effects of 
E1A E4 and phototoxicity using this approach. Two colour imaging required double the 
number  of exposures  which  contributed  further to  phototoxic  damage.  This  problem 
was compounded by the use of CFP which requires short wave (high energy) excitation 
wavelengths.  From these  initial  experiments  it was concluded that long duration two 
colour  imaging  experiments  were  not  possible  to  carry  out  due  to  high  levels  of 
phototoxic damage.  In addition to this, the CFP cell line produced poor quality images.
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Having been unable to produce usable data using the initial approach, it was decided to 
transfect  YFP-EIA E4  into  SiHa  cells  and  to  focus  on  the  effect  of YFP-EIA E4  on 
keratin network dynamics over a 1-2 hour frame using the AK 13 cell line as a control 
(Windoffer et al.,  1999).  The GFP labelled keratin  13  networks expressed in this cell 
line were significantly sharper to visualise than the K8/K18 networks expressed in AK- 
8 cells. Both the process of keratin filament formation and the migration of individual 
filaments towards the centre of the cell could be captured using the available imaging 
systems. After generating data in this cell line it was discovered that although dynamics 
occurred at the same rate as previously reported for AK13 cells (Windoffer et al., 1999) 
the  rates  of movement varied between  different cell  lines  (Yoon et al.,  2001).  As  a 
result of this discovery a third strategy was investigated.
6.7  GFP keratin 13 transfected into SiHa cells
At  the  time  of acquiring  the  AK8  and  AK-13  cell  lines,  a  GFP  labelled  keratin  13 
plasmid  (pHK13AP.EGFP) was  also  provided  by  Rudolph  Leube.  This  plasmid  was 
transfected into  SiHa cells to  investigate keratin  filament formation  and to  allow the 
monitoring of keratin network dynamics in the  same  cellular background.  SiHa cells 
express a keratin 8 and  18 network and so a GFP labelled keratin 8 or  18 would have 
been preferable.  In addition to keratin 8/18, around  10 % of SiHa cells also express 
keratin 13 (see chapter 4), and so it was uncertain whether expressed GFP-K13 protein 
would be able to incorporate into keratin filaments in SiHa cells. To examine this, SiHa 
cells  were transfected  with the  plasmid  and  stained  for  keratin  (C2562).  Transfected 
cells  expressed  high  levels  of  the  protein,  and  displayed  various  phenotypes. 
Fluorescent keratin aggregates (Fig 6.6 D-F) and filamentous structures were observed 
in  cells  (Fig  6.6  A-C),  GFP-K13  filaments  were  indistinguishable  from  endogenous 
filament network (Fig 6.6 A-C). Cells were observed at 12 and 24 h post transfection; a
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Figure 6.6 Formation of keratin filaments can be observ ed in GFP keratin  13 
transfected SiHa cells
SiHa cells transfected with GFP-Keratin  13 plasmid (Windoffer and Leube,  1999) fixed 
with methanol  and stained for keratin (C2562 red) and DNA (DAPI blue) GFP keratin 
13 could be seen to incorporate into keratin networks in a sub population of cells (A-C), 
whereas it formed aggregate structures in others (D-F). (G-L) When GFP-keratin  13 is 
transfected into live cells, filaments could be seen to form from diffuse fluorescent 
material at the edge of the cell (*).  Scale bars denote 5 pm.
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greater number of filamentous cells were observed at 24 h. Although a GFP keratin 8 or 
18 label would have been a more logical choice, from these observations it was decided 
that this system could be used as a control model to determine the affects of E1A E4 on 
keratin filament formation, migration and turnover in SiHa cells.
6.7.1  Formation  of  keratin  filaments  at  the  cell  cortex  can  be 
observed in GFP K13 transfected SiHa cells
It  was  decided  to  investigate  whether  E1A E4  caused  keratin  collapse  by  disrupting 
keratin polymerisation and filament formation at the cell cortex.  The process was first 
visualised  by  transfecting  SiHa  cells  with  the  pHK13AP.EGFP  plasmid.  Diffuse 
fluorescent  material  at  the  edge  of the  cell  edge  was  shown  to  condense  and  form 
filaments (Fig 6.6 G-L) with newly formed filaments migrating towards the centre of 
the cell (see Fig 6.8 A-C) (see movie GFP-K13) where they begin to fuse with centrally 
located  keratin  bundles.  As  filaments  move  inwards,  diffuse  fluorescent  material 
condense behind the old filament, with new filaments gradually forming (small arrows 
Fig  6.8).  These  observations  suggest  that  the  pHK13AP.EGFP  plasmid  could  be 
transfected  into  SiHa  cells  and  used  to  observe  keratin  filament  formation  and 
migration,  which  occurs  by  a  mechanism  similar  to  that  previously  described 
(Windoffer et al., 1999; Windoffer et al, 2001).
6.7.2  E1AE4 does not initially disrupt filament formation
A  reduction  in  soluble  keratin  in  E lA E4-positive  SiHa  cells  has  previously  been
demonstrated using fractionation experiments (see Fig 4.16 ) (Wang et al., 2004). This 
data would seem to suggest that the keratin “escalator” system may be inhibited. It was 
previously suggested that this was a result of E1A E4 associating with the soluble pool of
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keratin  and  linking  it to  the  insoluble  filaments by  a process  of cross-linking  and/or 
multimerisation  (Wang  et  al.,  2004).  During  initial  time-lapse  analysis  of  cells, 
performed 24 h after transfection, no filament formation could be observed suggesting 
that  the  process  of keratin  polymerisation  and  filament  formation  was  inhibited  by 
El A E4. However, analysis of SiHa cells 12 h after transfection with pYFP-EI A E4 shows 
that the build up of E1A E4 does not initially disrupt cytokeratin filament formation and 
subsequent inward translocation (Fig 6.7) (see movieYFP-ElA E4.1). In cells containing 
fine filamentous YFP-EI A E4 the process of filament formation could be observed. The 
formation of filaments from diffuse fluorescent E1A E4 occurred at the periphery of the 
cell, as observed in cells expressing fluorescently tagged keratin. Filaments joined with 
the existing filament network migrating towards the centre of the cell.  The data was 
colleted  using  5  z  sections  giving  a  focal  depth  of 2  pm  confirming  that  filament 
formation was indeed being observed and that the data could not be explained simply by 
filaments  drifting  into  the  plane  of  focus.  This  data  demonstrates  that  E1A E4  can 
associate  with  the  soluble  pool  of  keratin  without  initially  disrupting  keratin 
polymerisation and filament formation.
6.8  Tracking of the inward directed migration of GFP keratin 13 
and YFP-E1AE4 filaments in SiHa cells
To determine whether E1A E4 was able to affect keratin network dynamics by disrupting 
their  association  with  other  cytoskeletal  components  or  otherwise,  SiHa  cells  were 
transfected  with  pYFP-ElA E4  or  pHK13AP.EGFP.  2-hour  time-lapse  movies  were 
produced and the rate of inwards directed migration of filaments from the edge of the 
cell was determined. Data sets were analysed to quantify variation between YFP-EI A E4 
and  GFP-K13  network  dynamics  using  the  in-house  tracking  software  GM  view, 
developed by Gregory Mashanov (Mashanov et al., 2003; Mashanov et a l, 2004). Ten
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Figure 6.7 YFP-E1AE4 can be observed to assemble into filaments at the edge of 
the cell.
SiHa cells were transfected with p YFP-E1AE4 12 h prior to  imaging on a Deltavision 
epifluorescence microscope.  Diflftise YFP-E1AE4 at the edge of the cell was observed to 
assemble into filaments (marked by arrows). Filaments migrated towards the cell centre 
in a similar manner to that previously described for GFP labelled keratin filaments 
(Windoffer and Leube,  1999). Scale bar denotes 5  pm
225Chapter 6 The effect of E1A E4 on cvtokeratin network dynamics
different identifiable objects at the edge of the cell were selected and tracked for each 
time point making a total of approximately 600 measurements /cell.  Velocity values 
generated in GM view were double checked by frame to frame analysis of data sets in 
Softworks software (Applied Precision).  To determine the effects of phototoxicity on 
data  sets,  2-hour  movies  were  split  into  three  40  min  components  and  analysed 
separately in order to determine the cumulative effects of phototoxicity on dynamics. 
Average velocities were found to be  stable  over the  2  hour period  (data not shown). 
Furthermore,  cells  appeared  stable  and  did  not  show  obvious  signs  of apoptosis,  as 
observed  in  earlier  recordings,  suggesting  that  data  was  not  being  corrupted  by 
phototoxicity.
6.8.1  Rates  of  filaments  migration  observed  in  GFP  keratin  13 
labelled SiHa cells.
The rate of inward movement of keratin filaments was determined by analysing time-
lapse recordings of SiHa cells transfected with either GFP-K13 or YFP-E1A E4. The rate
and uniformity of the movement was determined by analysing the average velocity and
standard deviation values. Keratin filament migration was generally unidirectional (see
Fig  6.8  A-C)  (outward  “pulses”  of movements were  occasionally  observed  see  large
arrow Fig 6.8 A-B) (see movie GFP-K13), the rate of which varied slightly from cell to
cell and had an average velocity of 0.056  pm/min (with range of 0.03-0.084 pm/min)
and an average standard deviation of 0.036 pm/ min (Fig 6.9A). New filament could be
observed to form from diffuse material at the cell edge as the observed filament tracked
inwards;  demonstrating that filament turnover was ongoing  (Fig  6.8  B  small  arrows)
and indicating that phototoxicity was not affecting cells. Filament morphology appeared
to be in a continuous state of flux with filaments stretching, condensing and fusing with
one another. Filament mergers occurred in the perinuclear region of the cell sometimes
forming large bundles, the morphology of which was also in a continual state of flux
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Keratin
Figure 6.8 Tracking of keratin and E1AE4 in SiHa cells  revealed inward directed 
movement of both YFP-E1AE4 and GFP keratin.
GFP-keratin 13 (A-C) or YFP-E1AE4 (D-E) was transfected in to SiHa cells and time 
lapse movies were produced. Data was analysed with GM view, paths (track initiation 
points denoted by arrows) of ten objects per cell were recorded. Images (A & D) show 
cells at TO. GFP keratin was observed to track into the centre of the cell continuously 
with an average rate of ~0.06|im/min (A-C). New filaments were observed to form 
behind old filaments as they tracked inwards (small arrows B). An outward spread of 
new filaments was also observed (large arrow A-B).  Inward movement of YFP-E1AE4 
fillaments was observed in cells as network collapse occurred, no new fluorescent 
material is observed at the edge of the cell (E). Maximum velocities did not exceed and 
were comparable to those of keratin movement (compare track lengths).  YFP-E1AE4 
and GFP keratin networks both contained relatively static points moved that little in 2 h 
(red arrows). Scale bar denotes 5 jam.
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Figure 6.9 Average inward velocities of GFP keratin 13 and YFP-E1AE4 labelled 
keratin networks  in SiHa cells
Graphs show the average velocity of GFP keratin 13 (A) or YFP-E1AE4 (B) labelled 
keratin filaments in SiHa cells (5cells /population) as they migrate from the edge into 
the centre of the cell (see Fig 6.8).  Rates represent the average velocity of 10 objects per 
cell initiating at the cell edge and migrating inwards (see Fig 6.8), over the course of 2 
hr using GM view tracking software, error bars represent the standard deviation.
Average velocities of GFP keratin  13 and YFP-E1AE4 labelled keratin networks in SiHa 
cells were 0.059 and 0.043 jim/ min respectively.
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(see movie GFP-K13). These data indicated that GFP-K13 labelled filament networks in 
SiHa cells turnover at a rate comparable to those reported to occur in other cell lines 
(Windoffer et a l, 2004; Yoon et al., 2001).
6.8.2  Rates  of filaments  migration  observed  in YFP-E1AE4  labelled 
SiHa cells.
Data from SiHa cells transfected with YFP-E1A E4 must be interpreted carefully as it is 
possible to come to a variety of different conclusions, depending on the population of 
E1A E4  cells  being  studied.  Very  little  inward  motion  was  observed  in  cells  with 
collapsed keratin networks. Cells with well spread filamentous E1A E4 were selected for 
this study  and the rates of E1A E4 labelled filament movement was recorded. No new 
filament formation could be observed in cells undergoing collapse suggesting that this 
process  has  been  disrupted  at  the  point  of  network  collapse  (Fig  6.8  D-E)  (see 
movieYFP-ElA E4.2).YFP-ElA E4  labelled  filaments  could  also  be  observed  to  move 
inwards (Fig 6.8  D-E track lines) at a rate comparable to that observed for GFP-K13 
labelled filaments (compare graphs A and B Fig 6.9). Inward movement had an average 
velocity  of  0.043  pm/min  (with  a  range  of  0.019-0.072  pm/min)  and  a  standard 
deviation  of  0.029  pm/min.  Although  GFP-K13  labelled  networks  contained  some 
relatively static regions (red arrow Fig 6.8 A-C), these were generally more abundant in 
YFP-E1A E4 networks, depending on the extent of network collapse (red arrows Fig 6.8 
D-E), resulting in the reduced average velocities recorded. Points containing identifiable 
material  360°  around  the  cells  were  selected.  Data  could  have  been  skewed  by 
selectively  analysing  highly  dynamic  regions  and  is  therefore  open  to  interpretation. 
Dynamic regions (non-collapsed) moved at comparable velocities in both YFP-E1A E4 
and GFP-K13 transfected SiHa cells (YFP-E1A E4 max 0.072  pm/min, GFP K13 max 
0.084 pm/min also, compare track lengths Fig 6.8 C and E).
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Furthermore  the  usual  complex  shifting  dynamics  observed  within  normal  keratin 
networks  were  not  observed  in  E1A E4  associated  networks.  Filament  stretching  and 
mergers  were  not  observed  and  filaments  appeared  to  be  of  a  uniform  thickness. 
Individual filament junctions were stable over the 2 hour recordings (see Fig 6.1 OB and 
6.1 IB). Dynamic regions of E1A E4 associated keratin filament moved inwards at a rate 
comparable  to  those  observed  in  GFP-K13-labelled  networks,  suggesting  that  the 
association  of  E1A E4  to  filaments  appears  not  to  disrupt  the  association  to  other 
components  of  the  cell  cytoskeleton  responsible  for  keratin  filaments  dynamics. 
However, the association of E1A E4 appears to freeze dynamic alterations to the keratin 
network architecture that are apparent in normal  keratin networks, possibly  indicating 
the stabilisation of E1A E4 associated keratin filaments.
6.9  Fluorescence recovery after photobleaching (FRAP)
FRAP is a useful analytical technique that allows the study of protein diffusion and can 
provide data on protein-protein interactions in  living  cells.  FRAP  relies  on the  basic 
principal  of  photobleaching,  which  is  where  over  stimulated  fluorophores  sustain 
photon-induced chemical damage and undergo covalent modification,  destroying their 
fluorescent properties. Fluorophores can be photobleached with a brief pulse of bright 
light without  damaging  other  cellular proteins  (Prendergast,  1999).  As  lasers  can  be 
used to ablate fluorescence in localized regions within cells, fluorescence recovery can 
be monitored by time-lapse imaging to gain information on the kinetics and turnover of 
proteins within cells.  It was hoped that  such experiments would determine  if keratin 
bound E1A E4 is in equilibrium with a diffuse population or whether keratin binding is a 
stable/irreversible  event.  In  addition  to  this,  by  determining  the  E1A E4  recovery 
mechanism,  it  will  be  possible  to  determine  if E1A E4  can  bind  polymerised  keratin
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filaments  or  whether  it  binds  soluble  keratin  and  is  subsequently  incorporated  into 
networks during filament formation.
6.9.1  FRAP analysis of GFP labelled keratin filaments
Keratin FRAP has previously been performed by several researchers on cells expressing
fluorescent tagged keratin chimeras in order to better understand keratin network turn­
over.  Experiments  involving the bleaching  of bars perpendicular to  keratin filaments 
estimated a recovery half life of approximately 100 ±30 min. Recovery was not uniform 
across  the  length  of  the  bleached  region  with  fluorescence  extending  out  from 
fluorescent  ends  of the  filament.  These  experiments  also  demonstrated  that  parallel 
filaments  less  than  lpm  apart  moved  at  different  rates  and  in  different  directions 
demonstrating the complex nature of keratin filament dynamics (Yoon et al, 2001). A 
second study  looked at the recovery  of keratin filaments by  bleaching  wedge  shaped 
regions at the periphery of cells. These experiments revealed very limited recovery in 
the central regions suggesting that limited subunit exchange occurs within polymerised 
filaments.  Fluorescent recovery took place  in a sub-membranous compartment,  with 
diffuse  fluorescent  material  forming  new  filaments  which  then  migrated  into  the 
bleached  region  (see  Fig  6.10  B).  This  observation  was  further  supported  by  the 
bleaching of an entire cell and subsequent monitoring of a single unbleached peripheral 
filament.  Little  fluorescence reduction was detected over a 70  min period suggesting 
very  limited  release  of fluorescent  material  into  the  soluble  pool  (Windoffer  et  al, 
2004).  Over  a  200  min  period,  the  filament  migrated  towards  the  centre  of the  cell 
where  fluorescent  levels  began  to  decrease,  suggesting  a  recycling  of  fluorescent 
material  into  the  soluble  fraction.  A  corresponding  increase  in  the  fluorescence  of 
nearby  centrally  located  filaments  was  not  observed  indicating  that  shed  fluorescent 
subunits  were  not  being  incorporated  into  adjacent  filaments.  These  observations
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demonstrated  that  the  turnover  of a keratin  filament  does  not  occur  by  exchange  of 
subunits along its entire length and throughout the cytoplasm but is confined to the cell 
cortex (Windoffer et al, 2004).
6.10FRAP analysis of GFP keratin  13 labelled filaments  in SiHa 
cells
Analysis of keratin FRAP was complicated by several factors including the duration and 
mechanism  of recovery,  and  the  highly  dynamic  nature  of networks.  Recovery  of 
fluorescently tagged keratin in SiHa cells after the bleaching of perpendicular bars in 
cells  occurs  over more  than 2  hours  (Fig  6.10)  (see  movie  GFP-K13).  Fluorescence 
recovery occurred by a number of different processes.  These include the migration of 
diffuse non-filamentous material  into the bleached region.  Unbleached filaments also 
migrated into the bleached regions as a result of normal network dynamics.  Recovery 
was not uniform along the length of the filaments with limited recovery  appearing to 
occur by bleached ends growing together to reform a fluorescent filament as previously 
reported (Yoon et al., 2001). Due to the complex mechanism of recovery, data was not 
analysed  using  the  imageJ  software  patch  software  used  to  analyse  YFP-E1A E4 
recovery,  as it was only  able to measure the uniform recovery  of a single point and 
would  not  provide  useful  data  on  complex  keratin  recovery.  Recovery  of GFP-K13 
labelled keratin networks in  SiHa cells  occurred at a similar rate  and by  comparable 
mechanisms as has been previously described in other cell lines (Windoffer et a l, 2004; 
Yoon et al, 2001).  Internal keratin network architecture is also in a continual state of 
flux, filament connection are not stable over the 2 h period of the recoding (Fig 6.10B) 
(see movie GFP-K13).
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Figure 6.10A FRAP analysis of Keratin in SiHa cells
SiHa cells transfected with GFP Keratin 13 were subjected to FRAP analysis 24 h post 
transfection. Images were acquired (-1  s) before bars were bleached in cells (+1  s post 
bleach) (red arrow) using a 488 nm QLM module equipped deltavision microscope. 
Fluorescence recovery was recorded for two hours after bleaching. Recovery was 
almost completed within two hours, but was not uniform over the bleached region 
Recovery primarily occurred by the migration of new fluorescent filaments into 
bleached regions. The ongoing processes of filament synthesis at the periphery of cells 
was clearly visible (blue arrow) Scale bar denotes 5 pm.
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120 min
Figure 6.10B keratin filament networks are highly dynamic and in a continual 
state of flux
Figure shows enlarged  images from figure 6.10, keratin network architecture is in a 
continual state of flux and no points or filament junctions are stable over a 2 h time 
frame.
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6.10.1  FRAP analysis of YFP-E1AE4 in SiHa cells reveals rates of 
recovery varies in different structures
It was hoped that understanding the binding of E1A E4 to keratins would give insights
into how keratin network disruption occurs. FRAP experiments were performed on cells 
containing  both  E1A E4  filaments  and  aggregates.  Recovery  of  E1A E4  was  not 
comparable to keratin in either time or mechanism. Furthermore, two separate rates of 
E1A E4  recovery  were  observed,  depending  on  the  structures  studied.  SiHa  cells 
transfected with YFP-E1A E4 12 hrs prior to imaging which expressed E1A E4 with a fine 
filamentous pattern were selected for the first set of experiments.  Bars were bleached 
through cells and images taken every 2 min subsequently. Fluorescence returned to the 
bleached regions rapidly and almost complete recovery was deemed to have occurred 
within  approximately  30  min  (N  =  16)  (Fig  6.11  and  Fig  6.13)  (see  movie  YFP- 
E1A E4.3). By monitoring fluorescence levels in unbleached regions it was possible to 
demonstrate  that  recovery  was  not  due  to  new  protein  synthesis,  as  a  comparable 
increase  in  fluorescence  was  not  observed  in  control  regions  (Fig  6.13  C-D). 
Furthermore, unlike keratin, E1A E4 recovery appeared to be relatively uniform across 
the bleached region suggesting a dynamic equilibrium between the bound and soluble 
populations  of protein  (Fig  6.11  A-B).  The  rapid  uniform  recovery  of fluorescence 
suggests that E1A E4 is able to bind, the polymerised filaments and the association is not 
dependent on keratin incorporation during filament formation at the cortex of the cell. 
Although the rates of recovery were consistent, there was a significant variation in the 
extent of recovery to pre-bleach levels, which ranged between 69% and 94% (Fig 6.13C 
and D).  Fluorescence recovery  occasionally  involved  an  increase  in protein synthesis 
during 2 experiments; a representative graph is also shown (Fig 6.13  E).  This finding 
suggested  that  although  a  significant  percentage  of  E1A E4  binding  to  keratin  is 
transient; a second populations may be irreversibly bound, or have a significantly
235Chapter 6 The effect o fE lA E4 on cvtokeratin network dynamics
Figure 6.11A FRAP analysis of filamentous E1AE4 in SiHa cells
SiHa cells transfected with YFP-E1A E4 cell expressing filamentous E1AE4 were 
subjected to FRAP analysis  12 h post transfection  Images were acquired (-1  s) before 
bars were bleached (red arrow) in cells (+1  s post bleach) using a 488 nm QLM module 
equipped deltavision microscope. Fluorescence recovery occurred in 30 min with 
recovery occurring uniformly over the bleached region (red arrow).  Filament network 
architecture was not observed to alter significantly over two hours and multiple 
individual filaments were still detectable (Blue arrows) showing increased stability of 
E1A E4 associated filaments.  Scale bar denotes 5pm
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Figure 6.1 IB  E1AE4 association to keratin stabilises keratin filament networks.
Figure shows enlarged images from figure 6.11, the association of El AE4 to the keratin 
network freezes network architecture over 2 h.  Individual filament junctions are stable 
over 2 h (see arrows).
237Chapter 6 The effect of E1A E4 on cvtokeratin network dynamics
0
-1 S +1 s 12 min
#
24min 36 min 48 min
60 min
*
72 min 84 min
96 min 108 min 120 min
Figure 6.12 FRAP analysis of E1AE4 aggregates in SiHa cells
SiHa cells transfected with YFP-E1AE4 24 h prior to imaging, cells containing 
aggregates were subjected to FRAP analysis. Images were acquired (-1  s) before spots 
were bleached with a single laser pulse (+1  s post bleach) (red arrow) using a 488 nm 
QLM module equipped deltavision microscope. Only limited fluorescence recovery was 
observed over a 2 h period.  Small El AE4 aggregate structures were highly dynamic and 
were observed to under go rapid bidirectional translocation (blue arrow) scale bar 
denote 5 (am.
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Figure 6.13 Recovery  rates of E1AE4 filaments and aggregates
SiHa cells transfected with YFP E1A E4 and subjected to FRAP analysis. Data sets were 
analyzed in image J and revealed several different mechanisms of recovery (values 
denote grey scale ranging from 0-2500). E1A E4 aggregates (A-B) showed very little 
recovery over 2 h. Control unbleached regions (Pink) were stable over 2 h indicating 
that protein synthesis and photobleaching were not significantly affecting data sets. 
When disruption of data sets by focal drift occurred data was discarded (black arrows). 
Recovery analysis of filamentous El A E4 produced smooth recovery curves that flatten 
out between  1500-2000 s. Unbleached control regions did not reflect recovery curves, 
suggesting that recovery was not due to additional protein synthesis (C-D). Significant 
increases in control regions (which mimicked recovery curves) were observed in some 
recordings suggesting protein synthesis may be involved in the fluorescence recovery 
during some experiments (E).
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slower  dissociation  rate.The  inhibition  of  internal  dynamics  of  E1A E4  associated 
filament  architecture  is  also  apparent  as  filament  connections  are  stable  over  a  2  h 
period (Compare 6.1 OB and 6.1 IB).When FRAP experiments were performed on cells 
containing  E1A E4  aggregates  and  bundles,  the  results  were  significantly  different 
(N=12).  Early  experiment  attempted  to  look  at  the  recovery  of an  E1A E4  “keratin 
bundles” by bleaching a hole into the structures.  Recovery of the bleached region could 
not be measured properly as the bleached regions were hidden from view, as the objects 
changed shape and folded in on themselves or rotated (see movie YFP-E1A E4.4). When 
FRAP  experiments were performed on E1A E4  aggregates,  aggregate  morphology  did 
not alter, furthermore virtually very little fluorescence recovery was observed to occur 
over a 2 hour period (Fig 6.12 and 6.13 A-B) (see movie YFP-E1A E4.5). This lack of 
recovery suggests that E1A E4 within aggregate structures is not in a dynamic  state of 
equilibrium and may be irreversibly associated with collapsed keratins in Mallory body­
like structures. The observation of two different E1A E4 recovery rates suggests that the 
association of E1A E4 to keratin filaments is initially transient, but stabilises over time.
6.10.2  Fixation  of  E1AE4  expressing  cells  with  paraformaldehyde 
demonstrates that E1AE4 stabilises keratin filaments.
It  has  previously  been  speculated  that  E1A E4  may  induce  keratin  collapse  by
multimerisation or cross-linking (Wang et a l, 2004).  Data generated in this study has
shown that E1A E4 depletes the soluble pool of keratins over time (see Fig 4.16) and that
keratin filament formation (but not subunit polymerisation) is inhibited, by E1A E4 (see
section 6.7.2).  Furthermore,  FRAP  analysis has  demonstrated that,  although ElA E4’s
association to keratin is initially transient, E1A E4 association appears to stabilise over
time, possibly via a process of multimerisation as previously  suggested (Wang et al.,
2004). This process may result in the stabilisation of keratin filaments. To examine this
hypothesis,  SiHa  cells  were  transfected  with  HPV  16  E1A E4  and  fixed  with
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paraformaldehyde,  which  disrupts  keratin  filaments  (See  Fig  3.3).  ElA E4-associated 
keratin  structures were found to be resistant to paraformaldehyde  induced disruption, 
whereas no filamentous keratin could be observed in E1A E4 negative neighbouring cells 
(Fig 6.14).  This observation supports the hypothesis that E1A E4 association stabilises 
keratin  filaments  and  may  lead  to  the  contrasting  methods  of  keratin  disruption 
observed in vitro and in vivo.
6.11 Discussion
The  YFP-E1A E4  fusion protein  generated  for this  study  was  shown to  behave  in  an 
identical fashion to the wild type E1A E4 protein in all respects except that it lacked the 
ability to associate with mitochondria. For the purpose of this study this loss of function 
was beneficial as it was discovered that the protein was unable to form solid structures 
in the absence of keratin. This finding is significant as the LLXLL motif required for 
keratin binding is also required for the association with mitochondria (Raj et a l, 2004), 
demonstrating  that  separate  domains  are  required  for  mitochondrial  and  keratin 
association, or that binding occurs by a different mechanism and that the YFP-protein 
causes steric hindrance. Therefore, YFP-E1A E4 may be used to investigate the apoptotic 
properties of E1A E4 in the absence of mitochondrial association.
Initial experiments expressing YFP-E1A E4 in AK 8 cells expressing CFP keratin were 
abandoned due to the poor resolution of keratin filament in the cells and the high levels 
of phototoxicity produced by multiple exposures of high energy excitation wavelengths 
required to visualise CFP.
The  transfection  of GFP  keratin  13  into  SiHa  cells  allowed  the  visualisation  of the
keratin network, which were found to behave as previously described (Windoffer et a l,
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Figure 6.14 E1AE4 protects keratin filaments from paraformaldehyde mediated 
disruption
SiHa cells were transfected with wild type E1A E4 and fixed with 5 % paraformaldehyde 
(5 min) 24 h post transfection. Paraformaldehyde fixation does not disrupt the 
interaction between E lA E4 and keratin in either filamentous or condensed E1A E4 
structures (A-C)  Higher magnifications of these cells (regions indicated by arrows A) 
show that no intact keratin filaments can be observed in El A E4 negative cells (D-F. 
region indicated by large arrow A), conversely E1A E4 associated keratin filaments 
(regions indicated by small arrow A) are intact and not disrupted by paraformaldehyde 
(G-I). Scale bars denote 5 pm.
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1999). Expression of YFP-E1A E4 in SiHa cells demonstrated that E1A E4 appears not to 
initially inhibit keratin polymerisation and filament formation. Despite this observation, 
at early time points, it would appear that keratin filament formation is disrupted at the 
point  of keratin  network  collapse,  for  reasons  that  will  be  discussed  later.  E1A E4 
association  did  not  appear  to  directly  inhibit  the  inward  directed  motion  of keratin 
filaments  that  appears  to  be  responsible  for  the  collapse  and  perinuclear  location  of 
collapsed keratin filaments (see Fig 6.8 and 6.9).
FRAP experiments demonstrated that E1A E4 recovery occurs at a different rate and by a 
different mechanism than keratin recovery. E1A E4 is able to bind to polymerised keratin 
filaments;  this binding  is  initially transient.  As  E1A E4  filaments  collapse  and  E1A E4 
aggregate structures form, E1A E4 binding appears to stabilise the keratin network. The 
percentage  recovery  of E1A E4  fluorescence  varies,  suggesting  that the  percentage  of 
stably  bound  E1A E4  may  increase  at  latter  time  points  as  filaments  collapse.  It  is 
thought  that  the  stable  binding  of  E1A E4  to  keratins  filaments  may  stabilise  the 
filaments. This hypothesis is supported by the finding that E1A E4 association is able to 
protect filaments against paraformaldehyde mediated disruption and by the observation 
that keratin filament architecture  cannot be  altered when it is E1A E4  bound  (see  Fig 
6.1 OB and 6.1 IB).
From observations made  in this chapter it is possible to  speculate  about how E1A E4 
association with  keratin  can result  in the two  contrasting  events  seen  in  vivo  and  in 
vitro.  Although initially transient,  as E1A E4  levels build up on keratin  filaments  and 
binding stabilises (possibly by multimerisation, as previously suggested) (Wang et al.,
2004), it is possible that the concentration of E1A E4 on keratin filaments may nucleate
243Chapter 6 The effect of E1A E4 on cvtokeratin network dynamics
multimerisation reactions. The binding of E1A E4 stabilises the keratin filaments; which 
would prevent the disassembly  of filaments as they migrate to the centre  of the cell. 
Inhibition of filament disassembly would result in a depletion of the soluble keratin pool 
as observed in figure 4.16.  As the pool is depleted no new materials are available for 
incorporation into new filaments (approximately 2 % of total keratin is synthesised per 
h (Windoffer et al., 2004)), which are continually moved inwards by actin (Woll et a l,
2005). This inward movement causes networks to pull away from the edge of the cell 
and collapse.  It is  likely that this process puts mechanical  stress on filaments,  which 
results in their becoming phosphorylated and ubiquitinated,  as observed  in vitro  (see 
chapter 4). The finding that keratin collapse occurs at the same rate as inward directed 
keratin migration,  suggests that it is dependent on network dynamics,  which explains 
why  keratin  filament  collapse  is  rarely  observed  in  vivo.  Differentiation-dependent 
cross-linking  and  modifications  that  keratins  undergo  within  tissue  probably  inhibits 
inward keratin dynamics in vivo. The build up of E1A E4 in vivo may also put stress on 
networks  resulting  in  their  disruption,  whether  this  process  results  in  keratin 
ubiquitination and subsequent degradation remains unclear.
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7  Final Discussion
7.1  Specific  functions  are  conserved  to  different  degrees 
between divergent E1AE4 proteins
E1A E4 proteins from different HPV types are very divergent at the amino acid level, 
raising the question as to whether they perform a similar role in the virus life cycle and 
if so whether this achieved by similar modes of action. Preliminary analysis of E1A E4 
proteins from several a-group HPV types (including HPV types 2,  16,  18, 31, 35 and 
45), and two y-group viruses (HPV 4 and 65), has shown that the E1A E4 proteins of all 
possess an ability to associate with the cell cytoskeleton. Several reports suggested that 
this function also extends to the E1A E4 proteins of the p,-group HPV viruses (Doorbar et 
al.,  1996;  Roberts et a l,  1993;  Rogel-Gaillard  et al.,  1992b).  Despite this  conserved 
ability, significant differences still exist between different groups. The a-group E1A E4 
proteins are able to bind and disrupt the keratin networks of cells in culture, with the 
HPV  16  E1A E4  protein  having  the  ability  to  bind  and  disrupt  the  keratin  network 
expressed  in  HaCat  cells  in  a keratin  subtype  independent  manner.  HPV  1   E1A E4, 
which is a p,-group HPV type,  has been reported to bind keratins transiently,  without 
inducing  collapse,  before  forming  aggregates  (Doorbar  et  al.,  1996;  Roberts  et  al., 
1993).  The y-group viruses, HPV 4 and 65  were  shown here to bind to microtubules 
when  expressed  in  SiHa  cells  but  have  since  been  shown  to  have  the  capacity  to 
associate with the differentiation-dependent keratin 4/13  networks when expressed  in 
NIKS  cells,  although  no  network  collapse  was  observed  (personal  communication, 
Woei Peh).
The  expression  profile  of E1A E4  proteins  in  lesions  may  explain  the  differences  in 
keratin binding observed in vitro. The expression of HPV 16 E1A E4 in vivo varies in its
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timing,  and  can  occur  before  or  after  the  first  appearance  of  the  differentiation- 
dependent  keratin  4/13  network  in  lesions  (personal  communication,  John  Doorbar), 
with reorganisation of the assembled network occurring in the ElA E4-expressing cells. 
It appears that the a-group E1A E4 proteins may have evolved the ability to target and 
disrupt  the  terminally  differentiated  keratin  network  after  formation  (which  may  be 
reinforced by covalent cross linking),  which is likely to be necessary considering the 
late onset of E1A E4 expression in the  a virus lifecycle (Middleton et al., 2003; Peh et 
al.,  2002).  HPV  1   E1A E4 also has the  ability to  bind keratin but lacks the  ability to 
collapse  or  reorganise  pre-existing  intact  networks  in  vitro  (Roberts  et  al.,  1993). 
Interestingly HPV1  E1A E4 expression occurs much lower down in the epithelium, and 
the differentiation-dependent keratin 1/10 network does not establish itselves in HPV  1  
ElA E4-positive  cells  (Breitburd  et al.,  1987;  Doorbar  et al.,  1997).  This  observation 
may indicate that HPV1 E1A E4 expression is able to disrupt the keratin 1/10 network as 
it  is  formed  (and  thus  inhibits  network  assembly),  possibly  by  preventing  the 
polymerisation of Kl/10 subunits.
The absence  of differentiation-dependent keratins has also been observed  in HPV  65 
lesions  (personal  communication,  John  Doorbar),  in which  E1A E4  expression  occurs 
close to  the  basal  layer.  Selective  targeting  of differentiation-dependent keratins  by 
HPV  65  may  allow  early  E1A E4  expression  without  compromising  the  mechanical 
integrity of the cells in these layers, which are expressing K5/14 networks, that are lost 
anyway  during  differentiation.  If this  hypothesis  is  correct,  it  may  be  that  E1A E4 
proteins maintain the ability to disrupt keratin networks by subtly different mechanisms, 
depending on the region of epithelium where late events are triggered.
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Although the  reasons  for the  cytokeratin interactions have  not yet been conclusively 
demonstrated,  it is reasonable to speculate that keratin disruption may facilitate virion 
release,  and  that  the  protein  has  a  role  that  has  been  conserved  during  evolution. 
Although less well understood, the association with mitochondria was observed in all 
a-group  viruses  examined,  but  not  observed  amongst  the  E1A E4  proteins  of  the 
y-group  viruses,  suggesting  that  this  may  be  a  more  recently  evolved  function.  By 
contrast  Cyclin  B  association  (as  visualised  by  immunofluorescence)  was  not  even 
conserved across all members of the a-group viruses.  In addition to this, the y-group 
E1A E4  proteins  were  shown  to  associate  with  microtubules  in  the  absence  of 
differentiation-dependent  keratins.  Amongst  the  viruses  examined  here,  this  function 
was unique to y-group proteins. Although its purpose is unknown, it may facilitate cell 
cycle  arrest  in  the  absence  of a  cyclin-binding  domain,  in  order  to  facilitate  viral 
genome amplification. The fact that most functions are not conserved between E1A E4 
proteins from different phylogenetic groups suggests that the highly conserved ability of 
the  E1A E4  proteins  to  interact  with  keratins  may  be  essential  for  the  successful 
completion of the papillomavirus lifecycle.
7.2  The disruption of keratins in vivo and in vitro
The  ability  of the  HPV  16  E1A E4  proteins  to  disrupt  keratins  in  vitro  was  further 
investigated in order to better understand the processes involved. The analysis of cells 
expressing keratin 4/13  networks would have been ideal for this work, but due to the 
limited  amount  of  molecular  information  available  on  these  networks  SiHa  cells 
expressing the better studied keratin 8/18 network were used instead.
E1A E4 has previously  been reported to  induce the collapse  of the  keratin network in 
SiHa cells (Wang et a l, 2004). This ability has also been demonstrated in HaCat cells,
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which express more robust,  differentiation-dependent keratins.  Although the network 
present in HaCat cells was more resistant to network reorganisation, collapse was in fact 
generally  observed,  suggesting  that  16  E1A E4  has  the  ability  to  associate  with  and 
induce collapse of, multiple types of intact keratin network. This finding suggests that 
the lack of apparent network collapse in vivo cannot simply be attributed to the presence 
of certain types of keratin network and indicates that other factors may be responsible 
for the observed differences.
Western  blotting  and  immunofluorescence  studies  were  able  to  demonstrate  the 
presence of highly phosphorylated keratins in vitro following E1A E4 expression.  Some 
evidence that phosphorylated keratins accumulate in cells expressing 16 E1A E4 was also 
obtained from in vivo studies.  However, the antibodies used in the study were specific 
for  keratins  8  and  18,  and  it  was  uncertain  whether  the  phosphorylation  of 
differentiation-dependent keratins also took place. 2D gel electrophoresis of HaCat cell 
lysates and/or tissue extracts may be able to answer these questions.  Western blotting 
analysis of cell extracts revealed that HPV  16 E1A E4 expression induced the formation 
of high molecular weight keratin ladders.  The use of proteasome inhibitors, IP assays 
and isopeptidase demonstrated that the keratin ladders were caused by the ubiquitination 
of keratin species. The molecular mass of the ladders (which indicated conjugation of 
more  than  4  ubiquitin  molecules),  coupled  with  the  results  from  experiments  using 
proteasome  inhibitors,  suggested  that  keratins  were  being  targeted  for  proteasome- 
mediated  degradation  by  E1A E4.  Interestingly,  the  accumulation  of  ubiquitinated 
keratins, also appeared to induce proteasome inhibition, which has also been reported 
for other protein aggresomes (Bence et a l, 2001; Bennett et al., 2005). Although it has 
been  speculated  that  proteasome  inhibition  may  occur  in  the  presence  of  keratin
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aggresomes  (Janig  et  a l,  2005),  this  has  not  previously  been  experimentally 
demonstrated. The effect on proteasome activity was not investigated in vivo, but such a 
function may  allow the  build  up  of viral  proteins  in the  upper  epithelial  layers,  and 
could play a role in the completion of virus life cycle. The immunofluorescence studies 
have also demonstrated that E1A E4 staining coincides with ectopic ubiquitin expression 
in HPV 2 and 16 lesions, but it was not possible to show conclusive evidence for keratin 
ubiquitination in vivo. Even so, initial experiments were able to identity the presence of 
a high molecular weigh ubiquitin species in extracts from lesions, and this now warrants 
further investigation.
7.3  The involvement of the conserved  LLXLL motif in  keratin 
disruption
Experiments using the mutant M2  16 E1A E4 protein, which lacks the highly conserved
LLXLL keratin binding motif, demonstrated that although keratin binding was initially
greatly reduced, the protein still maintained the ability to bind and disrupt the keratin
network  at  later  time  points.  Despite  this  ability  to  disrupt  keratin  networks,  no
elevation in keratin biochemical modifications was observed when compared to  P-Gal
control  cells,  even  at  late  time  points.  Keratins  undergo  biochemical  modifications
during  cell  cycle  progression  (specifically  increased  phosphorylation  (Liao  et  a l,
1995)). Therefore, it is important to distinguish keratin modifications that may occur as
a result of ElA E4-induced cell cycle arrest (Davy et al., 2002), from those induced by
ElA E4’s  interaction  with  keratins.  The  work  presented  here  suggests  that  keratin
ubiquitination  and  phosphorylation  are  not  a  down-stream  consequence  of  E1A E4-
induced cell cycle arrest, but that it occurs as a result of the direct interaction between
E1A E4 and keratins. Furthermore, it was noticed that the disruption of keratins by M2
E1A E4  occurred by  a slightly  different mechanism than was  seen with the  wild type
protein.  The  percentage  of  M2  E1A E4  protein  colocalising  with  keratin  gradually
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increased over time, and gradually damaged the networks. In contrast, wild type E1A E4 
appears  to  associate  directly  with  keratin  networks,  saturating  them  and  inducing 
network  collapse.  These  observations  may  suggest that the  mechanism  of wild  type 
E1A E4 induced keratin disruption, which involves the highly conserved LLXLL motif, 
promotes the phosphorylation and ubiquitination of affected keratin.  This observation 
may suggest that the LLXLL domain conserved though out the a-group E1A E4 proteins, 
may specifically disrupt keratins in a manner that promotes the proteolytic degradation 
of affected networks.
7.4  The  timing  of  keratin  disruption  may  be  important  for 
completion of the virus lifecycle.
Quantitative  imaging  of HPV  16  lesions  showed  that  E1A E4  levels  rise  towards  the
surface of the tissue and that they correlate with specific events in the virus lifecycle.
Relatively low levels of E1A E4 were found in MCM-positive cells, where viral genome
amplification has been reported to occur (Doorbar et al.,  1997; Middleton et al., 2003).
Significantly higher E1A E4 levels were found to coincide with cells expressing the LI
capsid protein, where viral packaging is believed to occur. E1A E4 levels appeared to rise
still  further  after  the  onset  of  LI  expression,  indicating  the  possible  activation  of
additional protein functions. Cells expressing very high levels of E1A E4 displayed low-
level or disrupted keratin staining,  and in some  cases ectopic ubiquitin staining.  This
finding suggests that the keratin-disrupting function of E1A E4 is carefully controlled by
the  virus,  and  is  only  activated  after  viral  genome  amplification  and  packaging  has
occurred.  This  timing  may  be  important  for  the  successful  completion  of the  virus
lifecycle, as keratin disruption could otherwise cause the untimely shedding of affected
tissue  as  seen  in  the  skin  blistering  disease  EBS  (Coulombe  et  al.,  1991).  The
deregulation  of  E1A E4  induced  keratin  damage  could  lead  to  blistering  and  skin
damage,  and  may  prevent  successful  completion  of the  virus  lifecycle.  Interestingly
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HPV 2 lesions, which express E1A E4 and LI  much lower in the tissue than is seen in 
HPV  16 lesions, show a slightly different pattern of E1A E4 expression. HPV 16 lesions 
show relativity solid regions of E1A E4 expression but only at the surface of lesions, and 
it may be that its role is to damage the top few cell layers in order to allow the release of 
mature virions. HPV2 lesions show a much more sporadic presence of ElA E4-positive 
cells throughout the lesion. This may weaken individual cells in order to facilitate virion 
release, without significantly compromising the mechanical strength of the tissue. This 
may be particularly important, as the damaging of tissue normally subject to mechanical 
stress  may  cause  infected  sites  to  be  shed  away  (i.e.  blisters  or  ulcers  may  form 
exposing the dermis which cannot harbour the virus) before the virus has completed its 
lifecycle.
7.5  The  hypothesis  of  E1AE4-induced  keratin  filament 
stabilisation can help to explain the differences observed 
in vivo and in vitro
Data generated by time lapse analysis of YFP-labelled E1A E4 was able to provide some 
insight as to the mechanism of ElA E4-induced keratin disruption,  and may provide  a 
partial explanation for the different patterns of keratin disruption that are seen in vivo 
and in vitro. The experiments showed that E1A E4 expression did not initially inhibit the 
formation  of keratin  filaments  at  the  cell  edge,  suggesting  that  16  E1A E4  does  not 
necessarily  directly  inhibit  keratin  polymerisation.  Following  continued  E1A E4 
expression,  filament  formation  eventually  ceases  at  the  point  of  keratin  network 
collapse.  ElA E4-associated keratin networks collapse inwards at a rate comparable to 
that  observed  for  the  inward  movement  of  GFP-labelled  keratin  filaments.  This 
indicates that E1A E4 association may not necessarily disrupt the inward movement of 
keratin  filaments,  which  occurs  through  contacts  with  other  components  of  the 
cytoskeleton (microtubules and actin)  (Woll et al,  2005).  FRAP experiments showed
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that  in  cells  containing  GFP-keratin  13  labelled  networks,  fluorescence  recovery  of 
bleached regions took place over ~ 2h. The process involved new fluorescent filaments 
migrating  into  the  bleached  region,  demonstrating  that  keratin  subunits  can  only 
incorporate  into  filaments  at  the  cell  edge  as  previously  reported  (Windoffer  et  al, 
2004).  E1A E4 fluorescence recovery occurred by a different mechanism showing that 
E1A E4  can  associate with polymerised keratin  filaments  and  is  not just  incorporated 
during  filament  formation.  Fluorescence  recovery  was  uniform  over  the  bleached 
region, suggesting that E1A E4 association to keratin is initially transient, with complete 
turn  over  occurring  in  approximately  30  min.  By  contrast,  very  little  recovery  was 
observed in E1A E4 aggregates over 2 h. Although the rate of recovery of filamentous 
E1A E4 was very consistent, the extent to which recovery restored to pre-bleach levels 
varied.  These observations may  suggest that E1A E4  is associated with keratin  in two 
different  states.  E1A E4  is  predominantly  bound  irreversibly  (or  with  higher  binding 
affinity)  in  keratin  aggregates,  whereas  >50%  of E1A E4  appeared  to  be  transiently 
bound to filamentous structures. This finding is compatible with the hypothesis that 16 
E1A E4 may multimerise or polymerise on keratin filaments (Wang et al., 2004) in order 
to cause keratin disruption towards the surface of the lesion.  In undifferentiated cells, 
keratin networks  are  highly  dynamic  (Windoffer et al,  1999),  and  E1A E4  associates 
with and stabilises keratin filaments that migrate to the centre of the cell. High affinity / 
multimeric  E1A E4  binding  may  prevent  keratin  filaments  from  disassembling  and 
returning to the soluble factions (Fig 7.1). This would result in depletion of the soluble 
keratin pool as was observed in keratin fractionation experiments (seen in section 4.10.5 
and (Wang et al,  2004)).  Depletion of the  soluble keratin fraction would eventually 
prevent the formation of new keratin filaments, causing networks to rip away from the
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Figure 7.1 The mechanism of 16 E1AE4 induced keratin networks disruption
In a normal cell keratin tetramers (green) assemble into filaments at the cell edge, and 
gradually migrate towards the centre o f the cells where they disassemble and are 
subsequently transported along microtubules back to the cell edge,  where they are 
reincoiporated  into new filaments.  As E1AE4 (red) levels begin to elevate, keratin 
binding is transient and the cycle o f keratin filaments formation is not initially 
disrupted. As E1AE4  levels build  up, binding begins to stabilise.  This in turn stabilises 
keratin filaments which continue to migrate inwards  Stable E1AE4 binding prevents 
keratin filaments from disassembling at the centre o f the cell depleting the soluble pool 
of keratin that is required for new filament formation. W hen the soluble pool o f keratin 
drops below a certain threshold, new filaments cannot form.  Peripheral  filaments 
continue to migrate inwards causing them to rip away from the cell edge.  Keratins end 
up in peri-nuclear aggregates containing El AE4 and  highly phosphorylated and 
ubiquitinated keratins.
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edge of the cell as peripheral filaments continue to migrate inwards, leading ultimately 
to network collapse, as seen in vitro (Fig 7.1).
This hypothesis is supported by the finding that 16 ElA E4-binding protected the keratin 
network  from  paraformaldehyde-mediated  disruption,  which  normally  destroys  the 
filamentous appearance of keratins as visualised by immunofluorescence staining. The 
ability of the 4 and 65 E1A E4 proteins to protect microtubules from paraformaldehyde- 
mediated  disruption  (see  Fig  3.3  and  3.5)  may  indicate  that  cytoskeletal  filament 
stabilisation  is  a  conserved  mechanism  that  is  employed  by  E1A E4  proteins  from 
evolutionary divergent viruses.
The same mechanism that is seen in vitro is also  likely to be employed by  E1A E4 in 
vivo,  but due to the differentiation-dependant cross-linking modifications that reinforce 
keratin  networks  in  vivo  (e.g.  filaggrin  binding,  disulphide  bonding  and 
transglutaminase  linkage),  it is likely that the networks are much less dynamic.  This 
would  explain  why  perinuclear  keratin  collapse  is  rarely  observed  in  vivo.  The 
observation that E1A E4 can occasionally cause perinuclear keratin reorganisation in vivo 
(Doorbar  et  al,  1997;  Wang  et  al.,  2004)  may  reflect  the  presence  of  poorly 
differentiated  cells  containing  dynamic  keratin  networks.  By  contrast  when  keratin 
disruption  observed  in  the  upper  layers  of  the  epithelium,  keratins  are  either 
undetectable suggesting that they may have been degraded, or are seen to reorganise to 
the cell periphery.  The high affinity binding or multimerisation of E1A E4  on keratin 
filaments  in  vivo  may  put  networks  under  mechanical  stress  which  may  damage 
networks and lead to their reorganisation. Reorganisation of filaments to the cell edge, 
as opposed to the perinuclear region, may also reflect the differentiation-dependent up-
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regulation  of desmosomes,  which  tightly  anchor  keratin  networks  to  the  epidermal 
junctions between cells (Amemann et al,  1993; Presland et al,  2002). Expression of 
E1A E4 in a keratinocyte cell line such as NIKS, followed by differentiated in semi-solid 
methyl cellulose media, could be used to test this hypothesis.
7.6  In summary
This  study  has  been  able  to  demonstrate  the  ability  of multiple  E1A E4  proteins  to 
interact  with  the  cell  cytoskeleton,  and  more  specifically,  the  keratin  network.  This 
suggests a general need amongst papillomaviruses to disrupt keratin networks,  which 
would  otherwise  present  a  barrier  that  hinders  virion  release  (Dohner  et  a l,  2005; 
Seksek  et  a l,  1997).  Keratin  disruption  has  been  observed  to  occur  by  different 
mechanisms (e.g. enzymatic cleavage (Chen et a l, 1993) and phosphorylation followed 
by subsequent  ubiquitination (Murata et a l, 2002)), by other viruses infecting epithelial 
tissue. It is believed that the association of E1A E4 to keratin filaments may stabilise the 
affected  filaments,  possibly  by  E1A E4  multimerisation.  In  vitro,  this  results  in  the 
perinuclear  collapse  of the  affected  networks,  and  leads  to  the  phosphorylation  and 
ubiquitination of keratins. In vivo networks appear to reorganise to the edge of the cell 
and may be  subsequently degraded,  allowing progeny virions to be released into the 
environment.
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Appendix I
Image shows the HPV 2 lesion used in section 5.5, that was cut in half, half was used 
for biochemical analysis and the other half was section and stained.  Image shows lesion 
stained for keratin (red), E1AE4 (green) and DNA (DAPI, Blue). The image was created 
by taking multiple images on a deltavision microscope using a 20 X objective lens and 
stitching them together to produce a composite image of the lesion.
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Appendix II
Image shows the HPV 2 lesion used in section 5.5, that was cut in half, half was used 
for biochemical analysis and the other half was section and stained.  Image shows lesion 
stained for Ubiquitin (red), El AE4 (green) and DNA (Blue). The image was created by 
taking multiple images on a deltavision microscope using a 20 X objective lens and 
stitching them together to produce a composite image of the lesion.
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Appendix III
Image shows the HPV 2 lesion used in section 5.5, that was cut in half, half was used 
for biochemical analysis and the other half was section and stained.  Image shows lesion 
stained LI  (red), E lA E4 (green) and DNA (Blue)  The image was created by taking 
multiple images on a deltavision microscope using a 20 X objective lens and stitching 
them together to produce a composite image of the lesion.
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pEYFP-C1 Vector Information
fcoO109l
(3854)
PT3176-5 
Catalog #6005-1
CMV  IE
HSVTK
pEYFP-C1
4.7 kb
SV40 on
Nhe I (592)
EcoM III (597) 
Age I (601)
fiS /G  I (1323)
MCS
(1330- 1417)
Afl II (1638)
TAC AAG TCCGGA CTC AGATCTCGA GCT CAA GCT TCG AAT TCT GCA GTCGAC GCT ACC CCGGGCCCG GGATCC ACC GGA TCT~AGA TO C TG ATC A 
Bsp£1
IJ90
69/II  Jftol  X  Hind I  S a c   I  
£c/136 II
fcoRI Sal I  Kpn I  7  4/mI  x  S.wnHI
Acct  <4sp71l I I   &p120l  Xmal
Sac II  Smal
x/w r Sc/I*
Restriction map and multiple cloning site (MCS) of pEYFP-C1. All restriction sites are shown are unique  The Xba I and
Bel I  sites (*) are methylated m the DNA provided by BD Biosciences Clontech. If you wish to digest the vectors with these 
enzymes, you will need to transform the vector into a danr host and make fresh DNA.
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Plasmid map was obtained from
http://orders, clontech. co m/clo ntech/techinfo/vectors_dis/pEYFP-C l .shtml
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